Mark N Lampert - Insider Trading Tracker

कैलिथेरा बायोसाइंसेज, इंक.

US ˙ OTCPK ˙ US13089P5070

परिचय

यह पृष्ठ Mark N Lampert के ज्ञात इनसाइडर व्यापार इतिहास का व्यापक विश्लेषण प्रदान करता है। इनसाइडर किसी कंपनी के अधिकारी, निदेशक या महत्वपूर्ण निवेशक होते हैं। इनसाइडर के लिए विशिष्ट, गैर-सार्वजनिक जानकारी के आधार पर अपनी कंपनियों में व्यापार करना गैरकानूनी है। इसका मतलब यह नहीं है कि उनके लिए अपनी कंपनियों में कोई भी व्यापार करना गैरकानूनी है। हालाँकि, उन्हें फॉर्म 4 के माध्यम से SEC को सभी ट्रेड्स की रिपोर्ट करनी होगी। इन प्रतिबंधों के बावजूद, अकादमिक शोध से पता चलता है कि इनसाइडर - सामान्य तौर पर - अपनी कंपनियों में बाजार से बेहतर प्रदर्शन करते हैं।

औसत व्यापार लाभप्रदता

औसत ट्रेड लाभप्रदता पिछले तीन वर्षों में इनसाइडर द्वारा की गई सभी खुले बाजार खरीद का औसत रिटर्न है। इसकी गणना करने के लिए, हम 10b5-1 ट्रेडिंग योजना के हिस्से के रूप में चिह्नित सभी ट्रेडों को छोड़कर, इनसाइडर द्वारा की गई प्रत्येक खुले बाजार, अनियोजित खरीदारी की जांच करते हैं। फिर हम 3, 6 और 12 महीनों में उन ट्रेडों के औसत प्रदर्शन की गणना करते हैं, प्रत्येक ट्रेड के लिए अंतिम प्रदर्शन मीट्रिक तैयार करने के लिए उनमें से प्रत्येक अवधि का औसत निकालते हैं। अंत में, हम इनसाइडर के लिए प्रदर्शन मीट्रिक की गणना करने के लिए सभी प्रदर्शन मीट्रिक का औसत निकालते हैं। इस सूची में केवल उन इनसाइडर को शामिल किया गया है जिन्होंने पिछले दो वर्षों में कम से कम तीन ट्रेड किए हैं।

यदि इस इनसाइडर ट्रेड की लाभप्रदता "N/A" है, तो इनसाइडर ने या तो पिछले तीन वर्षों में कोई खुले बाजार में खरीदारी नहीं की है, या उनके द्वारा किए गए व्यापार एक विश्वसनीय प्रदर्शन मीट्रिक की गणना करने के लिए बहुत हाल के हैं।

अपडेट फ्रीक्वेंसी: दैनिक

सर्वाधिक लाभदायक इनसाइडर व्यापारियों की सूची देखें।

उच्चतम रैंकिंग वाले इनसाइडर देखें

रिपोर्ट की गई इनसाइडर स्थिति वाली कंपनियाँ

SEC फाइलिंग से संकेत मिलता है कि Mark N Lampert ने निम्नलिखित कंपनियों में होल्डिंग्स या ट्रेड्स की सूचना दी है:

प्रतिभूति	टाइटल	नवीनतम रिपोर्ट की गई होल्डिंग्स
US:EPIX / ESSA Pharma Inc.	10% Owner	560,797
US:KYMR / Kymera Therapeutics, Inc.	Director	353,412
	10% Owner	62,383
US:XOMA / XOMA Royalty Corporation	10% Owner	1,267,545
US:ALLK / Allakos Inc.	10% Owner	0
US:OLMA / Olema Pharmaceuticals, Inc.	Director	347,970
		38,961
US:FDMT / 4D Molecular Therapeutics, Inc.		87,911
US: / Third Harmonic Bio, Inc.		176,692
US:MLTX / MoonLake Immunotherapeutics	Director, 10% Owner	1,287,768
US:ELDN / Eledon Pharmaceuticals, Inc.	10% Owner	220,460
	Director	0
US:PNT / POINT Biopharma Global Inc.		0
US:RPTX / Repare Therapeutics Inc.	10% Owner	548,938
	10% Owner	1,204,412
US:CTIC / CTI BioPharma Corp	Director, 10% Owner	0
US:GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)	10% Owner	0
US:CGEM / Cullinan Therapeutics, Inc.	10% Owner	64,161
US:VSTM / Verastem, Inc.	10% Owner	10,753,294
US:MRUS / Merus N.V.	10% Owner	232,747
	10% Owner	3,372,098
US:INFI / Infinity Pharmaceuticals Inc.	10% Owner	534,847
US:IDYA / IDEAYA Biosciences, Inc.		233,150
US:CTMX / CytomX Therapeutics, Inc.	10% Owner	2,945,743
US:CYTK / Cytokinetics, Incorporated		463,244
	10% Owner	3,547
US:CALA / Calithera Biosciences, Inc.	10% Owner	480,432
US:CNCE / Concert Pharmaceuticals Inc	10% Owner	169,589
US:IMDZ / Immune Design Corp.	10% Owner	370,391
US:SNDX / Syndax Pharmaceuticals, Inc.	10% Owner	188,746
US:ARQL / ArQule, Inc.	10% Owner	771,305
US:XENE / Xenon Pharmaceuticals Inc.	10% Owner	238,000
US:RGLS / Regulus Therapeutics Inc.	10% Owner	17,248,837
US:CAPS / Capstone Holding Corp.		890,487
US:NVLS / Nivalis Therapeutics, Inc.	10% Owner	201,811
US:ONTY / Oncothyreon, Inc.	Director, 10% Owner	6,197
US:CCXI / ChemoCentryx Inc		0
US:04269XAA3 / Array BioPharma Inc. Bonds 3.0% 6/1/2020		7,058,997
US:LGND / Ligand Pharmaceuticals Incorporated		130,175
US:RGDO /		2,632
US:PTN / Palatin Technologies, Inc.	10% Owner	2,494,521
US:RIGL / Rigel Pharmaceuticals, Inc.	10% Owner	646,559
US:TRGT / Targacept	10% Owner	1,713,907

चार्ट को कैसे समझे

निम्नलिखित चार्ट Mark N Lampert द्वारा किए गए प्रत्येक खुले-बाज़ार, गैर-योजनाबद्ध व्यापार के बाद प्रतिभूतियों के स्टॉक प्रदर्शन को दर्शाते हैं। गैर-योजनाबद्ध व्यापार वे व्यापार हैं जो 10b5-1 ट्रेडिंग योजना के हिस्से के रूप में नहीं किए गए थे। स्टॉक प्रदर्शन को शेयर मूल्य में संचयी प्रतिशत परिवर्तन के रूप में चार्ट किया गया है। उदाहरण के लिए, यदि कोई इनसाइडर व्यापार 1 जनवरी, 2019 को किया गया था, तो चार्ट आज तक प्रतिभूति में दैनिक प्रतिशत परिवर्तन दिखाएगा। यदि इस दौरान शेयर की कीमत $10 से $15 तक जाती है, तो शेयर की कीमत में संचयी प्रतिशत परिवर्तन 50% होगा। $10 से $20 तक की कीमत में परिवर्तन 100% होगा, और $10 से $5 की कीमत में परिवर्तन -50% होगा।

अंततः, हम यह निर्धारित करने का प्रयास कर रहे हैं कि इनसाइडर के व्यापार शेयर की कीमत में अतिरिक्त रिटर्न (सकारात्मक या नकारात्मक) से कितनी निकटता से संबंधित हैं, यह देखने के लिए कि क्या इनसाइडर, इनसाइडर जानकारी से लाभ के लिए अपने व्यापार का समय निर्धारित कर रहे हैं। उस स्थिति पर विचार करें जहां कोई इनसाइडर ऐसा कर रहा था। इस स्थिति में, हम या तो (a) खरीदारी के बाद सकारात्मक रिटर्न, या (a) बिक्री के बाद नकारात्मक रिटर्न की उम्मीद करेंगे। (a) के मामले में, खरीद चार्ट ऊपर की ओर झुके हुए वक्रों की एक श्रृंखला दिखाएगा, जो प्रत्येक खरीद लेनदेन के बाद सकारात्मक रिटर्न का संकेत देगा। (a) के मामले में, बिक्री चार्ट नीचे की ओर झुके हुए वक्रों की एक श्रृंखला दिखाएगा, जो प्रत्येक बिक्री लेनदेन के बाद नकारात्मक रिटर्न का संकेत देगा।

हालाँकि, केवल यह निष्कर्ष निकालने के लिए पर्याप्त नहीं है। यदि, उदाहरण के लिए, कंपनी का शेयर मूल्य कई वर्षों से गैर-चक्रीय चढ़ाई में था, तो हम उम्मीद करेंगे कि खरीद के बाद के सभी प्लॉट ऊपर की ओर झुके हुए होंगे। इसी तरह, कई वर्षों में गैर-चक्रीय गिरावट के परिणामस्वरूप व्यापार के बाद के प्लॉट नीचे की ओर झुकेंगे। इनमें से कोई भी चार्ट इनसाइडर व्यापार गतिविधि का सुझाव नहीं देगा।

सबसे मजबूत संकेतक वह स्थिति होगी जहां शेयर की कीमत बेहद चक्रीय थी, और खरीद चार्ट में सकारात्मक संकेत और बिक्री चार्ट पर नकारात्मक प्लॉट दोनों थे। यह स्थिति एक इनसाइडर के लिए अत्यधिक संकेत देने वाली होगी जो अपने वित्तीय लाभ के लिए ट्रेड्स का समय निर्धारित कर रहा था।

इनसाइडर खरीदारी CALA / Calithera Biosciences, Inc. - अल्पकालिक लाभ विश्लेषण

इस अनुभाग में, हम CALA / Calithera Biosciences, Inc. में की गई प्रत्येक अनियोजित, खुले बाज़ार की इनसाइडर खरीदारी की लाभप्रदता का विश्लेषण करते हैं। यह विश्लेषण यह समझने में मदद करता है कि क्या इनसाइडर लगातार असामान्य रिटर्न उत्पन्न करता है, और यह अनुसरण करने लायक है। यह विश्लेषण प्रत्येक व्यापार के बाद एक वर्ष के लिए है, और परिणाम सैद्धांतिक हैं।

निम्न तालिका सबसे हालिया खुले बाज़ार की खरीदारी को दर्शाती है जो स्वचालित ट्रेडिंग योजना का हिस्सा नहीं थी।

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2019-11-20	CALA	BVF PARTNERS L P/IL	98,518	3.9116	4,926	78.2320	385,363	147	157	387,862	100.65
2019-11-20	CALA	BVF PARTNERS L P/IL	79,285	3.9116	3,964	78.2320	310,131
2019-11-20	CALA	BVF PARTNERS L P/IL	14,151	3.9116	708	78.2320	55,353
2019-11-14	CALA	BVF PARTNERS L P/IL	71,495	3.3700	3,575	67.4000	240,938
2019-11-14	CALA	BVF PARTNERS L P/IL	45,888	3.3700	2,294	67.4000	154,643
2019-11-14	CALA	BVF PARTNERS L P/IL	11,105	3.3700	555	67.4000	37,424
2019-10-30	CALA	BVF PARTNERS L P/IL	408,592	2.7000	20,430	54.0000	1,103,198
2019-10-30	CALA	BVF PARTNERS L P/IL	331,048	2.7000	16,552	54.0000	893,830
2019-10-30	CALA	BVF PARTNERS L P/IL	57,868	2.7000	2,893	54.0000	156,244
2019-10-29	CALA	BVF PARTNERS L P/IL	872,373	2.6000	43,619	52.0000	2,268,170
2019-10-29	CALA	BVF PARTNERS L P/IL	610,052	2.6000	30,503	52.0000	1,586,135
2019-10-29	CALA	BVF PARTNERS L P/IL	116,552	2.6000	5,828	52.0000	303,035

समायोजित कीमत विभाजित-समायोजित कीमत है। समायोजित शेयर विभाजित-समायोजित शेयर हैं।

CALA / Calithera Biosciences, Inc. Insider Trades

इनसाइडर बिक्री CALA / Calithera Biosciences, Inc. - अल्पकालिक हानि विश्लेषण

इस अनुभाग में, हम CALA / Calithera Biosciences, Inc. में की गई प्रत्येक अनियोजित, खुले बाज़ार की इनसाइडर बिक्री के अल्पकालिक नुकसान से बचने का विश्लेषण करते हैं। हानि से बचने का एक सुसंगत पैटर्न यह सुझाव दे सकता है कि भविष्य में बिक्री लेनदेन कीमत में गिरावट की भविष्यवाणी कर सकते हैं। यह विश्लेषण प्रत्येक व्यापार के बाद एक वर्ष के लिए है, और परिणाम सैद्धांतिक हैं।

निम्न तालिका सबसे हालिया खुले बाज़ार की बिक्री को दर्शाती है जो स्वचालित ट्रेडिंग योजना का हिस्सा नहीं थी।

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
2020-05-21	CALA	BVF PARTNERS L P/IL	1,027,016	6.0000	51,351	120.0000	6,162,096	354	39.2	-4,149,176	-67.33
2020-05-21	CALA	BVF PARTNERS L P/IL	1,064,332	6.0000	53,217	120.0000	6,385,992
2020-05-21	CALA	BVF PARTNERS L P/IL	192,250	6.0000	9,612	120.0000	1,153,500

इनसाइडर खरीदारी CAPS / Capstone Holding Corp. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

CAPS / Capstone Holding Corp. Insider Trades

इनसाइडर बिक्री CAPS / Capstone Holding Corp. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
2017-07-14	CAPS	BVF PARTNERS L P/IL	3,993,637	0.0600	3,994	60.0000	239,618	182	0.0450	-239,438	-99.93
2017-07-14	CAPS	BVF PARTNERS L P/IL	242,236	0.0600	242	60.0000	14,534
2017-07-14	CAPS	BVF PARTNERS L P/IL	105,713	0.0600	106	60.0000	6,343

इनसाइडर खरीदारी CGEM / Cullinan Therapeutics, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2022-06-01	CGEM	BVF PARTNERS L P/IL	405,641	10.9994	405,641	10.9994	4,461,808	48	15.4200	1,793,177	40.19
2022-06-01	CGEM	BVF PARTNERS L P/IL	301,009	10.9994	301,009	10.9994	3,310,918
2022-06-01	CGEM	BVF PARTNERS L P/IL	44,746	10.9994	44,746	10.9994	492,179
2022-05-13	CGEM	BVF PARTNERS L P/IL	53,598	9.1350	53,598	9.1350	489,618
2022-05-13	CGEM	BVF PARTNERS L P/IL	38,558	9.1350	38,558	9.1350	352,227
2022-05-13	CGEM	BVF PARTNERS L P/IL	17,744	9.1350	17,744	9.1350	162,091
2022-05-12	CGEM	BVF PARTNERS L P/IL	542,999	9.0600	542,999	9.0600	4,919,571
2022-05-12	CGEM	BVF PARTNERS L P/IL	457,001	9.0600	457,001	9.0600	4,140,429
2022-04-01	CGEM	BVF PARTNERS L P/IL	266,598	10.7499	266,598	10.7499	2,865,902
2022-04-01	CGEM	BVF PARTNERS L P/IL	9,402	10.7499	9,402	10.7499	101,071

CGEM / Cullinan Therapeutics, Inc. Insider Trades

इनसाइडर बिक्री CGEM / Cullinan Therapeutics, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी CTMX / CytomX Therapeutics, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

CTMX / CytomX Therapeutics, Inc. Insider Trades

इनसाइडर बिक्री CTMX / CytomX Therapeutics, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी CYTK / Cytokinetics, Incorporated - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2019-12-11	CYTK	BVF PARTNERS L P/IL	60,103	9.5150	60,103	9.5150	571,880	217	28.9600	1,168,703	204.36
2019-12-11	CYTK	BVF PARTNERS L P/IL	49,804	9.5150	49,804	9.5150	473,885
2019-12-11	CYTK	BVF PARTNERS L P/IL	8,506	9.5150	8,506	9.5150	80,935
2019-12-10	CYTK	BVF PARTNERS L P/IL	113,529	9.4000	113,529	9.4000	1,067,173
2019-12-10	CYTK	BVF PARTNERS L P/IL	95,100	9.4000	95,100	9.4000	893,940
2019-12-10	CYTK	BVF PARTNERS L P/IL	15,030	9.4000	15,030	9.4000	141,282

CYTK / Cytokinetics, Incorporated Insider Trades

इनसाइडर बिक्री CYTK / Cytokinetics, Incorporated - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
2020-12-09	CYTK	BVF PARTNERS L P/IL	239,274	18.0000	239,274	18.0000	4,306,932	217	18.5400	129,208	3.00
2020-12-09	CYTK	BVF PARTNERS L P/IL	166,194	18.0000	166,194	18.0000	2,991,492
2020-12-09	CYTK	BVF PARTNERS L P/IL	25,486	18.0000	25,486	18.0000	458,748
2020-02-13	CYTK	BVF PARTNERS L P/IL	486,344	15.7868	486,344	15.7868	7,677,815
2020-02-13	CYTK	BVF PARTNERS L P/IL	510,793	15.7868	510,793	15.7868	8,063,787
2020-02-13	CYTK	BVF PARTNERS L P/IL	74,893	15.7868	74,893	15.7868	1,182,321

इनसाइडर खरीदारी ELDN / Eledon Pharmaceuticals, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	समायोजित शेयर	दिन अधिकतम	मूल्य अधिकतम
2024-05-09	ELDN	BVF PARTNERS L P/IL	1,031,385	1,031,385	176	5.3000
2024-05-09	ELDN	BVF PARTNERS L P/IL	821,121	821,121
2024-05-09	ELDN	BVF PARTNERS L P/IL	75,431	75,431
2023-05-05	ELDN	BVF PARTNERS L P/IL	1,055,445	1,055,445
2023-05-05	ELDN	BVF PARTNERS L P/IL	837,146	837,146
2023-05-05	ELDN	BVF PARTNERS L P/IL	86,341	86,341

ELDN / Eledon Pharmaceuticals, Inc. Insider Trades

इनसाइडर बिक्री ELDN / Eledon Pharmaceuticals, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी EPIX / ESSA Pharma Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर बिक्री EPIX / ESSA Pharma Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
2025-08-05	EPIX	BVF PARTNERS L P/IL	79	1.8779	79	1.8779	148	30	0.2316	-130	-87.64
2025-08-05	EPIX	BVF PARTNERS L P/IL	66	1.8779	66	1.8779	124
2025-08-05	EPIX	BVF PARTNERS L P/IL	11	1.8779	11	1.8779	21

इनसाइडर खरीदारी FDMT / 4D Molecular Therapeutics, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

FDMT / 4D Molecular Therapeutics, Inc. Insider Trades

इनसाइडर बिक्री FDMT / 4D Molecular Therapeutics, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock) - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock) Insider Trades

इनसाइडर बिक्री GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock) - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी IDYA / IDEAYA Biosciences, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2020-06-30	IDYA	BVF PARTNERS L P/IL	1,521	13.3164	1,521	13.3164	20,254	279	24.83	17,512	86.46
2020-06-30	IDYA	BVF PARTNERS L P/IL	929	13.3164	929	13.3164	12,371
2020-06-30	IDYA	BVF PARTNERS L P/IL	81	13.3164	81	13.3164	1,079
2020-06-22	IDYA	BVF PARTNERS L P/IL	10,524	13.9347	10,524	13.9347	146,649
2020-06-22	IDYA	BVF PARTNERS L P/IL	7,854	13.9347	7,854	13.9347	109,443
2020-06-22	IDYA	BVF PARTNERS L P/IL	1,354	13.9347	1,354	13.9347	18,868
2020-06-19	IDYA	BVF PARTNERS L P/IL	52,443	14.3895	52,443	14.3895	754,629
2020-06-19	IDYA	BVF PARTNERS L P/IL	39,052	14.3895	39,052	14.3895	561,939
2020-06-19	IDYA	BVF PARTNERS L P/IL	6,769	14.3895	6,769	14.3895	97,403

IDYA / IDEAYA Biosciences, Inc. Insider Trades

इनसाइडर बिक्री IDYA / IDEAYA Biosciences, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
2021-02-02	IDYA	BVF PARTNERS L P/IL	25,234	18.0000	25,234	18.0000	454,212	359	15.2100	-70,403	-15.50
2021-02-02	IDYA	BVF PARTNERS L P/IL	16,850	18.0000	16,850	18.0000	303,300
2021-02-02	IDYA	BVF PARTNERS L P/IL	4,325	18.0000	4,325	18.0000	77,850

इनसाइडर खरीदारी INFIQ / Infinity Pharmaceuticals, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2018-12-13	INFI	BVF PARTNERS L P/IL	54,461	1.1995	54,461	1.1995	65,326	91	1.9100	38,696	59.24
2018-12-13	INFI	BVF PARTNERS L P/IL	120,539	1.1995	120,539	1.1995	144,587
2018-11-28	INFI	BVF PARTNERS L P/IL	100,000	1.3000	100,000	1.3000	130,000
2018-11-21	INFI	BVF PARTNERS L P/IL	4,119	1.3500	4,119	1.3500	5,561
2018-11-21	INFI	BVF PARTNERS L P/IL	581	1.3500	581	1.3500	784
2018-11-19	INFI	BVF PARTNERS L P/IL	733,151	1.3698	733,151	1.3698	1,004,270
2018-11-19	INFI	BVF PARTNERS L P/IL	556,709	1.3698	556,709	1.3698	762,580
2018-11-19	INFI	BVF PARTNERS L P/IL	81,648	1.3698	81,648	1.3698	111,841
2018-11-19	INFI	BVF PARTNERS L P/IL	50,044	1.3500	50,044	1.3500	67,559
2018-11-19	INFI	BVF PARTNERS L P/IL	38,001	1.3500	38,001	1.3500	51,301
2018-11-19	INFI	BVF PARTNERS L P/IL	5,573	1.3500	5,573	1.3500	7,524
2018-11-15	INFI	BVF PARTNERS L P/IL	52,400	1.3500	52,400	1.3500	70,740
2018-11-15	INFI	BVF PARTNERS L P/IL	39,074	1.3500	39,074	1.3500	52,750
2018-11-14	INFI	BVF PARTNERS L P/IL	117,290	1.3400	117,290	1.3400	157,169
2018-11-14	INFI	BVF PARTNERS L P/IL	92,960	1.3400	92,960	1.3400	124,566
2018-11-13	INFI	BVF PARTNERS L P/IL	41,454	1.3500	41,454	1.3500	55,963
2018-11-13	INFI	BVF PARTNERS L P/IL	562,754	1.3500	562,754	1.3500	759,718
2018-06-21	INFI	BVF PARTNERS L P/IL	230,555	1.6500	230,555	1.6500	380,416
2018-06-21	INFI	BVF PARTNERS L P/IL	158,151	1.6500	158,151	1.6500	260,949
2018-06-21	INFI	BVF PARTNERS L P/IL	36,825	1.6500	36,825	1.6500	60,761
2018-06-19	INFI	BVF PARTNERS L P/IL	1,916,760	1.6500	1,916,760	1.6500	3,162,654
2018-06-19	INFI	BVF PARTNERS L P/IL	1,419,907	1.6500	1,419,907	1.6500	2,342,847
2018-06-19	INFI	BVF PARTNERS L P/IL	179,893	1.6500	179,893	1.6500	296,823
2018-04-10	INFI	BVF PARTNERS L P/IL	546,865	2.0000	546,865	2.0000	1,093,730
2018-04-10	INFI	BVF PARTNERS L P/IL	365,682	2.0000	365,682	2.0000	731,364
2018-04-10	INFI	BVF PARTNERS L P/IL	97,453	2.0000	97,453	2.0000	194,906
2018-04-09	INFI	BVF PARTNERS L P/IL	228,691	1.9000	228,691	1.9000	434,513
2018-04-09	INFI	BVF PARTNERS L P/IL	208,872	1.9000	208,872	1.9000	396,857
2018-04-09	INFI	BVF PARTNERS L P/IL	62,437	1.9000	62,437	1.9000	118,630
2017-10-04	INFI	BVF PARTNERS L P/IL	355,081	1.2840	355,081	1.2840	455,924
2017-10-04	INFI	BVF PARTNERS L P/IL	235,326	1.2840	235,326	1.2840	302,159
2017-10-04	INFI	BVF PARTNERS L P/IL	63,042	1.2840	63,042	1.2840	80,946
2017-10-03	INFI	BVF PARTNERS L P/IL	523,601	1.2350	523,601	1.2350	646,647
2017-10-03	INFI	BVF PARTNERS L P/IL	394,078	1.2350	394,078	1.2350	486,686
2017-10-03	INFI	BVF PARTNERS L P/IL	28,918	1.2350	28,918	1.2350	35,714
2017-01-03	INFI	BVF PARTNERS L P/IL	1,145	1.3397	1,145	1.3397	1,534
2017-01-03	INFI	BVF PARTNERS L P/IL	3,234	1.3397	3,234	1.3397	4,333
2016-12-30	INFI	BVF PARTNERS L P/IL	2,348	1.3396	2,348	1.3396	3,145
2016-12-30	INFI	BVF PARTNERS L P/IL	1,205	1.3396	1,205	1.3396	1,614
2016-12-28	INFI	BVF PARTNERS L P/IL	401,726	1.3356	401,726	1.3356	536,545
2016-12-28	INFI	BVF PARTNERS L P/IL	260,046	1.3356	260,046	1.3356	347,317
2016-12-28	INFI	BVF PARTNERS L P/IL	77,076	1.3356	77,076	1.3356	102,943
2016-12-20	INFI	BVF PARTNERS L P/IL	11,646	1.3549	11,646	1.3549	15,779
2016-12-20	INFI	BVF PARTNERS L P/IL	8,111	1.3549	8,111	1.3549	10,990
2016-12-20	INFI	BVF PARTNERS L P/IL	2,244	1.3549	2,244	1.3549	3,040
2016-12-19	INFI	BVF PARTNERS L P/IL	108,202	1.3584	108,202	1.3584	146,982
2016-12-19	INFI	BVF PARTNERS L P/IL	69,041	1.3584	69,041	1.3584	93,785
2016-12-19	INFI	BVF PARTNERS L P/IL	21,021	1.3584	21,021	1.3584	28,555
2016-12-16	INFI	BVF PARTNERS L P/IL	236,393	1.2800	236,393	1.2800	302,583
2016-12-16	INFI	BVF PARTNERS L P/IL	150,451	1.2800	150,451	1.2800	192,577
2016-12-16	INFI	BVF PARTNERS L P/IL	47,812	1.2800	47,812	1.2800	61,199
2016-12-02	INFI	BVF PARTNERS L P/IL	30,998	1.1901	30,998	1.1901	36,891
2016-12-02	INFI	BVF PARTNERS L P/IL	18,586	1.1901	18,586	1.1901	22,119
2016-12-02	INFI	BVF PARTNERS L P/IL	2,916	1.1901	2,916	1.1901	3,470
2016-12-01	INFI	BVF PARTNERS L P/IL	81,276	1.1845	81,276	1.1845	96,271
2016-12-01	INFI	BVF PARTNERS L P/IL	52,457	1.1845	52,457	1.1845	62,135
2016-12-01	INFI	BVF PARTNERS L P/IL	15,161	1.1845	15,161	1.1845	17,958

INFIQ / Infinity Pharmaceuticals, Inc. Insider Trades

इनसाइडर बिक्री INFIQ / Infinity Pharmaceuticals, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
2021-02-11	INFI	BVF PARTNERS L P/IL	1,215,491	5.3686	1,215,491	5.3686	6,525,485	350	1.1100	-5,176,289	-79.32
2021-02-11	INFI	BVF PARTNERS L P/IL	892,467	5.3686	892,467	5.3686	4,791,298
2021-02-11	INFI	BVF PARTNERS L P/IL	152,127	5.3686	152,127	5.3686	816,709
2021-01-22	INFI	BVF PARTNERS L P/IL	2,821,663	4.1388	2,821,663	4.1388	11,678,299
2021-01-22	INFI	BVF PARTNERS L P/IL	2,458,838	4.1388	2,458,838	4.1388	10,176,639
2021-01-22	INFI	BVF PARTNERS L P/IL	568,019	4.1388	568,019	4.1388	2,350,917

इनसाइडर खरीदारी KYMR / Kymera Therapeutics, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2025-06-30	KYMR	BVF PARTNERS L P/IL	142,604	44.0000	142,604	44.0000	6,274,576	23	46.4300	346,528	5.52
2025-06-30	KYMR	BVF PARTNERS L P/IL	115,783	44.0000	115,783	44.0000	5,094,452
2025-06-30	KYMR	BVF PARTNERS L P/IL	58,780	44.0000	58,780	44.0000	2,586,320
2023-11-03	KYMR	BVF PARTNERS L P/IL	103,885	14.0689	103,885	14.0689	1,461,548
2023-11-03	KYMR	BVF PARTNERS L P/IL	83,708	14.0689	83,708	14.0689	1,177,679
2023-11-03	KYMR	BVF PARTNERS L P/IL	10,106	14.0689	10,106	14.0689	142,180
2023-11-02	KYMR	BVF PARTNERS L P/IL	57,618	11.6444	57,618	11.6444	670,927
2023-11-02	KYMR	BVF PARTNERS L P/IL	132,016	11.6444	132,016	11.6444	1,537,247
2023-11-02	KYMR	BVF PARTNERS L P/IL	26,772	11.6444	26,772	11.6444	311,744
2023-01-12	KYMR	BVF PARTNERS L P/IL	2,985	31.2426	2,985	31.2426	93,259
2023-01-12	KYMR	BVF PARTNERS L P/IL	15,912	31.2426	15,912	31.2426	497,132
2023-01-11	KYMR	BVF PARTNERS L P/IL	10,961	29.8869	10,961	29.8869	327,590
2023-01-11	KYMR	BVF PARTNERS L P/IL	11,149	29.8869	11,149	29.8869	333,209
2022-08-22	KYMR	BVF PARTNERS L P/IL	285,046	26.0000	285,046	26.0000	7,411,196
2022-08-22	KYMR	BVF PARTNERS L P/IL	233,362	26.0000	233,362	26.0000	6,067,412
2022-08-22	KYMR	BVF PARTNERS L P/IL	27,117	26.0000	27,117	26.0000	705,042
2022-05-27	KYMR	BVF PARTNERS L P/IL	35,793	14.7828	35,793	14.7828	529,121
2022-05-27	KYMR	BVF PARTNERS L P/IL	26,353	14.7828	26,353	14.7828	389,571
2022-05-27	KYMR	BVF PARTNERS L P/IL	3,223	14.7828	3,223	14.7828	47,645
2022-05-26	KYMR	BVF PARTNERS L P/IL	123,043	14.2106	123,043	14.2106	1,748,515
2022-05-26	KYMR	BVF PARTNERS L P/IL	90,372	14.2106	90,372	14.2106	1,284,240
2022-05-26	KYMR	BVF PARTNERS L P/IL	10,642	14.2106	10,642	14.2106	151,229
2022-05-20	KYMR	BVF PARTNERS L P/IL	5,883	13.9994	5,883	13.9994	82,358
2022-05-20	KYMR	BVF PARTNERS L P/IL	4,180	13.9994	4,180	13.9994	58,517
2022-05-20	KYMR	BVF PARTNERS L P/IL	37	13.9994	37	13.9994	518
2022-05-06	KYMR	BVF PARTNERS L P/IL	55,210	19.2550	55,210	19.2550	1,063,069
2022-05-06	KYMR	BVF PARTNERS L P/IL	40,659	19.2550	40,659	19.2550	782,889
2022-05-06	KYMR	BVF PARTNERS L P/IL	4,131	19.2550	4,131	19.2550	79,542
2022-05-05	KYMR	BVF PARTNERS L P/IL	75,495	19.5991	75,495	19.5991	1,479,634
2022-05-05	KYMR	BVF PARTNERS L P/IL	70,439	19.5991	70,439	19.5991	1,380,541
2022-05-05	KYMR	BVF PARTNERS L P/IL	4,066	19.5991	4,066	19.5991	79,690
2022-01-31	KYMR	BVF PARTNERS L P/IL	20,085	40.7000	20,085	40.7000	817,460
2022-01-31	KYMR	BVF PARTNERS L P/IL	14,323	40.7000	14,323	40.7000	582,946
2022-01-27	KYMR	BVF PARTNERS L P/IL	58,042	38.3319	58,042	38.3319	2,224,860
2022-01-27	KYMR	BVF PARTNERS L P/IL	37,859	38.3319	37,859	38.3319	1,451,207
2022-01-24	KYMR	BVF PARTNERS L P/IL	158,041	37.7635	158,041	37.7635	5,968,181
2022-01-24	KYMR	BVF PARTNERS L P/IL	114,726	37.7635	114,726	37.7635	4,332,455
2021-07-01	KYMR	BVF PARTNERS L P/IL	304,997	47.0000	304,997	47.0000	14,334,859
2021-07-01	KYMR	BVF PARTNERS L P/IL	211,711	47.0000	211,711	47.0000	9,950,417
2021-07-01	KYMR	BVF PARTNERS L P/IL	27,458	47.0000	27,458	47.0000	1,290,526

KYMR / Kymera Therapeutics, Inc. Insider Trades

इनसाइडर बिक्री KYMR / Kymera Therapeutics, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी MLTX / MoonLake Immunotherapeutics - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

MLTX / MoonLake Immunotherapeutics Insider Trades

इनसाइडर बिक्री MLTX / MoonLake Immunotherapeutics - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
2024-10-04	MLTX	BVF PARTNERS L P/IL	1,030,589	50.0016	1,030,589	50.0016	51,531,099	186	32.8350	-17,691,708	-34.33
2024-10-04	MLTX	BVF PARTNERS L P/IL	836,862	50.0016	836,862	50.0016	41,844,439
2024-10-04	MLTX	BVF PARTNERS L P/IL	132,549	50.0016	132,549	50.0016	6,627,662

इनसाइडर खरीदारी MRUS / Merus N.V. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2021-03-30	MRUS	BVF PARTNERS L P/IL	165,000	19.7500	165,000	19.7500	3,258,750	275	32.29	2,069,100	63.49
2021-03-30	MRUS	BVF PARTNERS L P/IL	108,106	19.7500	108,106	19.7500	2,135,094
2021-03-30	MRUS	BVF PARTNERS L P/IL	26,894	19.7500	26,894	19.7500	531,156
2021-03-22	MRUS	BVF PARTNERS L P/IL	71,756	22.7500	71,756	22.7500	1,632,449
2021-03-22	MRUS	BVF PARTNERS L P/IL	7,744	22.7500	7,744	22.7500	176,176
2021-03-16	MRUS	BVF PARTNERS L P/IL	53,061	22.9996	53,061	22.9996	1,220,382
2021-03-16	MRUS	BVF PARTNERS L P/IL	195,768	22.9996	195,768	22.9996	4,502,586
2021-03-16	MRUS	BVF PARTNERS L P/IL	1,171	22.9996	1,171	22.9996	26,933
2021-01-21	MRUS	BVF PARTNERS L P/IL	457,814	24.7500	457,814	24.7500	11,330,896
2021-01-21	MRUS	BVF PARTNERS L P/IL	343,444	24.7500	343,444	24.7500	8,500,239
2021-01-21	MRUS	BVF PARTNERS L P/IL	43,422	24.7500	43,422	24.7500	1,074,694
2020-12-18	MRUS	BVF PARTNERS L P/IL	114,968	16.0500	114,968	16.0500	1,845,236
2020-12-18	MRUS	BVF PARTNERS L P/IL	45,032	16.0500	45,032	16.0500	722,764
2020-09-15	MRUS	BVF PARTNERS L P/IL	77,751	11.7500	77,751	11.7500	913,574
2020-09-15	MRUS	BVF PARTNERS L P/IL	58,745	11.7500	58,745	11.7500	690,254
2020-09-15	MRUS	BVF PARTNERS L P/IL	10,258	11.7500	10,258	11.7500	120,532
2020-09-10	MRUS	BVF PARTNERS L P/IL	100,461	11.0982	100,461	11.0982	1,114,936
2020-09-10	MRUS	BVF PARTNERS L P/IL	76,374	11.0982	76,374	11.0982	847,614
2020-09-10	MRUS	BVF PARTNERS L P/IL	12,816	11.0982	12,816	11.0982	142,235
2020-09-03	MRUS	BVF PARTNERS L P/IL	104,827	11.1700	104,827	11.1700	1,170,918
2020-09-03	MRUS	BVF PARTNERS L P/IL	82,740	11.1700	82,740	11.1700	924,206
2020-09-03	MRUS	BVF PARTNERS L P/IL	14,339	11.1700	14,339	11.1700	160,167
2020-06-08	MRUS	BVF PARTNERS L P/IL	46,966	15.2000	46,966	15.2000	713,883
2020-06-08	MRUS	BVF PARTNERS L P/IL	33,321	15.2000	33,321	15.2000	506,479
2020-06-08	MRUS	BVF PARTNERS L P/IL	6,967	15.2000	6,967	15.2000	105,898
2020-06-01	MRUS	BVF PARTNERS L P/IL	806,443	14.0000	806,443	14.0000	11,290,202
2020-06-01	MRUS	BVF PARTNERS L P/IL	561,966	14.0000	561,966	14.0000	7,867,524
2020-06-01	MRUS	BVF PARTNERS L P/IL	94,101	14.0000	94,101	14.0000	1,317,414
2020-01-16	MRUS	BVF PARTNERS L P/IL	146,442	16.1500	146,442	16.1500	2,365,038
2020-01-16	MRUS	BVF PARTNERS L P/IL	112,561	16.1500	112,561	16.1500	1,817,860
2020-01-16	MRUS	BVF PARTNERS L P/IL	19,727	16.1500	19,727	16.1500	318,591
2020-01-13	MRUS	BVF PARTNERS L P/IL	53,448	14.9784	53,448	14.9784	800,566
2020-01-13	MRUS	BVF PARTNERS L P/IL	25,108	14.9784	25,108	14.9784	376,078
2020-01-13	MRUS	BVF PARTNERS L P/IL	5,406	14.9784	5,406	14.9784	80,973

इनसाइडर बिक्री MRUS / Merus N.V. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
2021-10-08	MRUS	BVF PARTNERS L P/IL	80,011	27.7865	80,011	27.7865	2,223,226	230	13.9800	-1,104,671	-49.69
2021-10-08	MRUS	BVF PARTNERS L P/IL	58,327	27.7865	58,327	27.7865	1,620,703
2021-10-08	MRUS	BVF PARTNERS L P/IL	8,929	27.7865	8,929	27.7865	248,106
2021-10-07	MRUS	BVF PARTNERS L P/IL	530,999	27.5311	530,999	27.5311	14,618,987
2021-10-07	MRUS	BVF PARTNERS L P/IL	384,914	27.5311	384,914	27.5311	10,597,106
2021-10-07	MRUS	BVF PARTNERS L P/IL	69,534	27.5311	69,534	27.5311	1,914,348
2021-07-02	MRUS	BVF PARTNERS L P/IL	1,106,478	20.7500	1,106,478	20.7500	22,959,418
2021-07-02	MRUS	BVF PARTNERS L P/IL	928,739	20.7500	928,739	20.7500	19,271,334
2021-07-02	MRUS	BVF PARTNERS L P/IL	150,805	20.7500	150,805	20.7500	3,129,204

इनसाइडर खरीदारी OLMA / Olema Pharmaceuticals, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2023-09-12	OLMA	BVF PARTNERS L P/IL	775,278	9.8400	775,278	9.8400	7,628,736	57	17.1400	5,659,530	74.19
2023-09-12	OLMA	BVF PARTNERS L P/IL	677,853	9.8400	677,853	9.8400	6,670,074
2023-09-12	OLMA	BVF PARTNERS L P/IL	52,801	9.8400	52,801	9.8400	519,562
2022-06-10	OLMA	BVF PARTNERS L P/IL	158,583	4.0345	158,583	4.0345	639,803
2022-06-10	OLMA	BVF PARTNERS L P/IL	41,417	4.0345	41,417	4.0345	167,097
2021-11-30	OLMA	BVF PARTNERS L P/IL	362,430	9.3903	362,430	9.3903	3,403,326
2021-11-30	OLMA	BVF PARTNERS L P/IL	341,977	9.3903	341,977	9.3903	3,211,267
2021-11-30	OLMA	BVF PARTNERS L P/IL	35,268	9.3903	35,268	9.3903	331,177
2020-11-19	OLMA	BVF PARTNERS L P/IL	613,918	19.0000	613,918	19.0000	11,664,442
2020-11-19	OLMA	BVF PARTNERS L P/IL	446,425	19.0000	446,425	19.0000	8,482,075
2020-11-19	OLMA	BVF PARTNERS L P/IL	74,991	19.0000	74,991	19.0000	1,424,829

OLMA / Olema Pharmaceuticals, Inc. Insider Trades

इनसाइडर बिक्री OLMA / Olema Pharmaceuticals, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी RIGL / Rigel Pharmaceuticals, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2013-06-07	RIGL	BVF PARTNERS L P/IL	24,598	3.4677	2,460	34.6770	85,298	276	47.5	31,504	36.93
2013-06-07	RIGL	BVF PARTNERS L P/IL	8,102	3.4677	810	34.6770	28,095

RIGL / Rigel Pharmaceuticals, Inc. Insider Trades

इनसाइडर बिक्री RIGL / Rigel Pharmaceuticals, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
2013-11-19	RIGL	BVF PARTNERS L P/IL	331,566	2.6418	33,157	26.4180	875,931	286	2.6	-789,725	-90.16
2013-11-19	RIGL	BVF PARTNERS L P/IL	153,056	2.6418	15,306	26.4180	404,343

इनसाइडर खरीदारी RPTX / Repare Therapeutics Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2023-11-16	RPTX	BVF PARTNERS L P/IL	153,693	5.3837	153,693	5.3837	827,437	88	8.4100	465,121	56.21
2023-11-16	RPTX	BVF PARTNERS L P/IL	125,909	5.3837	125,909	5.3837	677,856
2023-11-16	RPTX	BVF PARTNERS L P/IL	16,143	5.3837	16,143	5.3837	86,909
2023-11-15	RPTX	BVF PARTNERS L P/IL	493,337	4.9999	493,337	4.9999	2,466,636
2023-11-15	RPTX	BVF PARTNERS L P/IL	390,507	4.9999	390,507	4.9999	1,952,496
2023-11-15	RPTX	BVF PARTNERS L P/IL	47,712	4.9999	47,712	4.9999	238,555
2023-11-02	RPTX	BVF PARTNERS L P/IL	218,979	3.6000	218,979	3.6000	788,324
2023-11-02	RPTX	BVF PARTNERS L P/IL	492,251	3.6000	492,251	3.6000	1,772,104
2023-11-02	RPTX	BVF PARTNERS L P/IL	72,479	3.6000	72,479	3.6000	260,924
2022-06-13	RPTX	BVF PARTNERS L P/IL	74,666	12.7300	74,666	12.7300	950,498
2022-06-13	RPTX	BVF PARTNERS L P/IL	68,327	12.7300	68,327	12.7300	869,803
2022-06-13	RPTX	BVF PARTNERS L P/IL	6,168	12.7300	6,168	12.7300	78,519
2022-06-06	RPTX	BVF PARTNERS L P/IL	3,809	13.2118	3,809	13.2118	50,324
2022-06-06	RPTX	BVF PARTNERS L P/IL	3,040	13.2118	3,040	13.2118	40,164
2022-06-06	RPTX	BVF PARTNERS L P/IL	20	13.2118	20	13.2118	264
2022-06-03	RPTX	BVF PARTNERS L P/IL	353,344	12.2860	353,344	12.2860	4,341,184
2022-06-03	RPTX	BVF PARTNERS L P/IL	258,797	12.2860	258,797	12.2860	3,179,580
2022-06-03	RPTX	BVF PARTNERS L P/IL	31,903	12.2860	31,903	12.2860	391,960
2022-06-02	RPTX	BVF PARTNERS L P/IL	660,654	11.6824	660,654	11.6824	7,718,024
2022-06-02	RPTX	BVF PARTNERS L P/IL	464,235	11.6824	464,235	11.6824	5,423,379
2022-06-02	RPTX	BVF PARTNERS L P/IL	61,156	11.6824	61,156	11.6824	714,449
2022-05-18	RPTX	BVF PARTNERS L P/IL	224,388	8.5000	224,388	8.5000	1,907,298
2022-05-18	RPTX	BVF PARTNERS L P/IL	189,882	8.5000	189,882	8.5000	1,613,997
2022-05-18	RPTX	BVF PARTNERS L P/IL	5,730	8.5000	5,730	8.5000	48,705
2022-01-19	RPTX	BVF PARTNERS L P/IL	577,798	14.1000	577,798	14.1000	8,146,952
2022-01-19	RPTX	BVF PARTNERS L P/IL	412,264	14.1000	412,264	14.1000	5,812,922
2022-01-19	RPTX	BVF PARTNERS L P/IL	7,899	14.1000	7,899	14.1000	111,376

RPTX / Repare Therapeutics Inc. Insider Trades

इनसाइडर बिक्री RPTX / Repare Therapeutics Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी SNDX / Syndax Pharmaceuticals, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

SNDX / Syndax Pharmaceuticals, Inc. Insider Trades

इनसाइडर बिक्री SNDX / Syndax Pharmaceuticals, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी VSTM / Verastem, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर बिक्री VSTM / Verastem, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी XENE / Xenon Pharmaceuticals Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2017-08-15	XENE	BVF PARTNERS L P/IL	11,429	2.4122	11,429	2.4122	27,569	359	12.1	110,722	401.62
2017-08-15	XENE	BVF PARTNERS L P/IL	7,429	2.4122	7,429	2.4122	17,920
2017-08-14	XENE	BVF PARTNERS L P/IL	28,007	2.7036	28,007	2.7036	75,720
2017-08-14	XENE	BVF PARTNERS L P/IL	13,337	2.7036	13,337	2.7036	36,058
2017-06-27	XENE	BVF PARTNERS L P/IL	46,795	4.0000	46,795	4.0000	187,180
2017-06-27	XENE	BVF PARTNERS L P/IL	30,170	4.0000	30,170	4.0000	120,680
2017-06-27	XENE	BVF PARTNERS L P/IL	8,496	4.0000	8,496	4.0000	33,984
2017-06-27	XENE	BVF PARTNERS L P/IL	46,795	3.0361	46,795	3.0361	142,074
2017-06-27	XENE	BVF PARTNERS L P/IL	30,170	3.0361	30,170	3.0361	91,599
2017-06-27	XENE	BVF PARTNERS L P/IL	8,496	3.0361	8,496	3.0361	25,795
2017-06-19	XENE	BVF PARTNERS L P/IL	1,967	3.8500	1,967	3.8500	7,573
2017-06-19	XENE	BVF PARTNERS L P/IL	1,271	3.8500	1,271	3.8500	4,893
2017-06-19	XENE	BVF PARTNERS L P/IL	357	3.8500	357	3.8500	1,374
2017-06-16	XENE	BVF PARTNERS L P/IL	6,097	3.8500	6,097	3.8500	23,473
2017-06-16	XENE	BVF PARTNERS L P/IL	3,873	3.8500	3,873	3.8500	14,911
2017-06-16	XENE	BVF PARTNERS L P/IL	1,064	3.8500	1,064	3.8500	4,096
2017-06-15	XENE	BVF PARTNERS L P/IL	6,774	3.8370	6,774	3.8370	25,992
2017-06-15	XENE	BVF PARTNERS L P/IL	3,845	3.8370	3,845	3.8370	14,753
2017-06-15	XENE	BVF PARTNERS L P/IL	1,160	3.8370	1,160	3.8370	4,451
2017-06-07	XENE	BVF PARTNERS L P/IL	113,446	3.8512	113,446	3.8512	436,903
2017-06-07	XENE	BVF PARTNERS L P/IL	73,749	3.8512	73,749	3.8512	284,022
2017-06-07	XENE	BVF PARTNERS L P/IL	20,594	3.8512	20,594	3.8512	79,312
2017-06-06	XENE	BVF PARTNERS L P/IL	96,736	3.7500	96,736	3.7500	362,760
2017-06-06	XENE	BVF PARTNERS L P/IL	53,260	3.7500	53,260	3.7500	199,725
2017-06-06	XENE	BVF PARTNERS L P/IL	913	3.7500	913	3.7500	3,424

XENE / Xenon Pharmaceuticals Inc. Insider Trades

इनसाइडर बिक्री XENE / Xenon Pharmaceuticals Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी XOMAO / XOMA Royalty Corporation - Preferred Stock - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2023-01-06	XOMA	BVF PARTNERS L P/IL	1,676	21.9817	1,676	21.9817	36,841	14	23.1200	1,908	5.18
2023-01-06	XOMA	BVF PARTNERS L P/IL	1,573	21.9817	1,573	21.9817	34,577
2023-01-05	XOMA	BVF PARTNERS L P/IL	3,330	18.3852	3,330	18.3852	61,223
2023-01-05	XOMA	BVF PARTNERS L P/IL	15,670	18.3852	15,670	18.3852	288,096
2022-09-27	XOMA	BVF PARTNERS L P/IL	1,004	16.8902	1,004	16.8902	16,958
2022-09-27	XOMA	BVF PARTNERS L P/IL	678	16.8902	678	16.8902	11,452
2022-09-26	XOMA	BVF PARTNERS L P/IL	3,339	16.8317	3,339	16.8317	56,201
2022-09-26	XOMA	BVF PARTNERS L P/IL	3,021	16.8317	3,021	16.8317	50,849
2022-09-23	XOMA	BVF PARTNERS L P/IL	6,715	16.4970	6,715	16.4970	110,777
2022-09-23	XOMA	BVF PARTNERS L P/IL	9,885	16.4970	9,885	16.4970	163,073
2022-09-16	XOMA	BVF PARTNERS L P/IL	10,897	17.8873	10,897	17.8873	194,918
2022-09-16	XOMA	BVF PARTNERS L P/IL	13,396	17.8873	13,396	17.8873	239,618
2022-09-15	XOMA	BVF PARTNERS L P/IL	5,575	17.9620	5,575	17.9620	100,138
2022-09-14	XOMA	BVF PARTNERS L P/IL	26,441	17.2476	26,441	17.2476	456,044
2020-09-23	XOMA	BVF PARTNERS L P/IL	9,888	18.1998	9,888	18.1998	179,960
2020-09-23	XOMA	BVF PARTNERS L P/IL	7,201	18.1998	7,201	18.1998	131,057
2020-09-22	XOMA	BVF PARTNERS L P/IL	6,960	18.4457	6,960	18.4457	128,382
2020-09-22	XOMA	BVF PARTNERS L P/IL	4,991	18.4457	4,991	18.4457	92,062
2020-09-21	XOMA	BVF PARTNERS L P/IL	12,259	18.3851	12,259	18.3851	225,383
2020-09-21	XOMA	BVF PARTNERS L P/IL	10,069	18.3851	10,069	18.3851	185,120
2020-09-04	XOMA	BVF PARTNERS L P/IL	3,907	18.7706	3,907	18.7706	73,337
2020-09-04	XOMA	BVF PARTNERS L P/IL	3,830	18.7706	3,830	18.7706	71,891
2020-09-01	XOMA	BVF PARTNERS L P/IL	9,900	18.8661	9,900	18.8661	186,774
2020-09-01	XOMA	BVF PARTNERS L P/IL	7,672	18.8661	7,672	18.8661	144,741
2020-08-31	XOMA	BVF PARTNERS L P/IL	9,143	18.4806	9,143	18.4806	168,968
2020-08-31	XOMA	BVF PARTNERS L P/IL	6,862	18.4806	6,862	18.4806	126,814
2020-08-28	XOMA	BVF PARTNERS L P/IL	1,122	19.1719	1,122	19.1719	21,511
2020-08-28	XOMA	BVF PARTNERS L P/IL	922	19.1719	922	19.1719	17,676
2020-08-25	XOMA	BVF PARTNERS L P/IL	3,443	19.7450	3,443	19.7450	67,982
2020-08-25	XOMA	BVF PARTNERS L P/IL	2,244	19.7450	2,244	19.7450	44,308
2020-08-24	XOMA	BVF PARTNERS L P/IL	6,504	19.3093	6,504	19.3093	125,588
2020-08-24	XOMA	BVF PARTNERS L P/IL	5,179	19.3093	5,179	19.3093	100,003
2020-08-21	XOMA	BVF PARTNERS L P/IL	9,198	19.3216	9,198	19.3216	177,720
2020-08-21	XOMA	BVF PARTNERS L P/IL	1,607	19.3216	1,607	19.3216	31,050
2020-08-20	XOMA	BVF PARTNERS L P/IL	1,772	19.1200	1,772	19.1200	33,881
2020-08-19	XOMA	BVF PARTNERS L P/IL	3,496	19.7016	3,496	19.7016	68,877
2020-08-18	XOMA	BVF PARTNERS L P/IL	895	19.2694	895	19.2694	17,246
2020-08-14	XOMA	BVF PARTNERS L P/IL	21,922	18.6940	21,922	18.6940	409,810
2020-08-13	XOMA	BVF PARTNERS L P/IL	1,050	17.8032	1,050	17.8032	18,693
2020-08-12	XOMA	BVF PARTNERS L P/IL	4,050	17.3415	4,050	17.3415	70,233
2020-03-25	XOMA	BVF PARTNERS L P/IL	8,264	17.1986	8,264	17.1986	142,129
2020-03-18	XOMA	BVF PARTNERS L P/IL	4,439	14.5246	4,439	14.5246	64,475
2020-03-17	XOMA	BVF PARTNERS L P/IL	8,113	15.7337	8,113	15.7337	127,648
2020-03-16	XOMA	BVF PARTNERS L P/IL	10,164	15.7336	10,164	15.7336	159,916
2020-03-13	XOMA	BVF PARTNERS L P/IL	100,000	18.3409	100,000	18.3409	1,834,090
2019-12-19	XOMA	BVF PARTNERS L P/IL	207,234	22.0000	207,234	22.0000	4,559,148
2019-12-19	XOMA	BVF PARTNERS L P/IL	165,961	22.0000	165,961	22.0000	3,651,142
2019-05-14	XOMA	BVF PARTNERS L P/IL	13,816	14.7412	13,816	14.7412	203,664
2019-05-13	XOMA	BVF PARTNERS L P/IL	3,797	14.3604	3,797	14.3604	54,526
2019-05-10	XOMA	BVF PARTNERS L P/IL	10,300	14.5667	10,300	14.5667	150,037
2018-12-17	XOMA	BVF PARTNERS L P/IL	25,000	14.1917	25,000	14.1917	354,792
2018-12-13	XOMA	BVF PARTNERS L P/IL	24,253	14.4116	24,253	14.4116	349,525
2018-12-12	XOMA	BVF PARTNERS L P/IL	2,810	14.7500	2,810	14.7500	41,448
2018-12-11	XOMA	BVF PARTNERS L P/IL	9,400	14.4968	9,400	14.4968	136,270
2018-12-10	XOMA	BVF PARTNERS L P/IL	18,081	14.5441	18,081	14.5441	262,972
2018-12-07	XOMA	BVF PARTNERS L P/IL	32,015	14.7674	32,015	14.7674	472,778
2018-12-06	XOMA	BVF PARTNERS L P/IL	10,927	14.7980	10,927	14.7980	161,698
2018-12-04	XOMA	BVF PARTNERS L P/IL	4,171	14.9880	4,171	14.9880	62,515
2018-12-03	XOMA	BVF PARTNERS L P/IL	806	14.9000	806	14.9000	12,009
2018-11-30	XOMA	BVF PARTNERS L P/IL	4,823	14.8486	4,823	14.8486	71,615
2018-11-29	XOMA	BVF PARTNERS L P/IL	10,016	14.9304	10,016	14.9304	149,543
2018-11-28	XOMA	BVF PARTNERS L P/IL	8,288	15.1136	8,288	15.1136	125,262
2018-11-27	XOMA	BVF PARTNERS L P/IL	11,396	15.2404	11,396	15.2404	173,680
2018-11-21	XOMA	BVF PARTNERS L P/IL	25,000	14.9957	25,000	14.9957	374,892
2018-11-20	XOMA	BVF PARTNERS L P/IL	37,482	13.6786	37,482	13.6786	512,701
2018-11-19	XOMA	BVF PARTNERS L P/IL	9,771	13.9253	9,771	13.9253	136,064
2018-11-16	XOMA	BVF PARTNERS L P/IL	10,849	13.8249	10,849	13.8249	149,986
2018-11-15	XOMA	BVF PARTNERS L P/IL	21,141	13.3088	21,141	13.3088	281,361

XOMAO / XOMA Royalty Corporation - Preferred Stock Insider Trades

इनसाइडर बिक्री XOMAO / XOMA Royalty Corporation - Preferred Stock - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
2025-05-16	XOMA	BVF PARTNERS L P/IL	127,407	27.1000	127,407	27.1000	3,452,730	28	23.8500	-414,072	-11.99
2025-05-16	XOMA	BVF PARTNERS L P/IL	265,316	27.1000	265,316	27.1000	7,190,064
2025-01-24	XOMA	BVF PARTNERS L P/IL	339,679	26.1000	339,679	26.1000	8,865,622
2025-01-24	XOMA	BVF PARTNERS L P/IL	85,776	26.1000	85,776	26.1000	2,238,754
2025-01-24	XOMA	BVF PARTNERS L P/IL	75,287	26.1000	75,287	26.1000	1,964,991
2025-01-24	XOMA	BVF PARTNERS L P/IL	149,975	26.1000	149,975	26.1000	3,914,348
2021-03-31	XOMA	BVF PARTNERS L P/IL	279,740	38.3600	279,740	38.3600	10,730,826
2021-03-31	XOMA	BVF PARTNERS L P/IL	205,807	38.3600	205,807	38.3600	7,894,757
2021-03-31	XOMA	BVF PARTNERS L P/IL	84,250	38.3600	84,250	38.3600	3,231,830
2021-03-31	XOMA	BVF PARTNERS L P/IL	81,903	38.3600	81,903	38.3600	3,141,799

इनसाइडर व्यापार इतिहास

यह तालिका सिक्योरिटीज एक्सचेंज कमीशन (SEC) को बताए अनुसार Mark N Lampert द्वारा किए गए इनसाइडर व्यापारों की पूरी सूची दिखाती है।

फ़ाइल तिथि	ट्रांजेक्शन तिथि	फॉर्म	टिकर	प्रतिभूति	कोड	शेयर	शेष शेयर	प्रतिशत परिवर्तन	शेयर कीमत	ट्रांजेक्शन वैल्यू	शेष मूल्य
2025-08-07	2025-08-05	4	EPIX	ESSA Pharma Inc. Common Stock	S - Sale	-11	560,797	0.00	1.88	-21	1,053,121
2025-08-07	2025-08-05	4	EPIX	ESSA Pharma Inc. Common Stock	S - Sale	-66	4,726,743	0.00	1.88	-124	8,876,351
2025-08-07	2025-08-05	4	EPIX	ESSA Pharma Inc. Common Stock	S - Sale	-79	6,194,145	0.00	1.88	-148	11,631,985
2025-08-07	2025-08-05	4	EPIX	ESSA Pharma Inc. Common Stock	X - Other	203,336	560,808	56.88	0.00	20	56
2025-08-07	2025-08-05	4	EPIX	ESSA Pharma Inc. Common Stock	X - Other	1,235,030	4,726,809	35.37	0.00	124	473
2025-08-07	2025-08-05	4	EPIX	ESSA Pharma Inc. Common Stock	X - Other	1,481,634	6,194,224	31.44	0.00	148	619
2025-07-01	2025-06-30	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	P - Purchase	58,780	353,412	19.95	44.00	2,586,320	15,550,128
2025-07-01	2025-06-30	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	P - Purchase	115,783	2,219,858	5.50	44.00	5,094,452	97,673,752
2025-07-01	2025-06-30	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	P - Purchase	142,604	2,798,795	5.37	44.00	6,274,576	123,146,980
2025-06-17	2025-06-13	4	CBIO	GLYCOMIMETICS INC Common Stock	J - Other	56,079	62,383	889.58
2025-06-17	2025-06-13	4	CBIO	GLYCOMIMETICS INC Common Stock	J - Other	556,617	593,740	1,499.39
2025-06-17	2025-06-13	4	CBIO	GLYCOMIMETICS INC Common Stock	J - Other	657,308	707,116	1,319.68
2025-05-20	2025-05-16	4	XOMA	XOMA Royalty Corp Common Stock, $0.0075 par value per share	S - Sale	-265,316	1,267,545	-17.31	27.10	-7,190,064	34,350,470
2025-05-20	2025-05-16	4	XOMA	XOMA Royalty Corp Common Stock, $0.0075 par value per share	S - Sale	-127,407	1,322,758	-8.79	27.10	-3,452,730	35,846,742
2025-05-19	2025-05-15	4	ALLK	Allakos Inc. Common Stock, $0.001 par value	D - Sale to Issuer	-855,211	0	-100.00
2025-05-19	2025-05-15	4	ALLK	Allakos Inc. Common Stock, $0.001 par value	D - Sale to Issuer	-6,777,935	0	-100.00
2025-05-19	2025-05-15	4	ALLK	Allakos Inc. Common Stock, $0.001 par value	D - Sale to Issuer	-8,679,726	0	-100.00
2025-01-28	2025-01-24	4	XOMA	XOMA Royalty Corp Common Stock, $0.0075 par value per share	S - Sale	-149,975	0	-100.00	26.10	-3,914,348
2025-01-28	2025-01-24	4	XOMA	XOMA Royalty Corp Common Stock, $0.0075 par value per share	S - Sale	-75,287	0	-100.00	26.10	-1,964,991
2025-01-28	2025-01-24	4	XOMA	XOMA Royalty Corp Common Stock, $0.0075 par value per share	S - Sale	-85,776	1,532,861	-5.30	26.10	-2,238,754	40,007,672
2025-01-28	2025-01-24	4	XOMA	XOMA Royalty Corp Common Stock, $0.0075 par value per share	S - Sale	-339,679	1,450,165	-18.98	26.10	-8,865,622	37,849,306
2025-01-14	2025-01-10	4	OLMA	Olema Pharmaceuticals, Inc. Common stock, $0.0001 par value	D - Sale to Issuer	-22,740	347,970	-6.13
2025-01-14	2025-01-10	4	OLMA	Olema Pharmaceuticals, Inc. Common stock, $0.0001 par value	D - Sale to Issuer	-161,810	2,003,966	-7.47
2025-01-14	2025-01-10	4	OLMA	Olema Pharmaceuticals, Inc. Common stock, $0.0001 par value	D - Sale to Issuer	-235,450	2,655,977	-8.14
2024-12-17	2024-12-13	4	PVLA	PALVELLA THERAPEUTICS, INC. Common Stock, $0.001 par value	J - Other	29,648	38,961	318.35
2024-12-17	2024-12-13	4	PVLA	PALVELLA THERAPEUTICS, INC. Common Stock, $0.001 par value	J - Other	174,958	282,223	163.11
2024-12-17	2024-12-13	4	PVLA	PALVELLA THERAPEUTICS, INC. Common Stock, $0.001 par value	J - Other	234,323	371,916	170.30
2024-12-04	2024-12-04	4	OLMA	Olema Pharmaceuticals, Inc. Common stock, $0.0001 par value	D - Sale to Issuer	-153,441	370,710	-29.27
2024-12-04	2024-12-04	4	OLMA	Olema Pharmaceuticals, Inc. Common stock, $0.0001 par value	D - Sale to Issuer	-1,418,736	2,165,776	-39.58
2024-12-04	2024-12-04	4	OLMA	Olema Pharmaceuticals, Inc. Common stock, $0.0001 par value	D - Sale to Issuer	-1,797,527	2,891,427	-38.34
2024-11-13	2024-11-08	4	FDMT	4D Molecular Therapeutics, Inc. Common Stock, $0.0001 par value	J - Other	-240,000	87,911	-73.19
2024-11-13	2024-11-08	4	FDMT	4D Molecular Therapeutics, Inc. Common Stock, $0.0001 par value	J - Other	-2,378,000	662,970	-78.20
2024-11-13	2024-11-08	4	FDMT	4D Molecular Therapeutics, Inc. Common Stock, $0.0001 par value	J - Other	-3,062,000	830,237	-78.67
2024-10-31	2024-10-29	4	THRD	Third Harmonic Bio, Inc. Common Stock	S - Sale	-64,617	176,692	-26.78	14.30	-924,023	2,526,696
2024-10-31	2024-10-29	4	THRD	Third Harmonic Bio, Inc. Common Stock	S - Sale	-396,963	1,367,257	-22.50	14.30	-5,676,571	19,551,775
2024-10-31	2024-10-29	4	THRD	Third Harmonic Bio, Inc. Common Stock	S - Sale	-538,420	1,794,218	-23.08	14.30	-7,699,406	25,657,317
2024-10-08	2024-10-04	4	MLTX	MoonLake Immunotherapeutics Class A Ordinary Shares, $0.0001 par value	S - Sale	-132,549	1,287,768	-9.33	50.00	-6,627,662	64,390,460
2024-10-08	2024-10-04	4	MLTX	MoonLake Immunotherapeutics Class A Ordinary Shares, $0.0001 par value	S - Sale	-836,862	8,168,838	-9.29	50.00	-41,844,439	408,454,970
2024-10-08	2024-10-04	4	MLTX	MoonLake Immunotherapeutics Class A Ordinary Shares, $0.0001 par value	S - Sale	-1,030,589	10,235,089	-9.15	50.00	-51,531,099	511,770,826
2024-08-01		3	FDMT	4D Molecular Therapeutics, Inc. Common Stock, $0.0001 par value			3,892,237
2024-08-01		3	FDMT	4D Molecular Therapeutics, Inc. Common Stock, $0.0001 par value			3,040,970
2024-08-01		3	FDMT	4D Molecular Therapeutics, Inc. Common Stock, $0.0001 par value			327,911
2024-05-13	2024-05-09	4	ELDN	Eledon Pharmaceuticals, Inc. Common Stock, $0.001 par value	P - Purchase	75,431	220,460	52.01
2024-05-13	2024-05-09	4	ELDN	Eledon Pharmaceuticals, Inc. Common Stock, $0.001 par value	P - Purchase	821,121	2,633,679	45.30
2024-05-13	2024-05-09	4	ELDN	Eledon Pharmaceuticals, Inc. Common Stock, $0.001 par value	P - Purchase	1,031,385	3,361,803	44.26
2024-01-29	2024-01-25	4	RAIN	Rain Oncology Inc. Non-Voting Common Stock, $0.001 par value	U - Other	-341,547	0	-100.00
2024-01-29	2024-01-25	4	RAIN	Rain Oncology Inc. Common Stock, $0.001 par value	U - Other	-185,388	0	-100.00
2024-01-29	2024-01-25	4	RAIN	Rain Oncology Inc. Non-Voting Common Stock, $0.001 par value	U - Other	-2,076,085	0	-100.00
2024-01-29	2024-01-25	4	RAIN	Rain Oncology Inc. Common Stock, $0.001 par value	U - Other	-1,367,838	0	-100.00
2024-01-29	2024-01-25	4	RAIN	Rain Oncology Inc. Non-Voting Common Stock, $0.001 par value	U - Other	-2,870,985	0	-100.00
2024-01-29	2024-01-25	4	RAIN	Rain Oncology Inc. Common Stock, $0.001 par value	U - Other	-1,734,960	0	-100.00
2024-01-26		3	ALLK	Allakos Inc. Common Stock, $0.001 par value			8,679,726
2024-01-26		3	ALLK	Allakos Inc. Common Stock, $0.001 par value			6,777,935
2024-01-26		3	ALLK	Allakos Inc. Common Stock, $0.001 par value			855,211
2023-12-20	2023-12-18	4	PNT	POINT Biopharma Global Inc. Common Stock, $0.0001 par value	S - Sale	-896,366	0	-100.00	12.45	-11,159,757
2023-12-20	2023-12-18	4	PNT	POINT Biopharma Global Inc. Common Stock, $0.0001 par value	S - Sale	-7,290,667	0	-100.00	12.45	-90,768,804
2023-12-20	2023-12-18	4	PNT	POINT Biopharma Global Inc. Common Stock, $0.0001 par value	S - Sale	-8,974,245	0	-100.00	12.45	-111,729,350
2023-11-17	2023-11-16	4	RPTX	Repare Therapeutics Inc. Common Shares, no par value	P - Purchase	16,143	548,938	3.03	5.38	86,909	2,955,318
2023-11-17	2023-11-16	4	RPTX	Repare Therapeutics Inc. Common Shares, no par value	P - Purchase	125,909	4,308,573	3.01	5.38	677,856	23,196,064
2023-11-17	2023-11-16	4	RPTX	Repare Therapeutics Inc. Common Shares, no par value	P - Purchase	153,693	5,309,432	2.98	5.38	827,437	28,584,389
2023-11-17	2023-11-15	4	RPTX	Repare Therapeutics Inc. Common Shares, no par value	P - Purchase	47,712	532,795	9.84	5.00	238,555	2,663,922
2023-11-17	2023-11-15	4	RPTX	Repare Therapeutics Inc. Common Shares, no par value	P - Purchase	390,507	4,182,664	10.30	5.00	1,952,496	20,912,902
2023-11-17	2023-11-15	4	RPTX	Repare Therapeutics Inc. Common Shares, no par value	P - Purchase	493,337	5,155,739	10.58	5.00	2,466,636	25,778,179
2023-11-13		3	ENGN	enGene Holdings Inc. Class A Common Shares			1,204,412
2023-11-13		3	ENGN	enGene Holdings Inc. Class A Common Shares			912,776
2023-11-13		3	ENGN	enGene Holdings Inc. Class A Common Shares			104,257
2023-11-06		3	PNT	POINT Biopharma Global Inc. Common Stock, $0.0001 par value			8,974,245
2023-11-06		3	PNT	POINT Biopharma Global Inc. Common Stock, $0.0001 par value			7,290,667
2023-11-06		3	PNT	POINT Biopharma Global Inc. Common Stock, $0.0001 par value			896,366
2023-11-06	2023-11-03	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	P - Purchase	10,106	294,632	3.55	14.07	142,180	4,145,148
2023-11-06	2023-11-03	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	P - Purchase	83,708	2,104,075	4.14	14.07	1,177,679	29,602,021
2023-11-06	2023-11-03	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	P - Purchase	103,885	2,656,191	4.07	14.07	1,461,548	37,369,686
2023-11-06	2023-11-02	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	P - Purchase	26,772	284,526	10.39	11.64	311,744	3,313,135
2023-11-06	2023-11-02	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	P - Purchase	132,016	2,020,367	6.99	11.64	1,537,247	23,525,961
2023-11-06	2023-11-02	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	P - Purchase	57,618	2,552,306	2.31	11.64	670,927	29,720,072
2023-11-03	2023-11-02	4	RPTX	Repare Therapeutics Inc. Common Shares, no par value	P - Purchase	72,479	485,083	17.57	3.60	260,924	1,746,299
2023-11-03	2023-11-02	4	RPTX	Repare Therapeutics Inc. Common Shares, no par value	P - Purchase	492,251	3,792,157	14.92	3.60	1,772,104	13,651,765
2023-11-03	2023-11-02	4	RPTX	Repare Therapeutics Inc. Common Shares, no par value	P - Purchase	218,979	4,662,402	4.93	3.60	788,324	16,784,647
2023-09-14	2023-09-14	4	OLMA	Olema Pharmaceuticals, Inc. Common stock, $0.0001 par value	J - Other	99,556	99,556
2023-09-14	2023-09-12	4	OLMA	Olema Pharmaceuticals, Inc. Common stock, $0.0001 par value	P - Purchase	52,801	524,151	11.20	9.84	519,562	5,157,646
2023-09-14	2023-09-12	4	OLMA	Olema Pharmaceuticals, Inc. Common stock, $0.0001 par value	P - Purchase	677,853	3,584,512	23.32	9.84	6,670,074	35,271,598
2023-09-14	2023-09-12	4	OLMA	Olema Pharmaceuticals, Inc. Common stock, $0.0001 par value	P - Purchase	775,278	4,688,954	19.81	9.84	7,628,736	46,139,307
2023-06-28	2023-06-26	4	CTIC	CTI BIOPHARMA CORP Common Stock, par value $0.001	U - Other	-43,139	0	-100.00	9.10	-392,565
2023-06-28	2023-06-26	4	CTIC	CTI BIOPHARMA CORP Common Stock, par value $0.001	U - Other	-1,526,147	0	-100.00	9.10	-13,887,938
2023-06-28	2023-06-26	4	CTIC	CTI BIOPHARMA CORP Common Stock, par value $0.001	U - Other	-702,505	0	-100.00	9.10	-6,392,796
2023-06-28	2023-06-26	4	CTIC	CTI BIOPHARMA CORP Common Stock, par value $0.001	U - Other	-2,595,239	0	-100.00	9.10	-23,616,675
2023-06-28	2023-06-26	4	CTIC	CTI BIOPHARMA CORP Common Stock, par value $0.001	U - Other	-3,989,130	0	-100.00	9.10	-36,301,083
2023-05-22		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			11,007,420
2023-05-22		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			8,581,171
2023-05-22		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			744,966
2023-05-12	2023-05-10	4	GPCR	Structure Therapeutics Inc. Ordinary Shares, $0.0001 par value per share	J - Other	-462,605	0	-100.00
2023-05-12	2023-05-10	4	GPCR	Structure Therapeutics Inc. Ordinary Shares, $0.0001 par value per share	J - Other	-2,929,660	0	-100.00
2023-05-12	2023-05-10	4	GPCR	Structure Therapeutics Inc. Ordinary Shares, $0.0001 par value per share	J - Other	-4,018,253	0	-100.00
2023-05-09	2023-05-05	4	ELDN	Eledon Pharmaceuticals, Inc. Common Stock, $0.001 par value	P - Purchase	86,341	145,029	147.12
2023-05-09	2023-05-05	4	ELDN	Eledon Pharmaceuticals, Inc. Common Stock, $0.001 par value	P - Purchase	837,146	1,812,558	85.82
2023-05-09	2023-05-05	4	ELDN	Eledon Pharmaceuticals, Inc. Common Stock, $0.001 par value	P - Purchase	1,055,445	2,330,418	82.78
2023-02-13		3	GPCR	Structure Therapeutics Inc. Ordinary Shares, $0.0001 par value per share			4,018,253
2023-02-13		3	GPCR	Structure Therapeutics Inc. Ordinary Shares, $0.0001 par value per share			2,801,529
2023-02-13		3	GPCR	Structure Therapeutics Inc. Ordinary Shares, $0.0001 par value per share			2,929,660
2023-02-13		3	GPCR	Structure Therapeutics Inc. Ordinary Shares, $0.0001 par value per share			2,130,657
2023-02-13		3	GPCR	Structure Therapeutics Inc. Ordinary Shares, $0.0001 par value per share			462,605
2023-02-13		3	GPCR	Structure Therapeutics Inc. Ordinary Shares, $0.0001 par value per share			241,755
2023-01-19	2023-01-19	4	CGEM	Cullinan Oncology, Inc. Common Stock	J - Other	-300,000	64,161	-82.38
2023-01-19	2023-01-19	4	CGEM	Cullinan Oncology, Inc. Common Stock	J - Other	-2,600,000	392,808	-86.87
2023-01-19	2023-01-19	4	CGEM	Cullinan Oncology, Inc. Common Stock	J - Other	-3,500,000	558,854	-86.23
2023-01-13	2023-01-12	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	P - Purchase	15,912	1,888,351	0.85	31.24	497,132	58,996,995
2023-01-13	2023-01-12	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	P - Purchase	2,985	2,494,688	0.12	31.24	93,259	77,940,539
2023-01-13	2023-01-11	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	P - Purchase	11,149	1,872,439	0.60	29.89	333,209	55,961,397
2023-01-13	2023-01-11	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	P - Purchase	10,961	2,491,703	0.44	29.89	327,590	74,469,278
2023-01-09	2023-01-06	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	1,573	1,618,637	0.10	21.98	34,577	35,580,393
2023-01-09	2023-01-06	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	1,676	1,789,844	0.09	21.98	36,841	39,343,814
2023-01-09	2023-01-05	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	15,670	1,617,064	0.98	18.39	288,096	29,730,045
2023-01-09	2023-01-05	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	3,330	1,788,168	0.19	18.39	61,223	32,875,826
2022-12-22	2022-12-20	4	THRD	Third Harmonic Bio, Inc. Common Stock	P - Purchase	9,597	241,309	4.14	4.11	39,430	991,442
2022-12-22	2022-12-20	4	THRD	Third Harmonic Bio, Inc. Common Stock	P - Purchase	87,831	1,764,220	5.24	4.11	360,862	7,248,474
2022-12-22	2022-12-20	4	THRD	Third Harmonic Bio, Inc. Common Stock	P - Purchase	116,635	2,332,638	5.26	4.11	479,207	9,583,876
2022-12-22		3	THRD	Third Harmonic Bio, Inc. Common Stock			2,216,003
2022-12-22		3	THRD	Third Harmonic Bio, Inc. Common Stock			1,676,389
2022-12-22		3	THRD	Third Harmonic Bio, Inc. Common Stock			231,712
2022-11-10	2022-11-08	4	RAIN	Rain Therapeutics Inc. Non-Voting Common Stock, $0.001 par value	P - Purchase	54,857	341,547	19.13	5.83	319,816	1,991,219
2022-11-10	2022-11-08	4	RAIN	Rain Therapeutics Inc. Non-Voting Common Stock, $0.001 par value	P - Purchase	685,330	2,076,085	49.28	5.83	3,995,474	12,103,576
2022-11-10	2022-11-08	4	RAIN	Rain Therapeutics Inc. Non-Voting Common Stock, $0.001 par value	P - Purchase	970,171	2,870,985	51.04	5.83	5,656,097	16,737,843
2022-09-27	2022-09-27	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	678	1,601,394	0.04	16.89	11,452	27,047,865
2022-09-27	2022-09-27	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	1,004	1,784,838	0.06	16.89	16,958	30,146,271
2022-09-27	2022-09-26	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	3,021	1,600,716	0.19	16.83	50,849	26,942,771
2022-09-27	2022-09-26	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	3,339	1,783,834	0.19	16.83	56,201	30,024,959
2022-09-27	2022-09-23	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	9,885	1,597,695	0.62	16.50	163,073	26,357,174
2022-09-27	2022-09-23	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	6,715	1,780,495	0.38	16.50	110,777	29,372,826
2022-09-16	2022-09-16	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	13,396	1,773,780	0.76	17.89	239,618	31,728,135
2022-09-16	2022-09-16	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	10,897	1,587,810	0.69	17.89	194,918	28,401,634
2022-09-16	2022-09-15	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	5,575	1,576,913	0.35	17.96	100,138	28,324,511
2022-09-16	2022-09-14	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	26,441	1,571,338	1.71	17.25	456,044	27,101,809
2022-08-23	2022-08-22	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	P - Purchase	27,117	257,754	11.76	26.00	705,042	6,701,604
2022-08-23	2022-08-22	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	P - Purchase	233,362	1,861,290	14.33	26.00	6,067,412	48,393,540
2022-08-23	2022-08-22	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	P - Purchase	285,046	2,480,742	12.98	26.00	7,411,196	64,499,292
2022-08-11	2022-08-09	4	CTIC	CTI BIOPHARMA CORP Common Stock, par value $0.001	C - Conversion	1,519,999	1,526,147	24,723.47
2022-08-11	2022-08-09	4	CTIC	CTI BIOPHARMA CORP Common Stock, par value $0.001	S - Sale	-1,289,434	6,148	-99.53	6.12	-7,891,336	37,626
2022-08-11	2022-08-09	4	CTIC	CTI BIOPHARMA CORP Common Stock, par value $0.001	C - Conversion	682,666	702,505	3,441.03
2022-08-11	2022-08-09	4	CTIC	CTI BIOPHARMA CORP Common Stock, par value $0.001	S - Sale	-469,040	19,839	-95.94	6.12	-2,870,525	121,415
2022-08-11	2022-08-09	4	CTIC	CTI BIOPHARMA CORP Common Stock, par value $0.001	C - Conversion	2,426,666	2,595,239	1,439.53
2022-08-11	2022-08-09	4	CTIC	CTI BIOPHARMA CORP Common Stock, par value $0.001	S - Sale	-2,890,723	168,573	-94.49	6.12	-17,691,225	1,031,667
2022-08-11	2022-08-09	4	CTIC	CTI BIOPHARMA CORP Common Stock, par value $0.001	C - Conversion	3,754,000	3,989,130	1,596.56
2022-08-11	2022-08-09	4	CTIC	CTI BIOPHARMA CORP Common Stock, par value $0.001	S - Sale	-3,850,803	235,130	-94.25	6.12	-23,566,914	1,438,996
2022-07-21		3	EPIX	ESSA Pharma Inc. Common Stock			4,712,590
2022-07-21		3	EPIX	ESSA Pharma Inc. Common Stock			3,491,779
2022-07-21		3	EPIX	ESSA Pharma Inc. Common Stock			357,472
2022-06-27		3	FDMT	4D Molecular Therapeutics, Inc. Common Stock			2,132,411
2022-06-27		3	FDMT	4D Molecular Therapeutics, Inc. Common Stock			1,570,857
2022-06-27		3	FDMT	4D Molecular Therapeutics, Inc. Common Stock			209,716
2022-06-15	2022-06-13	4	RPTX	Repare Therapeutics Inc. Common Shares, no par value	P - Purchase	6,168	412,604	1.52	12.73	78,519	5,252,449
2022-06-15	2022-06-13	4	RPTX	Repare Therapeutics Inc. Common Shares, no par value	P - Purchase	68,327	3,299,906	2.11	12.73	869,803	42,007,803
2022-06-15	2022-06-13	4	RPTX	Repare Therapeutics Inc. Common Shares, no par value	P - Purchase	74,666	4,443,423	1.71	12.73	950,498	56,564,775
2022-06-14	2022-06-10	4	OLMA	Olema Pharmaceuticals, Inc. Common stock, $0.0001 par value	P - Purchase	41,417	2,906,659	1.45	4.03	167,097	11,726,916
2022-06-14	2022-06-10	4	OLMA	Olema Pharmaceuticals, Inc. Common stock, $0.0001 par value	P - Purchase	158,583	3,913,676	4.22	4.03	639,803	15,789,726
2022-06-06	2022-06-06	4	RPTX	Repare Therapeutics Inc. Common Shares, no par value	P - Purchase	20	406,436	0.00	13.21	264	5,369,751
2022-06-06	2022-06-06	4	RPTX	Repare Therapeutics Inc. Common Shares, no par value	P - Purchase	3,040	3,231,579	0.09	13.21	40,164	42,694,975
2022-06-06	2022-06-06	4	RPTX	Repare Therapeutics Inc. Common Shares, no par value	P - Purchase	3,809	4,368,757	0.09	13.21	50,324	57,719,144
2022-06-06	2022-06-03	4	RPTX	Repare Therapeutics Inc. Common Shares, no par value	P - Purchase	31,903	406,416	8.52	12.29	391,960	4,993,227
2022-06-06	2022-06-03	4	RPTX	Repare Therapeutics Inc. Common Shares, no par value	P - Purchase	258,797	3,228,539	8.71	12.29	3,179,580	39,665,830
2022-06-06	2022-06-03	4	RPTX	Repare Therapeutics Inc. Common Shares, no par value	P - Purchase	353,344	4,364,948	8.81	12.29	4,341,184	53,627,751
2022-06-06	2022-06-02	4	RPTX	Repare Therapeutics Inc. Common Shares, no par value	P - Purchase	61,156	374,513	19.52	11.68	714,449	4,375,211
2022-06-06	2022-06-02	4	RPTX	Repare Therapeutics Inc. Common Shares, no par value	P - Purchase	464,235	2,969,742	18.53	11.68	5,423,379	34,693,714
2022-06-06	2022-06-02	4	RPTX	Repare Therapeutics Inc. Common Shares, no par value	P - Purchase	660,654	4,011,604	19.72	11.68	7,718,024	46,865,163
2022-06-03	2022-06-01	4	CGEM	Cullinan Oncology, Inc. Common Stock	P - Purchase	44,746	364,161	14.01	11.00	492,179	4,005,553
2022-06-03	2022-06-01	4	CGEM	Cullinan Oncology, Inc. Common Stock	P - Purchase	301,009	2,992,808	11.18	11.00	3,310,918	32,919,092
2022-06-03	2022-06-01	4	CGEM	Cullinan Oncology, Inc. Common Stock	P - Purchase	405,641	4,058,854	11.10	11.00	4,461,808	44,644,959
2022-05-31	2022-05-27	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	P - Purchase	3,223	230,637	1.42	14.78	47,645	3,409,461
2022-05-31	2022-05-27	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	P - Purchase	26,353	1,627,928	1.65	14.78	389,571	24,065,334
2022-05-31	2022-05-27	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	P - Purchase	35,793	2,195,696	1.66	14.78	529,121	32,458,535
2022-05-31	2022-05-26	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	P - Purchase	10,642	227,414	4.91	14.21	151,229	3,231,689
2022-05-31	2022-05-26	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	P - Purchase	90,372	1,601,575	5.98	14.21	1,284,240	22,759,342
2022-05-31	2022-05-26	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	P - Purchase	123,043	2,159,903	6.04	14.21	1,748,515	30,693,518
2022-05-24	2022-05-20	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	P - Purchase	37	216,772	0.02	14.00	518	3,034,678
2022-05-24	2022-05-20	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	P - Purchase	4,180	1,511,203	0.28	14.00	58,517	21,155,935
2022-05-24	2022-05-20	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	P - Purchase	5,883	2,036,860	0.29	14.00	82,358	28,514,818
2022-05-20	2022-05-18	4	RPTX	Repare Therapeutics Inc. Common Shares, no par value	P - Purchase	5,730	313,357	1.86	8.50	48,705	2,663,534
2022-05-20	2022-05-18	4	RPTX	Repare Therapeutics Inc. Common Shares, no par value	P - Purchase	189,882	2,505,507	8.20	8.50	1,613,997	21,296,810
2022-05-20	2022-05-18	4	RPTX	Repare Therapeutics Inc. Common Shares, no par value	P - Purchase	224,388	3,350,950	7.18	8.50	1,907,298	28,483,075
2022-05-20	2022-05-18	4	XOMA	XOMA Corp Non-Qualified Stock Option (right to buy)	A - Award	8,996	8,996
2022-05-16	2022-05-13	4	CGEM	Cullinan Oncology, Inc. Common Stock	P - Purchase	17,744	319,415	5.88	9.14	162,091	2,917,856
2022-05-16	2022-05-13	4	CGEM	Cullinan Oncology, Inc. Common Stock	P - Purchase	38,558	2,691,799	1.45	9.14	352,227	24,589,584
2022-05-16	2022-05-13	4	CGEM	Cullinan Oncology, Inc. Common Stock	P - Purchase	53,598	3,653,213	1.49	9.14	489,618	33,372,101
2022-05-16	2022-05-12	4	CGEM	Cullinan Oncology, Inc. Common Stock	P - Purchase	457,001	2,653,241	20.81	9.06	4,140,429	24,038,363
2022-05-16	2022-05-12	4	CGEM	Cullinan Oncology, Inc. Common Stock	P - Purchase	542,999	3,599,615	17.76	9.06	4,919,571	32,612,512
2022-05-09	2022-05-06	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	P - Purchase	4,131	216,735	1.94	19.26	79,542	4,173,232
2022-05-09	2022-05-06	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	P - Purchase	40,659	1,507,023	2.77	19.26	782,889	29,017,728
2022-05-09	2022-05-06	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	P - Purchase	55,210	2,030,977	2.79	19.26	1,063,069	39,106,462
2022-05-09	2022-05-05	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	P - Purchase	4,066	212,604	1.95	19.60	79,690	4,166,847
2022-05-09	2022-05-05	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	P - Purchase	70,439	1,466,364	5.05	19.60	1,380,541	28,739,415
2022-05-09	2022-05-05	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	P - Purchase	75,495	1,975,767	3.97	19.60	1,479,634	38,723,255
2022-04-15		3	MLTX	MoonLake Immunotherapeutics Class A Ordinary Shares, $0.0001 par value			11,265,678
2022-04-15		3	MLTX	MoonLake Immunotherapeutics Class A Ordinary Shares, $0.0001 par value			9,005,699
2022-04-15		3	MLTX	MoonLake Immunotherapeutics Class A Ordinary Shares, $0.0001 par value			1,420,317
2022-04-05	2022-04-01	4	CGEM	Cullinan Oncology, Inc. Common Stock	P - Purchase	9,402	2,196,240	0.43	10.75	101,071	23,609,360
2022-04-05	2022-04-01	4	CGEM	Cullinan Oncology, Inc. Common Stock	P - Purchase	266,598	3,056,616	9.56	10.75	2,865,902	32,858,316
2022-03-11	2022-03-09	4	CTIC	CTI BIOPHARMA CORP Stock Option (Right to Buy)	A - Award	80,000	80,000
2022-02-07		3	VSTM	Verastem, Inc. Common Stock			10,753,294
2022-02-07		3	VSTM	Verastem, Inc. Common Stock			7,883,287
2022-02-07		3	VSTM	Verastem, Inc. Common Stock			994,353
2022-01-31	2022-01-31	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	P - Purchase	14,323	1,395,925	1.04	40.70	582,946	56,814,148
2022-01-31	2022-01-31	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	P - Purchase	20,085	1,900,272	1.07	40.70	817,460	77,341,070
2022-01-31	2022-01-27	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	P - Purchase	37,859	1,381,602	2.82	38.33	1,451,207	52,959,430
2022-01-31	2022-01-27	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	P - Purchase	58,042	1,880,187	3.19	38.33	2,224,860	72,071,140
2022-01-31		3	ELDN	Eledon Pharmaceuticals, Inc. Common Stock, $0.001 par value			1,274,973
2022-01-31		3	ELDN	Eledon Pharmaceuticals, Inc. Common Stock, $0.001 par value			975,412
2022-01-31		3	ELDN	Eledon Pharmaceuticals, Inc. Common Stock, $0.001 par value			58,688
2022-01-26	2022-01-24	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	P - Purchase	114,726	1,343,743	9.33	37.76	4,332,455	50,744,439
2022-01-26	2022-01-24	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	P - Purchase	158,041	1,822,145	9.50	37.76	5,968,181	68,810,573
2022-01-21	2022-01-19	4	RPTX	Repare Therapeutics Inc. Common Shares, no par value	P - Purchase	7,899	307,627	2.64	14.10	111,376	4,337,541
2022-01-21	2022-01-19	4	RPTX	Repare Therapeutics Inc. Common Shares, no par value	P - Purchase	412,264	2,315,625	21.66	14.10	5,812,922	32,650,312
2022-01-21	2022-01-19	4	RPTX	Repare Therapeutics Inc. Common Shares, no par value	P - Purchase	577,798	3,126,562	22.67	14.10	8,146,952	44,084,524
2022-01-10		3	CGEM	Cullinan Oncology, Inc. Common Stock			2,790,018
2022-01-10		3	CGEM	Cullinan Oncology, Inc. Common Stock			2,186,838
2022-01-10		3	CGEM	Cullinan Oncology, Inc. Common Stock			301,671
2022-01-10	2022-01-07	4	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	P - Purchase	14,806	185,388	8.68	12.00	177,672	2,224,656
2022-01-10	2022-01-07	4	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	P - Purchase	226,079	1,367,838	19.80	12.00	2,712,948	16,414,056
2022-01-10	2022-01-07	4	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	P - Purchase	255,500	1,734,960	17.27	12.00	3,066,000	20,819,520
2022-01-10	2022-01-06	4	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	P - Purchase	61,343	1,141,759	5.68	12.00	736,018	13,699,281
2021-12-02	2021-11-30	4	OLMA	Olema Pharmaceuticals, Inc. Common stock, $0.0001 par value	P - Purchase	35,268	471,350	8.09	9.39	331,177	4,426,118
2021-12-02	2021-11-30	4	OLMA	Olema Pharmaceuticals, Inc. Common stock, $0.0001 par value	P - Purchase	341,977	2,865,242	13.55	9.39	3,211,267	26,905,482
2021-12-02	2021-11-30	4	OLMA	Olema Pharmaceuticals, Inc. Common stock, $0.0001 par value	P - Purchase	362,430	3,755,093	10.68	9.39	3,403,326	35,261,450
2021-11-08		3	RPTX	Repare Therapeutics Inc. Common Stock			2,548,764
2021-11-08		3	RPTX	Repare Therapeutics Inc. Common Stock			1,903,361
2021-11-08		3	RPTX	Repare Therapeutics Inc. Common Stock			299,728
2021-10-08	2021-10-08	4	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share	S - Sale	-8,929	232,747	-3.69	27.79	-248,106	6,467,225
2021-10-08	2021-10-08	4	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share	S - Sale	-58,327	1,520,405	-3.69	27.79	-1,620,703	42,246,734
2021-10-08	2021-10-08	4	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share	S - Sale	-80,011	2,085,664	-3.69	27.79	-2,223,226	57,953,303
2021-10-08	2021-10-07	4	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share	S - Sale	-69,534	241,676	-22.34	27.53	-1,914,348	6,653,606
2021-10-08	2021-10-07	4	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share	S - Sale	-384,914	1,578,732	-19.60	27.53	-10,597,106	43,464,229
2021-10-08	2021-10-07	4	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share	S - Sale	-530,999	2,165,675	-19.69	27.53	-14,618,987	59,623,415
2021-09-23	2021-09-21	4	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	P - Purchase	590	170,582	0.35	13.94	8,226	2,378,357
2021-09-23	2021-09-21	4	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	P - Purchase	4,102	1,080,416	0.38	13.94	57,193	15,063,808
2021-09-23	2021-09-21	4	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	P - Purchase	6,341	1,479,460	0.43	13.94	88,410	20,627,519
2021-09-15	2021-09-13	4	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	P - Purchase	20,512	169,992	13.72	16.49	338,243	2,803,168
2021-09-15	2021-09-13	4	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	P - Purchase	158,511	1,076,314	17.27	16.49	2,613,846	17,748,418
2021-09-15	2021-09-13	4	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	P - Purchase	213,246	1,473,119	16.93	16.49	3,516,427	24,291,732
2021-07-07	2021-07-02	4	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share	S - Sale	-150,805	311,210	-32.64	20.75	-3,129,204	6,457,608
2021-07-07	2021-07-02	4	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share	S - Sale	-928,739	1,963,646	-32.11	20.75	-19,271,334	40,745,654
2021-07-07	2021-07-02	4	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share	S - Sale	-1,106,478	2,696,674	-29.09	20.75	-22,959,418	55,955,986
2021-07-06	2021-07-01	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	P - Purchase	27,458	208,538	15.16	47.00	1,290,526	9,801,286
2021-07-06	2021-07-01	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	P - Purchase	211,711	1,229,017	20.81	47.00	9,950,417	57,763,799
2021-07-06	2021-07-01	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	P - Purchase	304,997	1,664,104	22.44	47.00	14,334,859	78,212,888
2021-07-06	2021-07-06	4	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	P - Purchase	16,980	149,480	12.82	15.25	258,945	2,279,570
2021-07-06	2021-07-06	4	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	P - Purchase	106,627	917,803	13.14	15.25	1,626,062	13,996,496
2021-07-06	2021-07-06	4	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	P - Purchase	146,116	1,259,873	13.12	15.25	2,228,269	19,213,063
2021-07-06	2021-07-01	4	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	P - Purchase	20,018	132,500	17.80	15.65	313,282	2,073,625
2021-07-06	2021-07-01	4	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	P - Purchase	124,804	811,176	18.18	15.65	1,953,183	12,694,904
2021-07-06	2021-07-01	4	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	P - Purchase	172,457	1,113,757	18.32	15.65	2,698,952	17,430,297
2021-06-21	2021-06-16	4	KYMR	Kymera Therapeutics, Inc. Stock Option (Right to Buy)	A - Award	20,063	20,063
2021-05-26	2021-03-31	4	OLMA	Olema Pharmaceuticals, Inc. Common stock, $0.0001 par value	J - Other	99,556	99,556
2021-05-25	2021-05-24	4	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	P - Purchase	129	112,482	0.11	15.90	2,050	1,787,924
2021-05-25	2021-05-24	4	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	P - Purchase	513	686,372	0.07	15.90	8,154	10,910,020
2021-05-25	2021-05-24	4	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	P - Purchase	719	941,300	0.08	15.90	11,429	14,962,152
2021-05-25	2021-05-21	4	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	P - Purchase	7,592	112,353	7.25	15.94	121,032	1,791,132
2021-05-25	2021-05-21	4	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	P - Purchase	48,152	685,859	7.55	15.94	767,639	10,933,964
2021-05-25	2021-05-21	4	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	P - Purchase	66,242	940,581	7.58	15.94	1,056,030	14,994,742
2021-05-21	2021-05-19	4	XOMA	XOMA Corp Non-Qualified Stock Option (right to buy)	A - Award	5,101	5,101
2021-05-20	2021-05-19	4	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	P - Purchase	1,115	104,761	1.08	15.88	17,711	1,664,055
2021-05-20	2021-05-19	4	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	P - Purchase	6,962	637,707	1.10	15.88	110,586	10,129,529
2021-05-20	2021-05-19	4	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	P - Purchase	9,191	874,339	1.06	15.88	145,993	13,888,263
2021-05-20	2021-05-18	4	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	P - Purchase	11,946	103,646	13.03	16.65	198,901	1,725,706
2021-05-20	2021-05-18	4	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	P - Purchase	75,640	630,745	13.63	16.65	1,259,406	10,501,904
2021-05-20	2021-05-18	4	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	P - Purchase	103,611	865,148	13.61	16.65	1,725,123	14,404,714
2021-05-17	2021-04-26	4/A	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	P - Purchase	1,747	88,226	2.02	14.90	26,032	1,314,647
2021-05-17	2021-04-26	4/A	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	P - Purchase	10,876	532,384	2.09	14.90	162,062	7,933,001
2021-05-17	2021-04-26	4/A	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	P - Purchase	14,790	729,732	2.07	14.90	220,384	10,873,664
2021-05-17	2021-04-23	4/A	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	P - Purchase	6,141	86,479	7.64	15.93	97,817	1,377,481
2021-05-17	2021-04-23	4/A	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	P - Purchase	62,948	80,338	361.98	17.00	1,070,116	1,365,746
2021-05-17	2021-04-23	4/A	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	P - Purchase	38,858	521,508	8.05	15.93	618,950	8,306,840
2021-05-17	2021-04-23	4/A	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	P - Purchase	398,300	482,650	472.20	17.00	6,771,100	8,205,050
2021-05-17	2021-04-23	4/A	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	P - Purchase	53,303	714,942	8.06	15.93	849,037	11,387,954
2021-05-17	2021-04-23	4/A	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	P - Purchase	546,346	661,639	473.88	17.00	9,287,882	11,247,863
2021-05-17	2021-05-13	4	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	P - Purchase	3,474	91,700	3.94	14.26	49,544	1,307,780
2021-05-17	2021-05-13	4	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	P - Purchase	22,721	555,105	4.27	14.26	324,036	7,916,630
2021-05-17	2021-05-13	4	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	P - Purchase	31,805	761,537	4.36	14.26	453,587	10,860,660
2021-04-27	2021-04-26	4	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	A - Award	1,747	88,226	2.02	14.90	26,032	1,314,647
2021-04-27	2021-04-26	4	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	A - Award	10,876	532,384	2.09	14.90	162,062	7,933,001
2021-04-27	2021-04-26	4	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	A - Award	14,790	729,732	2.07	14.90	220,384	10,873,664
2021-04-27	2021-04-23	4	RAIN	Rain Therapeutics Inc. Series B Convertible Preferred Stock	C - Conversion	-134,515	0	-100.00
2021-04-27	2021-04-23	4	RAIN	Rain Therapeutics Inc. Series A Convertible Preferred Stock	C - Conversion	-152,176	0	-100.00
2021-04-27	2021-04-23	4	RAIN	Rain Therapeutics Inc. Series A Convertible Preferred Stock	C - Conversion	-17,390	152,176	-10.26
2021-04-27	2021-04-23	4	RAIN	Rain Therapeutics Inc. Series B Convertible Preferred Stock	C - Conversion	-837,397	0	-100.00
2021-04-27	2021-04-23	4	RAIN	Rain Therapeutics Inc. Series A Convertible Preferred Stock	C - Conversion	-553,359	0	-100.00
2021-04-27	2021-04-23	4	RAIN	Rain Therapeutics Inc. Series A Convertible Preferred Stock	C - Conversion	-84,350	553,359	-13.23
2021-04-27	2021-04-23	4	RAIN	Rain Therapeutics Inc. Series B Convertible Preferred Stock	C - Conversion	-1,068,554	0	-100.00
2021-04-27	2021-04-23	4	RAIN	Rain Therapeutics Inc. Series A Convertible Preferred Stock	C - Conversion	-832,261	0	-100.00
2021-04-27	2021-04-23	4	RAIN	Rain Therapeutics Inc. Series A Convertible Preferred Stock	C - Conversion	-115,293	832,261	-12.17
2021-04-27	2021-04-23	4	RAIN	Rain Therapeutics Inc. Non-Voting Common Stock, $0.001 par value	C - Conversion	134,515	286,691	88.39
2021-04-27	2021-04-23	4	RAIN	Rain Therapeutics Inc. Non-Voting Common Stock, $0.001 par value	C - Conversion	152,176	152,176
2021-04-27	2021-04-23	4	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	A - Award	6,141	86,479	7.64	15.93	97,817	1,377,481
2021-04-27	2021-04-23	4	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	A - Award	62,948	80,338	361.98	17.00	1,070,116	1,365,746
2021-04-27	2021-04-23	4	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	C - Conversion	17,390	17,390
2021-04-27	2021-04-23	4	RAIN	Rain Therapeutics Inc. Non-Voting Common Stock, $0.001 par value	C - Conversion	837,397	1,390,756	151.33
2021-04-27	2021-04-23	4	RAIN	Rain Therapeutics Inc. Non-Voting Common Stock, $0.001 par value	C - Conversion	553,359	553,359
2021-04-27	2021-04-23	4	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	A - Award	38,858	521,508	8.05	15.93	618,950	8,306,840
2021-04-27	2021-04-23	4	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	A - Award	398,300	482,650	472.20	17.00	6,771,100	8,205,050
2021-04-27	2021-04-23	4	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	C - Conversion	84,350	84,350
2021-04-27	2021-04-23	4	RAIN	Rain Therapeutics Inc. Non-Voting Common Stock, $0.001 par value	C - Conversion	1,068,554	1,900,815	128.39
2021-04-27	2021-04-23	4	RAIN	Rain Therapeutics Inc. Non-Voting Common Stock, $0.001 par value	C - Conversion	832,261	832,261
2021-04-27	2021-04-23	4	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	A - Award	53,303	714,942	8.06	15.93	849,037	11,387,954
2021-04-27	2021-04-23	4	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	A - Award	546,346	661,639	473.88	17.00	9,287,882	11,247,863
2021-04-27	2021-04-23	4	RAIN	Rain Therapeutics Inc. Common Stock, $0.001 par value	C - Conversion	115,293	115,293
2021-04-05	2021-04-01	4	CTIC	CTI BIOPHARMA CORP Series X1 Convertible Preferred Stock	P - Purchase	17	17		25,000.00	425,000	425,000
2021-04-05	2021-04-01	4	CTIC	CTI BIOPHARMA CORP Series X1 Convertible Preferred Stock	P - Purchase	239	239		25,000.00	5,975,000	5,975,000
2021-04-05	2021-04-01	4	CTIC	CTI BIOPHARMA CORP Series X1 Convertible Preferred Stock	P - Purchase	344	344		25,000.00	8,600,000	8,600,000
2021-04-05	2021-04-01	4	CTIC	CTI BIOPHARMA CORP Common Stock, par value $0.001	P - Purchase	5,171	488,879	1.07	2.50	12,928	1,222,198
2021-04-05	2021-04-01	4	CTIC	CTI BIOPHARMA CORP Common Stock, par value $0.001	P - Purchase	950,016	3,059,296	45.04	2.50	2,375,040	7,648,240
2021-04-05	2021-04-01	4	CTIC	CTI BIOPHARMA CORP Common Stock, par value $0.001	P - Purchase	1,044,813	4,085,933	34.36	2.50	2,612,032	10,214,832
2021-04-02	2021-03-31	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	S - Sale	-81,903	149,975	-35.32	38.36	-3,141,799	5,753,041
2021-04-02	2021-03-31	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	S - Sale	-84,250	75,287	-52.81	38.36	-3,231,830	2,888,009
2021-04-02	2021-03-31	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	S - Sale	-205,807	1,544,897	-11.76	38.36	-7,894,757	59,262,249
2021-04-02	2021-03-31	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	S - Sale	-279,740	1,760,384	-13.71	38.36	-10,730,826	67,528,330
2021-04-01	2021-03-30	4	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share	P - Purchase	26,894	462,015	6.18	19.75	531,156	9,124,796
2021-04-01	2021-03-30	4	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share	P - Purchase	108,106	2,892,385	3.88	19.75	2,135,094	57,124,604
2021-04-01	2021-03-30	4	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share	P - Purchase	165,000	3,803,152	4.54	19.75	3,258,750	75,112,252
2021-03-24	2021-03-22	4	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share	P - Purchase	7,744	435,121	1.81	22.75	176,176	9,899,003
2021-03-24	2021-03-22	4	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share	P - Purchase	71,756	3,638,152	2.01	22.75	1,632,449	82,767,958
2021-03-18	2021-03-16	4	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share	P - Purchase	1,171	427,377	0.27	23.00	26,933	9,829,500
2021-03-18	2021-03-16	4	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share	P - Purchase	195,768	2,784,279	7.56	23.00	4,502,586	64,037,303
2021-03-18	2021-03-16	4	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share	P - Purchase	53,061	3,566,396	1.51	23.00	1,220,382	82,025,681
2021-03-12	2021-03-10	4	CTIC	CTI BIOPHARMA CORP Stock Option (Right to Buy)	A - Award	80,000	80,000
2021-03-08		3	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value per share			3,372,098
2021-03-08		3	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value per share			2,484,643
2021-03-08		3	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value per share			405,344
2021-02-16	2021-02-11	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	S - Sale	-152,127	534,847	-22.14	5.37	-816,709	2,871,380
2021-02-16	2021-02-11	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	S - Sale	-892,467	3,279,831	-21.39	5.37	-4,791,298	17,608,101
2021-02-16	2021-02-11	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	S - Sale	-1,215,491	4,448,421	-21.46	5.37	-6,525,485	23,881,793
2021-02-04	2021-02-02	4	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value	S - Sale	-4,325	233,150	-1.82	18.00	-77,850	4,196,700
2021-02-04	2021-02-02	4	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value	S - Sale	-16,850	1,188,131	-1.40	18.00	-303,300	21,386,358
2021-02-04	2021-02-02	4	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value	S - Sale	-25,234	1,642,186	-1.51	18.00	-454,212	29,559,348
2021-01-26	2021-01-22	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	S - Sale	-568,019	686,974	-45.26	4.14	-2,350,917	2,843,248
2021-01-26	2021-01-22	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	S - Sale	-2,458,838	4,172,298	-37.08	4.14	-10,176,639	17,268,307
2021-01-26	2021-01-22	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	S - Sale	-2,821,663	5,663,912	-33.25	4.14	-11,678,299	23,441,799
2021-01-25	2021-01-21	4	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share	P - Purchase	43,422	426,206	11.34	24.75	1,074,694	10,548,598
2021-01-25	2021-01-21	4	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share	P - Purchase	343,444	2,588,511	15.30	24.75	8,500,239	64,065,647
2021-01-25	2021-01-21	4	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share	P - Purchase	457,814	3,513,335	14.98	24.75	11,330,896	86,955,041
2020-12-28	2020-12-22	4	NVUS	Eledon Pharmaceuticals, Inc. Series X1 Convertible Preferred Stock	C - Conversion	-1,757	6,758	-20.63
2020-12-28	2020-12-22	4	NVUS	Eledon Pharmaceuticals, Inc. Series X1 Convertible Preferred Stock	C - Conversion	-9,169	39,693	-18.77
2020-12-28	2020-12-22	4	NVUS	Eledon Pharmaceuticals, Inc. Series X1 Convertible Preferred Stock	C - Conversion	-11,776	52,145	-18.42
2020-12-28	2020-12-22	4	NVUS	Eledon Pharmaceuticals, Inc. Series X Convertible Preferred	C - Conversion	-35	0	-100.00
2020-12-28	2020-12-22	4	NVUS	Eledon Pharmaceuticals, Inc. Series X Convertible Preferred	C - Conversion	-203	0	-100.00
2020-12-28	2020-12-22	4	NVUS	Eledon Pharmaceuticals, Inc. Series X Convertible Preferred	C - Conversion	-273	0	-100.00
2020-12-28	2020-12-22	4	NVUS	Eledon Pharmaceuticals, Inc. Common Stock, $0.001 par value	C - Conversion	97,615	113,152	628.27
2020-12-28	2020-12-22	4	NVUS	Eledon Pharmaceuticals, Inc. Common Stock, $0.001 par value	C - Conversion	1,944	15,537	14.30
2020-12-28	2020-12-22	4	NVUS	Eledon Pharmaceuticals, Inc. Common Stock, $0.001 par value	C - Conversion	509,410	598,624	571.00
2020-12-28	2020-12-22	4	NVUS	Eledon Pharmaceuticals, Inc. Common Stock, $0.001 par value	C - Conversion	11,278	89,214	14.47
2020-12-28	2020-12-22	4	NVUS	Eledon Pharmaceuticals, Inc. Common Stock, $0.001 par value	C - Conversion	654,215	771,780	556.47
2020-12-28	2020-12-22	4	NVUS	Eledon Pharmaceuticals, Inc. Common Stock, $0.001 par value	C - Conversion	15,166	117,565	14.81
2020-12-28		3	CTMX	CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share			2,945,743
2020-12-28		3	CTMX	CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share			2,164,406
2020-12-28		3	CTMX	CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share			358,450
2020-12-22	2020-12-18	4	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share	P - Purchase	45,032	2,245,067	2.05	16.05	722,764	36,033,325
2020-12-22	2020-12-18	4	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share	P - Purchase	114,968	3,055,521	3.91	16.05	1,845,236	49,041,112
2020-12-15	2020-12-11	4	XOMA	XOMA Corp 8.625% Series A Cumulative Perpetual Preferred Stock	P - Purchase	200,000	200,000		25.00	5,000,000	5,000,000
2020-12-11	2020-12-09	4	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value	S - Sale	-25,486	463,244	-5.21	18.00	-458,748	8,338,392
2020-12-11	2020-12-09	4	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value	S - Sale	-166,194	2,760,185	-5.68	18.00	-2,991,492	49,683,330
2020-12-11	2020-12-09	4	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value	S - Sale	-239,274	3,811,271	-5.91	18.00	-4,306,932	68,602,878
2020-12-04		3	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value			4,050,545
2020-12-04		3	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value			2,926,379
2020-12-04		3	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value			488,730
2020-11-20	2020-11-20	4	CYTK	CYTOKINETICS INC Call Option	J - Other	-93	0	-100.00
2020-11-20	2020-11-20	4	CYTK	CYTOKINETICS INC Call Option	J - Other	-551	0	-100.00
2020-11-20	2020-11-20	4	CYTK	CYTOKINETICS INC Call Option	J - Other	-740	0	-100.00
2020-11-20	2020-11-19	4	OLMA	Olema Pharmaceuticals, Inc. Series C Convertible Preferred Stock	C - Conversion	-73,399	0	-100.00
2020-11-20	2020-11-19	4	OLMA	Olema Pharmaceuticals, Inc. Series C Convertible Preferred Stock	C - Conversion	-522,403	0	-100.00
2020-11-20	2020-11-19	4	OLMA	Olema Pharmaceuticals, Inc. Series C Convertible Preferred Stock	C - Conversion	-760,155	0	-100.00
2020-11-20	2020-11-19	4	OLMA	Olema Pharmaceuticals, Inc. Series B Convertible Preferred Stock	C - Conversion	-101,784	0	-100.00
2020-11-20	2020-11-19	4	OLMA	Olema Pharmaceuticals, Inc. Series B Convertible Preferred Stock	C - Conversion	-673,281	0	-100.00
2020-11-20	2020-11-19	4	OLMA	Olema Pharmaceuticals, Inc. Series B Convertible Preferred Stock	C - Conversion	-889,186	0	-100.00
2020-11-20	2020-11-19	4	OLMA	Olema Pharmaceuticals, Inc. Series A-1 Convertible Preferred Stock	C - Conversion	-185,908	0	-100.00
2020-11-20	2020-11-19	4	OLMA	Olema Pharmaceuticals, Inc. Series A-1 Convertible Preferred Stock	C - Conversion	-881,156	0	-100.00
2020-11-20	2020-11-19	4	OLMA	Olema Pharmaceuticals, Inc. Series A-1 Convertible Preferred Stock	C - Conversion	-1,129,404	0	-100.00
2020-11-20	2020-11-19	4	OLMA	Olema Pharmaceuticals, Inc. Common stock, $0.0001 par value	P - Purchase	74,991	436,082	20.77	19.00	1,424,829	8,285,558
2020-11-20	2020-11-19	4	OLMA	Olema Pharmaceuticals, Inc. Common stock, $0.0001 par value	C - Conversion	73,399	361,091	25.51
2020-11-20	2020-11-19	4	OLMA	Olema Pharmaceuticals, Inc. Common stock, $0.0001 par value	C - Conversion	101,784	287,692	54.75
2020-11-20	2020-11-19	4	OLMA	Olema Pharmaceuticals, Inc. Common stock, $0.0001 par value	C - Conversion	185,908	185,908
2020-11-20	2020-11-19	4	OLMA	Olema Pharmaceuticals, Inc. Common stock, $0.0001 par value	P - Purchase	446,425	2,523,265	21.50	19.00	8,482,075	47,942,035
2020-11-20	2020-11-19	4	OLMA	Olema Pharmaceuticals, Inc. Common stock, $0.0001 par value	C - Conversion	522,403	2,076,840	33.61
2020-11-20	2020-11-19	4	OLMA	Olema Pharmaceuticals, Inc. Common stock, $0.0001 par value	C - Conversion	673,281	1,554,437	76.41
2020-11-20	2020-11-19	4	OLMA	Olema Pharmaceuticals, Inc. Common stock, $0.0001 par value	C - Conversion	881,156	881,156
2020-11-20	2020-11-19	4	OLMA	Olema Pharmaceuticals, Inc. Common stock, $0.0001 par value	P - Purchase	613,918	3,392,663	22.09	19.00	11,664,442	64,460,597
2020-11-20	2020-11-19	4	OLMA	Olema Pharmaceuticals, Inc. Common stock, $0.0001 par value	C - Conversion	760,155	2,778,745	37.66
2020-11-20	2020-11-19	4	OLMA	Olema Pharmaceuticals, Inc. Common stock, $0.0001 par value	C - Conversion	889,186	2,018,590	78.73
2020-11-20	2020-11-19	4	OLMA	Olema Pharmaceuticals, Inc. Common stock, $0.0001 par value	C - Conversion	1,129,404	1,129,404
2020-11-20	2020-11-18	4	OLMA	Olema Pharmaceuticals, Inc. Stock Option (Right to buy)	A - Award	21,520	21,520
2020-11-20	2020-11-18	4	OLMA	Olema Pharmaceuticals, Inc. Stock Option (Right to buy)	A - Award	21,520	21,520
2020-11-20	2020-11-18	4	OLMA	Olema Pharmaceuticals, Inc. Stock Option (Right to buy)	A - Award	21,520	21,520
2020-11-16		3	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value			3,822,766
2020-11-16		3	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value			2,777,320
2020-11-16		3	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value			465,924
2020-11-13	2020-11-11	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	S - Sale	-502,649	81,263	-86.08	20.19	-10,146,825	1,640,432
2020-11-13	2020-11-11	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	S - Sale	-2,949,477	485,513	-85.87	20.19	-59,540,207	9,800,905
2020-11-13	2020-11-11	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	S - Sale	-3,941,214	670,695	-85.46	20.19	-79,560,105	13,539,119
2020-11-06	2020-11-04	4	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value	P - Purchase	86,090	630,453	15.81	2.60	223,834	1,639,178
2020-11-06	2020-11-04	4	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value	P - Purchase	506,155	3,712,350	15.79	2.60	1,316,003	9,652,110
2020-11-06	2020-11-04	4	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value	P - Purchase	674,492	4,980,812	15.66	2.60	1,753,679	12,950,111
2020-11-06	2020-11-06	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	2,334	583,912	0.40	4.98	11,633	2,910,217
2020-11-06	2020-11-06	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	10,436	3,434,990	0.30	4.98	52,013	17,119,990
2020-11-06	2020-11-06	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	17,230	4,611,909	0.37	4.98	85,874	22,985,754
2020-11-06	2020-11-04	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	15,355	581,578	2.71	4.88	74,997	2,840,543
2020-11-06	2020-11-04	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	143,403	3,424,554	4.37	4.88	700,409	16,726,207
2020-11-06	2020-11-04	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	257,804	4,594,679	5.94	4.88	1,259,166	22,441,331
2020-11-03	2020-10-30	4	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value	P - Purchase	15,472	544,363	2.93	2.75	42,548	1,496,998
2020-11-03	2020-10-30	4	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value	P - Purchase	250,755	3,206,195	8.48	2.75	689,576	8,817,036
2020-11-03	2020-10-30	4	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value	P - Purchase	666,385	4,306,320	18.31	2.75	1,832,559	11,842,380
2020-10-08	2020-10-06	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	25,107	566,223	4.64	5.04	126,414	2,850,933
2020-10-08	2020-10-06	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	162,352	3,281,151	5.21	5.04	817,442	16,520,595
2020-10-08	2020-10-06	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	157,782	4,336,875	3.78	5.04	794,432	21,836,166
2020-10-05		3	NVUS	Novus Therapeutics, Inc. Common Stock			102,400
2020-10-05		3	NVUS	Novus Therapeutics, Inc. Common Stock			77,936
2020-10-05		3	NVUS	Novus Therapeutics, Inc. Common Stock			13,595
2020-09-24	2020-09-22	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	32	541,116	0.01	3.80	122	2,055,537
2020-09-23	2020-09-23	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	7,201	1,750,704	0.41	18.20	131,057	31,862,463
2020-09-23	2020-09-23	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	9,888	2,040,124	0.49	18.20	179,960	37,129,849
2020-09-23	2020-09-22	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	4,991	1,743,503	0.29	18.45	92,062	32,160,133
2020-09-23	2020-09-22	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	6,960	2,030,236	0.34	18.45	128,382	37,449,124
2020-09-23	2020-09-21	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	10,069	1,738,512	0.58	18.39	185,120	31,962,717
2020-09-23	2020-09-21	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	12,259	2,023,276	0.61	18.39	225,383	37,198,132
2020-09-17	2020-09-15	4	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share	P - Purchase	10,258	382,784	2.75	11.75	120,532	4,497,712
2020-09-17	2020-09-15	4	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share	P - Purchase	58,745	2,200,035	2.74	11.75	690,254	25,850,411
2020-09-17	2020-09-15	4	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share	P - Purchase	77,751	2,940,553	2.72	11.75	913,574	34,551,498
2020-09-14	2020-09-10	4	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share	P - Purchase	12,816	372,526	3.56	11.10	142,235	4,134,368
2020-09-14	2020-09-10	4	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share	P - Purchase	76,374	2,141,290	3.70	11.10	847,614	23,764,465
2020-09-14	2020-09-10	4	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share	P - Purchase	100,461	2,862,802	3.64	11.10	1,114,936	31,771,949
2020-09-10	2020-09-04	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	3,830	1,728,443	0.22	18.77	71,891	32,443,912
2020-09-10	2020-09-04	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	3,907	2,011,017	0.19	18.77	73,337	37,747,996
2020-09-08	2020-09-03	4	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share	P - Purchase	14,339	359,710	4.15	11.17	160,167	4,017,961
2020-09-08	2020-09-03	4	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share	P - Purchase	82,740	2,064,916	4.17	11.17	924,206	23,065,112
2020-09-08	2020-09-03	4	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share	P - Purchase	104,827	2,762,341	3.94	11.17	1,170,918	30,855,349
2020-09-01	2020-09-01	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	7,672	1,724,613	0.45	18.87	144,741	32,536,721
2020-09-01	2020-09-01	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	9,900	2,007,110	0.50	18.87	186,774	37,866,338
2020-09-01	2020-08-31	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	6,862	1,716,941	0.40	18.48	126,814	31,730,100
2020-09-01	2020-08-31	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	9,143	1,997,210	0.46	18.48	168,968	36,909,639
2020-09-01	2020-08-28	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	922	1,710,079	0.05	19.17	17,676	32,785,464
2020-09-01	2020-08-28	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	1,122	1,988,067	0.06	19.17	21,511	38,115,022
2020-08-25	2020-08-21	4	KYMR	Kymera Therapeutics, Inc. Series C Preferred Stock	C - Conversion	-180,686	0	-100.00
2020-08-25	2020-08-21	4	KYMR	Kymera Therapeutics, Inc. Series C Preferred Stock	C - Conversion	-1,000,955	0	-100.00
2020-08-25	2020-08-21	4	KYMR	Kymera Therapeutics, Inc. Series C Preferred Stock	C - Conversion	-1,336,390	0	-100.00
2020-08-25	2020-08-21	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	A - Award	67,791	181,081	59.84	20.00	1,355,820	3,621,620
2020-08-25	2020-08-21	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	C - Conversion	113,290	113,290
2020-08-25	2020-08-21	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	A - Award	389,709	1,017,307	62.10	20.00	7,794,180	20,346,140
2020-08-25	2020-08-21	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	C - Conversion	627,598	627,598
2020-08-25	2020-08-21	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	A - Award	521,193	1,359,109	62.20	20.00	10,423,860	27,182,180
2020-08-25	2020-08-21	4	KYMR	Kymera Therapeutics, Inc. Common Stock, $0.0001 par value	C - Conversion	837,916	837,916
2020-08-25	2020-08-20	4	KYMR	Kymera Therapeutics, Inc. Stock Option (Right to Buy)	A - Award	-40,127	40,127	-50.00
2020-08-25	2020-08-25	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	2,244	1,709,157	0.13	19.74	44,308	33,747,305
2020-08-25	2020-08-25	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	3,443	1,986,945	0.17	19.74	67,982	39,232,229
2020-08-25	2020-08-24	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	5,179	1,706,913	0.30	19.31	100,003	32,959,295
2020-08-25	2020-08-24	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	6,504	1,983,502	0.33	19.31	125,588	38,300,035
2020-08-25	2020-08-21	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	1,607	1,701,734	0.09	19.32	31,050	32,880,224
2020-08-25	2020-08-21	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	9,198	1,976,998	0.47	19.32	177,720	38,198,765
2020-08-20	2020-08-18	4	PRNB	Principia Biopharma Inc. Call Option (Right to Buy)	P - Purchase	158	3,547	4.66	35.79	5,655	126,947
2020-08-20	2020-08-18	4	PRNB	Principia Biopharma Inc. Call Option (Right to Buy)	P - Purchase	905	20,390	4.64	35.79	32,390	729,758
2020-08-20	2020-08-18	4	PRNB	Principia Biopharma Inc. Call Option (Right to Buy)	P - Purchase	1,205	27,265	4.62	35.79	43,127	975,814
2020-08-20	2020-08-20	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	1,772	1,967,800	0.09	19.12	33,881	37,624,336
2020-08-20	2020-08-19	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	3,496	1,966,028	0.18	19.70	68,877	38,733,897
2020-08-20	2020-08-18	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	895	1,962,532	0.05	19.27	17,246	37,816,814
2020-08-14	2020-08-14	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	21,922	1,961,637	1.13	18.69	409,810	36,670,842
2020-08-14	2020-08-13	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	1,050	1,939,715	0.05	17.80	18,693	34,533,134
2020-08-14	2020-08-12	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	4,050	1,938,665	0.21	17.34	70,233	33,619,359
2020-07-02	2020-06-30	4	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value	P - Purchase	81	237,475	0.03	13.32	1,079	3,162,312
2020-07-02	2020-06-30	4	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value	P - Purchase	929	1,204,981	0.08	13.32	12,371	16,046,009
2020-07-02	2020-06-30	4	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value	P - Purchase	1,521	1,667,420	0.09	13.32	20,254	22,204,032
2020-06-22	2020-06-22	4	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value	P - Purchase	1,354	237,394	0.57	13.93	18,868	3,308,014
2020-06-22	2020-06-22	4	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value	P - Purchase	7,854	1,204,052	0.66	13.93	109,443	16,778,103
2020-06-22	2020-06-22	4	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value	P - Purchase	10,524	1,665,899	0.64	13.93	146,649	23,213,803
2020-06-22	2020-06-19	4	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value	P - Purchase	6,769	236,040	2.95	14.39	97,403	3,396,498
2020-06-22	2020-06-19	4	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value	P - Purchase	39,052	1,196,198	3.37	14.39	561,939	17,212,691
2020-06-22	2020-06-19	4	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value	P - Purchase	52,443	1,655,375	3.27	14.39	754,629	23,820,019
2020-06-22		3	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value			4,592,281
2020-06-22		3	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value			4,146,495
2020-06-22		3	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value			3,218,620
2020-06-22		3	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value			4,592,281
2020-06-22		3	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value			4,146,495
2020-06-22		3	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value			3,218,620
2020-06-22		3	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value			4,592,281
2020-06-22		3	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value			4,146,495
2020-06-22		3	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value			3,218,620
2020-06-22		3	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value			4,592,281
2020-06-22		3	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value			4,146,495
2020-06-22		3	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value			3,218,620
2020-06-22		3	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value			4,592,281
2020-06-22		3	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value			4,146,495
2020-06-22		3	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value			3,218,620
2020-06-22		3	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value			4,592,281
2020-06-22		3	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value			4,146,495
2020-06-22		3	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value			3,218,620
2020-06-22		3	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value			4,592,281
2020-06-22		3	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value			4,146,495
2020-06-22		3	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value			3,218,620
2020-06-22		3	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value			4,592,281
2020-06-22		3	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value			4,146,495
2020-06-22		3	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value			3,218,620
2020-06-22		3	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value			4,592,281
2020-06-22		3	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value			4,146,495
2020-06-22		3	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value			3,218,620
2020-06-22		3	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value			4,592,281
2020-06-22		3	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value			4,146,495
2020-06-22		3	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value			3,218,620
2020-06-22		3	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value			4,592,281
2020-06-22		3	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value			4,146,495
2020-06-22		3	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value			3,218,620
2020-06-22		3	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value			4,592,281
2020-06-22		3	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value			4,146,495
2020-06-22		3	IDYA	IDEAYA Biosciences, Inc. Common Stock, $0.0001 par value			3,218,620
2020-06-10	2020-06-08	4	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share	P - Purchase	6,967	345,371	2.06	15.20	105,898	5,249,639
2020-06-10	2020-06-08	4	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share	P - Purchase	33,321	1,982,176	1.71	15.20	506,479	30,129,075
2020-06-10	2020-06-08	4	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share	P - Purchase	46,966	2,657,514	1.80	15.20	713,883	40,394,213
2020-06-03	2020-06-01	4	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share	P - Purchase	94,101	338,404	38.52	14.00	1,317,414	4,737,656
2020-06-03	2020-06-01	4	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share	P - Purchase	561,966	1,948,855	40.52	14.00	7,867,524	27,283,970
2020-06-03	2020-06-01	4	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share	P - Purchase	806,443	2,610,548	44.70	14.00	11,290,202	36,547,672
2020-05-26	2020-05-21	4	CALA	Calithera Biosciences, Inc. Common Stock, $0.0001 par value	S - Sale	-192,250	480,432	-28.58	6.00	-1,153,500	2,882,592
2020-05-26	2020-05-21	4	CALA	Calithera Biosciences, Inc. Common Stock, $0.0001 par value	S - Sale	-1,064,332	2,766,561	-27.78	6.00	-6,385,992	16,599,366
2020-05-26	2020-05-21	4	CALA	Calithera Biosciences, Inc. Common Stock, $0.0001 par value	S - Sale	-1,027,016	3,712,340	-21.67	6.00	-6,162,096	22,274,040
2020-05-18	2020-05-14	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	4,476	541,084	0.83	4.10	18,352	2,218,444
2020-05-18	2020-05-14	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	39,810	3,118,799	1.29	4.10	163,221	12,787,076
2020-05-18	2020-05-14	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	249,301	4,179,093	6.34	4.10	1,022,134	17,134,281
2020-04-17	2020-04-15	4	XOMA	XOMA Corp Series Y Convertible Preferred Stock	C - Conversion	-597	0	-100.00
2020-04-17	2020-04-15	4	XOMA	XOMA Corp Series Y Convertible Preferred Stock	C - Conversion	-656	0	-100.00
2020-04-17	2020-04-15	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	C - Conversion	596,813	1,700,127	54.09	13.00	7,758,569	22,101,651
2020-04-17	2020-04-15	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	C - Conversion	655,959	1,934,615	51.30	13.00	8,527,467	25,149,995
2020-03-27	2020-03-25	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	8,264	1,278,656	0.65	17.20	142,129	21,991,093
2020-03-20	2020-03-18	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	4,439	1,270,392	0.35	14.52	64,475	18,451,936
2020-03-17	2020-03-17	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	8,113	1,265,953	0.64	15.73	127,648	19,918,125
2020-03-17	2020-03-16	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	10,164	1,257,840	0.81	15.73	159,916	19,790,351
2020-03-17	2020-03-13	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	100,000	1,247,676	8.71	18.34	1,834,090	22,883,501
2020-03-04	2020-03-04	4	CTIC	CTI BIOPHARMA CORP Series X Convertible Preferred Stock	P - Purchase	12	12
2020-03-04	2020-03-04	4	CTIC	CTI BIOPHARMA CORP Series X Convertible Preferred Stock	P - Purchase	87	191	83.65
2020-03-04	2020-03-04	4	CTIC	CTI BIOPHARMA CORP Series X Convertible Preferred Stock	P - Purchase	841	1,250	205.62
2020-03-04	2020-03-04	4	CTIC	CTI BIOPHARMA CORP Series X Convertible Preferred Stock	P - Purchase	981	1,594	160.03
2020-03-04	2020-03-02	4	CTIC	CTI BIOPHARMA CORP Series X Convertible Preferred Stock	X - Other	104	104
2020-03-04	2020-03-02	4	CTIC	CTI BIOPHARMA CORP Subscription Rights (right to buy)	X - Other	-104	0	-100.00
2020-03-04	2020-03-02	4	CTIC	CTI BIOPHARMA CORP Series X Convertible Preferred Stock	X - Other	409	409
2020-03-04	2020-03-02	4	CTIC	CTI BIOPHARMA CORP Subscription Rights (right to buy)	X - Other	-409	0	-100.00
2020-03-04	2020-03-02	4	CTIC	CTI BIOPHARMA CORP Series X Convertible Preferred Stock	X - Other	613	613
2020-03-04	2020-03-02	4	CTIC	CTI BIOPHARMA CORP Subscription Rights (right to buy)	X - Other	-613	0	-100.00
2020-02-18	2020-02-13	4	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value	S - Sale	-74,893	424,419	-15.00	15.79	-1,182,321	6,700,218
2020-02-18	2020-02-13	4	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value	S - Sale	-510,793	2,350,829	-17.85	15.79	-8,063,787	37,112,067
2020-02-18	2020-02-13	4	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value	S - Sale	-486,344	3,131,432	-13.44	15.79	-7,677,815	49,435,291
2020-01-21	2020-01-16	4	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share	P - Purchase	19,727	244,303	8.78	16.15	318,591	3,945,493
2020-01-21	2020-01-16	4	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share	P - Purchase	112,561	1,386,889	8.83	16.15	1,817,860	22,398,257
2020-01-21	2020-01-16	4	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share	P - Purchase	146,442	1,804,105	8.83	16.15	2,365,038	29,136,296
2020-01-15	2020-01-13	4	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share	P - Purchase	5,406	224,576	2.47	14.98	80,973	3,363,789
2020-01-15	2020-01-13	4	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share	P - Purchase	25,108	1,274,328	2.01	14.98	376,078	19,087,395
2020-01-15	2020-01-13	4	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share	P - Purchase	53,448	1,657,663	3.33	14.98	800,566	24,829,139
2020-01-13		3	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share			4,676,820
2020-01-13		3	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share			4,321,825
2020-01-13		3	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share			3,291,775
2020-01-13		3	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share			4,676,820
2020-01-13		3	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share			4,321,825
2020-01-13		3	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share			3,291,775
2020-01-13		3	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share			4,676,820
2020-01-13		3	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share			4,321,825
2020-01-13		3	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share			3,291,775
2020-01-13		3	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share			4,676,820
2020-01-13		3	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share			4,321,825
2020-01-13		3	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share			3,291,775
2020-01-13		3	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share			4,676,820
2020-01-13		3	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share			4,321,825
2020-01-13		3	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share			3,291,775
2020-01-13		3	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share			4,676,820
2020-01-13		3	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share			4,321,825
2020-01-13		3	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share			3,291,775
2020-01-13		3	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share			4,676,820
2020-01-13		3	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share			4,321,825
2020-01-13		3	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share			3,291,775
2020-01-13		3	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share			4,676,820
2020-01-13		3	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share			4,321,825
2020-01-13		3	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share			3,291,775
2020-01-13		3	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share			4,676,820
2020-01-13		3	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share			4,321,825
2020-01-13		3	MRUS	Merus N.V. Common Shares, (euro)0.09 nominal value per share			3,291,775
2019-12-26	2019-12-20	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	32,606	536,608	6.47	4.05	132,054	2,173,262
2019-12-26	2019-12-20	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	201,096	3,078,989	6.99	4.05	814,439	12,469,905
2019-12-26	2019-12-20	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	281,318	3,929,792	7.71	4.05	1,139,338	15,915,658
2019-12-20	2019-12-19	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	165,961	1,103,314	17.71	22.00	3,651,142	24,272,908
2019-12-20	2019-12-19	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	207,234	1,147,676	22.04	22.00	4,559,148	25,248,872
2019-12-20	2019-12-18	4	XOMA	XOMA Corp Subscription Rights (right to buy)	X - Other	-35,888	0	-100.00
2019-12-20	2019-12-18	4	XOMA	XOMA Corp Subscription Rights (right to buy)	X - Other	-190,899	0	-100.00
2019-12-20	2019-12-18	4	XOMA	XOMA Corp Subscription Rights (right to buy)	X - Other	-245,481	0	-100.00
2019-12-20	2019-12-18	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	X - Other	35,888	159,537	29.02	22.00	789,536	3,509,814
2019-12-20	2019-12-18	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	X - Other	190,899	937,353	25.57	22.00	4,199,778	20,621,766
2019-12-20	2019-12-18	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	X - Other	245,481	940,442	35.32	22.00	5,400,582	20,689,724
2019-12-12		3	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value			10,080,782
2019-12-12		3	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value			9,353,356
2019-12-12		3	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value			7,112,414
2019-12-12		3	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value			10,080,782
2019-12-12		3	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value			9,353,356
2019-12-12		3	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value			7,112,414
2019-12-12		3	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value			10,080,782
2019-12-12		3	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value			9,353,356
2019-12-12		3	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value			7,112,414
2019-12-12		3	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value			10,080,782
2019-12-12		3	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value			9,353,356
2019-12-12		3	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value			7,112,414
2019-12-12		3	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value			10,080,782
2019-12-12		3	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value			9,353,356
2019-12-12		3	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value			7,112,414
2019-12-12		3	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value			10,080,782
2019-12-12		3	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value			9,353,356
2019-12-12		3	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value			7,112,414
2019-12-12		3	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value			10,080,782
2019-12-12		3	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value			9,353,356
2019-12-12		3	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value			7,112,414
2019-12-12		3	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value			10,080,782
2019-12-12		3	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value			9,353,356
2019-12-12		3	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value			7,112,414
2019-12-12		3	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value			10,080,782
2019-12-12		3	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value			9,353,356
2019-12-12		3	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value			7,112,414
2019-12-12	2019-12-11	4	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value	P - Purchase	8,506	499,312	1.73	9.52	80,935	4,750,954
2019-12-12	2019-12-11	4	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value	P - Purchase	49,804	2,861,622	1.77	9.52	473,885	27,228,333
2019-12-12	2019-12-11	4	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value	P - Purchase	60,103	3,617,776	1.69	9.52	571,880	34,423,139
2019-12-12	2019-12-10	4	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value	P - Purchase	15,030	490,806	3.16	9.40	141,282	4,613,576
2019-12-12	2019-12-10	4	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value	P - Purchase	95,100	2,811,818	3.50	9.40	893,940	26,431,089
2019-12-12	2019-12-10	4	CYTK	CYTOKINETICS INC Common Stock, $0.001 par value	P - Purchase	113,529	3,557,673	3.30	9.40	1,067,173	33,442,126
2019-12-11	2019-12-09	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	2,397	504,002	0.48	4.02	9,630	2,024,828
2019-12-11	2019-12-09	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	18,729	2,877,893	0.66	4.02	75,244	11,561,935
2019-12-11	2019-12-09	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	113,874	3,648,474	3.22	4.02	457,489	14,657,744
2019-11-26	2019-11-22	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	81,857	501,605	19.50	3.40	278,322	1,705,507
2019-11-26	2019-11-22	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	462,056	2,859,164	19.28	3.40	1,571,037	9,721,444
2019-11-26	2019-11-22	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	576,097	3,534,600	19.47	3.40	1,958,787	12,017,993
2019-11-22	2019-11-20	4	CALA	Calithera Biosciences, Inc. Common Stock, $0.0001 par value	P - Purchase	14,151	672,682	2.15	3.91	55,353	2,631,263
2019-11-22	2019-11-20	4	CALA	Calithera Biosciences, Inc. Common Stock, $0.0001 par value	P - Purchase	79,285	3,830,893	2.11	3.91	310,131	14,984,921
2019-11-22	2019-11-20	4	CALA	Calithera Biosciences, Inc. Common Stock, $0.0001 par value	P - Purchase	98,518	4,739,356	2.12	3.91	385,363	18,538,465
2019-11-18	2019-11-14	4	CALA	Calithera Biosciences, Inc. Common Stock, $0.0001 par value	P - Purchase	11,105	658,531	1.72	3.37	37,424	2,219,249
2019-11-18	2019-11-14	4	CALA	Calithera Biosciences, Inc. Common Stock, $0.0001 par value	P - Purchase	45,888	3,751,608	1.24	3.37	154,643	12,642,919
2019-11-18	2019-11-14	4	CALA	Calithera Biosciences, Inc. Common Stock, $0.0001 par value	P - Purchase	71,495	4,640,838	1.56	3.37	240,938	15,639,624
2019-11-07	2019-11-05	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	70,921	419,748	20.33	4.00	283,684	1,678,992
2019-11-07	2019-11-05	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	400,470	2,397,108	20.06	4.00	1,601,880	9,588,432
2019-11-07	2019-11-05	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	496,721	2,958,503	20.18	4.00	1,986,884	11,834,012
2019-10-31	2019-10-30	4	CALA	Calithera Biosciences, Inc. Common Stock, $0.0001 par value	P - Purchase	57,868	647,426	9.82	2.70	156,244	1,748,050
2019-10-31	2019-10-30	4	CALA	Calithera Biosciences, Inc. Common Stock, $0.0001 par value	P - Purchase	331,048	3,705,720	9.81	2.70	893,830	10,005,444
2019-10-31	2019-10-30	4	CALA	Calithera Biosciences, Inc. Common Stock, $0.0001 par value	P - Purchase	408,592	4,569,343	9.82	2.70	1,103,198	12,337,226
2019-10-31	2019-10-29	4	CALA	Calithera Biosciences, Inc. Common Stock, $0.0001 par value	P - Purchase	116,552	589,558	24.64	2.60	303,035	1,532,851
2019-10-31	2019-10-29	4	CALA	Calithera Biosciences, Inc. Common Stock, $0.0001 par value	P - Purchase	610,052	3,374,672	22.07	2.60	1,586,135	8,774,147
2019-10-31	2019-10-29	4	CALA	Calithera Biosciences, Inc. Common Stock, $0.0001 par value	P - Purchase	872,373	4,160,751	26.53	2.60	2,268,170	10,817,953
2019-10-31	2019-10-31	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	504	348,827	0.14	3.85	1,940	1,342,844
2019-10-31	2019-10-31	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	2,913	1,996,638	0.15	3.85	11,214	7,686,258
2019-10-31	2019-10-31	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	3,416	2,461,782	0.14	3.85	13,150	9,476,876
2019-10-31	2019-10-30	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	1,456	348,323	0.42	3.89	5,667	1,355,708
2019-10-31	2019-10-30	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	8,236	1,993,725	0.41	3.89	32,055	7,759,777
2019-10-31	2019-10-30	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	10,389	2,458,366	0.42	3.89	40,435	9,568,206
2019-10-31	2019-10-29	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	240	346,867	0.07	3.90	935	1,351,706
2019-10-31	2019-10-29	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	1,133	1,985,489	0.06	3.90	4,415	7,737,252
2019-10-31	2019-10-29	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	1,027	2,447,977	0.04	3.90	4,002	9,539,522
2019-10-25	2019-10-25	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	2,155	346,627	0.63	3.75	8,075	1,298,915
2019-10-25	2019-10-25	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	12,899	1,984,356	0.65	3.75	48,336	7,435,977
2019-10-25	2019-10-25	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	15,728	2,446,950	0.65	3.75	58,938	9,169,456
2019-10-25	2019-10-24	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	1,629	344,472	0.48	3.74	6,100	1,289,944
2019-10-25	2019-10-24	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	57,723	1,971,457	3.02	3.74	216,155	7,382,515
2019-10-25	2019-10-24	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	76,036	2,431,222	3.23	3.74	284,732	9,104,197
2019-10-25	2019-10-23	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	3,200	2,355,186	0.14	3.75	11,986	8,821,349
2019-10-08	2019-10-08	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	4,689	342,843	1.39	3.68	17,270	1,262,691
2019-10-08	2019-10-08	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	24,716	1,913,734	1.31	3.68	91,029	7,048,282
2019-10-08	2019-10-08	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	31,007	2,351,986	1.34	3.68	114,199	8,662,364
2019-10-08	2019-10-07	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	24,425	338,154	7.79	3.75	91,594	1,268,078
2019-10-08	2019-10-07	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	14,242	313,729	4.76	3.75	53,382	1,175,919
2019-10-08	2019-10-07	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	138,609	1,889,018	7.92	3.75	519,784	7,083,818
2019-10-08	2019-10-07	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	80,821	1,750,409	4.84	3.75	302,933	6,560,883
2019-10-08	2019-10-07	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	168,640	2,320,979	7.84	3.75	632,400	8,703,671
2019-10-08	2019-10-07	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	98,333	2,152,339	4.79	3.75	368,572	8,067,397
2019-10-08	2019-10-04	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	991	299,487	0.33	3.74	3,704	1,119,333
2019-10-08	2019-10-04	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	7,314	1,669,588	0.44	3.74	27,336	6,240,085
2019-10-08	2019-10-04	4	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value	P - Purchase	7,695	2,054,006	0.38	3.74	28,760	7,676,847
2019-10-02		3	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value			6,053,392
2019-10-02		3	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value			5,669,355
2019-10-02		3	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value			4,305,577
2019-10-02		3	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value			6,053,392
2019-10-02		3	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value			5,669,355
2019-10-02		3	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value			4,305,577
2019-10-02		3	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value			6,053,392
2019-10-02		3	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value			5,669,355
2019-10-02		3	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value			4,305,577
2019-10-02		3	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value			6,053,392
2019-10-02		3	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value			5,669,355
2019-10-02		3	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value			4,305,577
2019-10-02		3	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value			6,053,392
2019-10-02		3	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value			5,669,355
2019-10-02		3	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value			4,305,577
2019-10-02		3	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value			6,053,392
2019-10-02		3	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value			5,669,355
2019-10-02		3	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value			4,305,577
2019-10-02		3	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value			6,053,392
2019-10-02		3	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value			5,669,355
2019-10-02		3	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value			4,305,577
2019-10-02		3	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value			6,053,392
2019-10-02		3	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value			5,669,355
2019-10-02		3	FPRX	FIVE PRIME THERAPEUTICS, INC. Common Stock, $0.001 par value			4,305,577
2019-09-10	2019-09-06	4	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value	S - Sale	-1,128	314,139	-0.36	4.50	-5,075	1,413,437
2019-09-10	2019-09-06	4	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value	S - Sale	-25,720	2,233,074	-1.14	4.50	-115,725	10,047,493
2019-09-10	2019-09-06	4	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value	S - Sale	-23,152	2,385,055	-0.96	4.50	-104,170	10,731,316
2019-09-10		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			7,390,475
2019-09-10		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			7,241,062
2019-09-10		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			5,297,535
2019-09-10		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			7,390,475
2019-09-10		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			7,241,062
2019-09-10		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			5,297,535
2019-09-10		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			7,390,475
2019-09-10		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			7,241,062
2019-09-10		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			5,297,535
2019-09-10		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			7,390,475
2019-09-10		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			7,241,062
2019-09-10		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			5,297,535
2019-09-10		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			7,390,475
2019-09-10		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			7,241,062
2019-09-10		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			5,297,535
2019-09-10		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			7,390,475
2019-09-10		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			7,241,062
2019-09-10		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			5,297,535
2019-09-10		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			7,390,475
2019-09-10		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			7,241,062
2019-09-10		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			5,297,535
2019-09-10		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			7,390,475
2019-09-10		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			7,241,062
2019-09-10		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			5,297,535
2019-09-10		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			7,390,475
2019-09-10		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			7,241,062
2019-09-10		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			5,297,535
2019-09-09	2019-09-05	4	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value	P - Purchase	124,956	528,891	30.93	3.18	397,610	1,682,931
2019-09-09	2019-09-05	4	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value	P - Purchase	689,834	2,955,440	30.45	3.18	2,195,052	9,404,210
2019-09-09	2019-09-05	4	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value	P - Purchase	853,956	3,639,935	30.65	3.18	2,717,288	11,582,273
2019-08-26		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value			8,241,499
2019-08-26		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value			7,721,126
2019-08-26		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value			5,859,455
2019-08-26		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value			8,241,499
2019-08-26		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value			7,721,126
2019-08-26		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value			5,859,455
2019-08-26		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value			8,241,499
2019-08-26		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value			7,721,126
2019-08-26		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value			5,859,455
2019-08-26		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value			8,241,499
2019-08-26		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value			7,721,126
2019-08-26		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value			5,859,455
2019-08-26		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value			8,241,499
2019-08-26		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value			7,721,126
2019-08-26		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value			5,859,455
2019-08-26		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value			8,241,499
2019-08-26		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value			7,721,126
2019-08-26		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value			5,859,455
2019-08-26		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value			8,241,499
2019-08-26		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value			7,721,126
2019-08-26		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value			5,859,455
2019-08-26		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value			8,241,499
2019-08-26		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value			7,721,126
2019-08-26		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value			5,859,455
2019-08-26		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value			8,241,499
2019-08-26		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value			7,721,126
2019-08-26		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value			5,859,455
2019-07-01		3	CALA	Calithera Biosciences, Inc. Common Stock, $0.0001 par value			9,814,382
2019-07-01		3	CALA	Calithera Biosciences, Inc. Common Stock, $0.0001 par value			9,290,624
2019-07-01		3	CALA	Calithera Biosciences, Inc. Common Stock, $0.0001 par value			6,999,010
2019-07-01		3	CALA	Calithera Biosciences, Inc. Common Stock, $0.0001 par value			9,814,382
2019-07-01		3	CALA	Calithera Biosciences, Inc. Common Stock, $0.0001 par value			9,290,624
2019-07-01		3	CALA	Calithera Biosciences, Inc. Common Stock, $0.0001 par value			6,999,010
2019-07-01		3	CALA	Calithera Biosciences, Inc. Common Stock, $0.0001 par value			9,814,382
2019-07-01		3	CALA	Calithera Biosciences, Inc. Common Stock, $0.0001 par value			9,290,624
2019-07-01		3	CALA	Calithera Biosciences, Inc. Common Stock, $0.0001 par value			6,999,010
2019-07-01		3	CALA	Calithera Biosciences, Inc. Common Stock, $0.0001 par value			9,814,382
2019-07-01		3	CALA	Calithera Biosciences, Inc. Common Stock, $0.0001 par value			9,290,624
2019-07-01		3	CALA	Calithera Biosciences, Inc. Common Stock, $0.0001 par value			6,999,010
2019-07-01		3	CALA	Calithera Biosciences, Inc. Common Stock, $0.0001 par value			9,814,382
2019-07-01		3	CALA	Calithera Biosciences, Inc. Common Stock, $0.0001 par value			9,290,624
2019-07-01		3	CALA	Calithera Biosciences, Inc. Common Stock, $0.0001 par value			6,999,010
2019-07-01		3	CALA	Calithera Biosciences, Inc. Common Stock, $0.0001 par value			9,814,382
2019-07-01		3	CALA	Calithera Biosciences, Inc. Common Stock, $0.0001 par value			9,290,624
2019-07-01		3	CALA	Calithera Biosciences, Inc. Common Stock, $0.0001 par value			6,999,010
2019-07-01		3	CALA	Calithera Biosciences, Inc. Common Stock, $0.0001 par value			9,814,382
2019-07-01		3	CALA	Calithera Biosciences, Inc. Common Stock, $0.0001 par value			9,290,624
2019-07-01		3	CALA	Calithera Biosciences, Inc. Common Stock, $0.0001 par value			6,999,010
2019-07-01		3	CALA	Calithera Biosciences, Inc. Common Stock, $0.0001 par value			9,814,382
2019-07-01		3	CALA	Calithera Biosciences, Inc. Common Stock, $0.0001 par value			9,290,624
2019-07-01		3	CALA	Calithera Biosciences, Inc. Common Stock, $0.0001 par value			6,999,010
2019-07-01		3	CALA	Calithera Biosciences, Inc. Common Stock, $0.0001 par value			9,814,382
2019-07-01		3	CALA	Calithera Biosciences, Inc. Common Stock, $0.0001 par value			9,290,624
2019-07-01		3	CALA	Calithera Biosciences, Inc. Common Stock, $0.0001 par value			6,999,010
2019-06-12	2019-06-10	4	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value	S - Sale	-29,450	169,589	-14.80	10.70	-315,230	1,815,264
2019-06-12	2019-06-10	4	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value	S - Sale	-158,583	952,859	-14.27	10.70	-1,697,457	10,199,307
2019-06-12	2019-06-10	4	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value	S - Sale	-198,256	1,178,904	-14.40	10.70	-2,122,112	12,618,871
2019-05-14	2019-05-14	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	13,816	746,454	1.89	14.74	203,664	11,003,628
2019-05-14	2019-05-13	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	3,797	732,638	0.52	14.36	54,526	10,520,975
2019-05-14	2019-05-10	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	10,300	728,841	1.43	14.57	150,037	10,616,808
2019-04-02		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value			4,064,801
2019-04-02		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value			3,799,083
2019-04-02		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value			2,886,680
2019-04-02		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value			4,064,801
2019-04-02		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value			3,799,083
2019-04-02		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value			2,886,680
2019-04-02		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value			4,064,801
2019-04-02		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value			3,799,083
2019-04-02		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value			2,886,680
2019-04-02		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value			4,064,801
2019-04-02		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value			3,799,083
2019-04-02		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value			2,886,680
2019-04-02		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value			4,064,801
2019-04-02		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value			3,799,083
2019-04-02		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value			2,886,680
2019-04-02		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value			4,064,801
2019-04-02		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value			3,799,083
2019-04-02		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value			2,886,680
2019-04-02		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value			4,064,801
2019-04-02		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value			3,799,083
2019-04-02		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value			2,886,680
2019-04-02		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value			4,064,801
2019-04-02		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value			3,799,083
2019-04-02		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value			2,886,680
2019-04-02		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value			4,064,801
2019-04-02		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value			3,799,083
2019-04-02		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value			2,886,680
2019-02-01	2019-01-30	4	PIRS	PIERIS PHARMACEUTICALS, INC. Series B Convertible Preferred Stock, $0.001 par value	J - Other	284	284
2019-02-01	2019-01-30	4	PIRS	PIERIS PHARMACEUTICALS, INC. Series B Convertible Preferred Stock, $0.001 par value	J - Other	2,143	2,143
2019-02-01	2019-01-30	4	PIRS	PIERIS PHARMACEUTICALS, INC. Series B Convertible Preferred Stock, $0.001 par value	J - Other	2,573	2,573
2019-02-01	2019-01-30	4	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value	J - Other	-284,000	141,346	-66.77
2019-02-01	2019-01-30	4	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value	J - Other	-2,143,000	772,324	-73.51
2019-02-01	2019-01-30	4	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value	J - Other	-2,573,000	978,200	-72.45
2018-12-19	2018-12-18	4	XOMA	XOMA Corp Series Y Convertible Preferred Stock	X - Other	372	597	165.47	13,000.00	4,836,000	7,758,569
2018-12-19	2018-12-18	4	XOMA	XOMA Corp Series Y Convertible Preferred Stock	X - Other	311	656	89.96	13,000.00	4,038,398	8,527,467
2018-12-19	2018-12-17	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	25,000	718,541	3.60	14.19	354,792	10,197,318
2018-12-19	2018-12-14	4	XOMA	XOMA Corp Series Y Convertible Preferred Stock	X - Other	225	225		13,000.00	2,922,569	2,922,569
2018-12-19	2018-12-14	4	XOMA	XOMA Corp Subscription Rights	X - Other	-225	0	-100.00
2018-12-19	2018-12-14	4	XOMA	XOMA Corp Series Y Convertible Preferred Stock	X - Other	345	345		13,000.00	4,489,069	4,489,069
2018-12-19	2018-12-14	4	XOMA	XOMA Corp Subscription Rights	X - Other	-345	0	-100.00
2018-12-17	2018-12-13	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	120,539	6,631,136	1.85	1.20	144,587	7,954,048
2018-12-17	2018-12-13	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	54,461	8,485,575	0.65	1.20	65,326	10,178,447
2018-12-13	2018-12-13	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	24,253	693,541	3.62	14.41	349,525	9,995,035
2018-12-13	2018-12-12	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	2,810	669,288	0.42	14.75	41,448	9,871,998
2018-12-13	2018-12-11	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	9,400	666,478	1.43	14.50	136,270	9,661,798
2018-12-10	2018-12-10	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	18,081	657,078	2.83	14.54	262,972	9,556,608
2018-12-10	2018-12-07	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	32,015	638,997	5.27	14.77	472,778	9,436,324
2018-12-10	2018-12-06	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	10,927	606,982	1.83	14.80	161,698	8,982,120
2018-12-04	2018-12-04	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	4,171	596,055	0.70	14.99	62,515	8,933,672
2018-12-04	2018-12-03	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	806	591,884	0.14	14.90	12,009	8,819,072
2018-12-04	2018-11-30	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	4,823	591,078	0.82	14.85	71,615	8,776,681
2018-12-04	2018-12-04	4	IMDZ	IMMUNE DESIGN CORP. Common Stock, $0.001 par value	S - Sale	-89,948	370,391	-19.54	1.83	-164,929	679,149
2018-12-04	2018-12-04	4	IMDZ	IMMUNE DESIGN CORP. Common Stock, $0.001 par value	S - Sale	-382,017	1,942,764	-16.43	1.83	-700,466	3,562,252
2018-12-04	2018-12-04	4	IMDZ	IMMUNE DESIGN CORP. Common Stock, $0.001 par value	S - Sale	-430,035	2,502,758	-14.66	1.83	-788,512	4,589,057
2018-11-30	2018-11-28	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	100,000	6,510,597	1.56	1.30	130,000	8,463,776
2018-11-29	2018-11-29	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	10,016	586,255	1.74	14.93	149,543	8,753,022
2018-11-29	2018-11-28	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	8,288	576,239	1.46	15.11	125,262	8,709,046
2018-11-29	2018-11-27	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	11,396	567,951	2.05	15.24	173,680	8,655,800
2018-11-26		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			10,443,070
2018-11-26		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			9,807,194
2018-11-26		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			7,317,216
2018-11-26		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			10,443,070
2018-11-26		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			9,807,194
2018-11-26		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			7,317,216
2018-11-26		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			10,443,070
2018-11-26		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			9,807,194
2018-11-26		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			7,317,216
2018-11-26		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			10,443,070
2018-11-26		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			9,807,194
2018-11-26		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			7,317,216
2018-11-26		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			10,443,070
2018-11-26		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			9,807,194
2018-11-26		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			7,317,216
2018-11-26		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			10,443,070
2018-11-26		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			9,807,194
2018-11-26		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			7,317,216
2018-11-26		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			10,443,070
2018-11-26		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			9,807,194
2018-11-26		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			7,317,216
2018-11-26		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			10,443,070
2018-11-26		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			9,807,194
2018-11-26		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			7,317,216
2018-11-26		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			10,443,070
2018-11-26		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			9,807,194
2018-11-26		3	PIRS	PIERIS PHARMACEUTICALS, INC. Common Stock, $0.001 par value			7,317,216
2018-11-21	2018-11-21	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	25,000	556,555	4.70	15.00	374,892	8,345,932
2018-11-21	2018-11-20	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	37,482	531,555	7.59	13.68	512,701	7,270,928
2018-11-21	2018-11-19	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	9,771	494,073	2.02	13.93	136,064	6,880,115
2018-11-21	2018-11-21	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	581	1,254,993	0.05	1.35	784	1,694,241
2018-11-21	2018-11-21	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	4,119	8,431,114	0.05	1.35	5,561	11,382,004
2018-11-21	2018-11-19	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	5,573	1,254,412	0.45	1.35	7,524	1,693,456
2018-11-21	2018-11-19	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	38,001	6,410,597	0.60	1.35	51,301	8,654,306
2018-11-21	2018-11-19	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	50,044	8,426,995	0.60	1.35	67,559	11,376,443
2018-11-21	2018-11-19	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	81,648	1,248,839	7.00	1.37	111,841	1,710,660
2018-11-21	2018-11-19	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	556,709	6,372,596	9.57	1.37	762,580	8,729,182
2018-11-21	2018-11-19	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	733,151	8,376,951	9.59	1.37	1,004,270	11,474,747
2018-11-19	2018-11-16	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	10,849	484,302	2.29	13.82	149,986	6,695,427
2018-11-19	2018-11-15	4	XOMA	XOMA Corp Common Stock, $0.0075 par value per share	P - Purchase	21,141	473,453	4.67	13.31	281,361	6,301,091
2018-11-15	2018-11-15	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	39,074	5,815,887	0.68	1.35	52,750	7,851,447
2018-11-15	2018-11-15	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	52,400	7,643,800	0.69	1.35	70,740	10,319,130
2018-11-15	2018-11-14	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	92,960	5,776,813	1.64	1.34	124,566	7,740,929
2018-11-15	2018-11-14	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	117,290	7,591,400	1.57	1.34	157,169	10,172,476
2018-11-15	2018-11-13	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	562,754	5,683,853	10.99	1.35	759,718	7,673,202
2018-11-15	2018-11-13	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	41,454	7,474,110	0.56	1.35	55,963	10,090,048
2018-11-09		3	IMDZ	IMMUNE DESIGN CORP. Common Stock, $0.001 par value			8,650,706
2018-11-09		3	IMDZ	IMMUNE DESIGN CORP. Common Stock, $0.001 par value			8,042,694
2018-11-09		3	IMDZ	IMMUNE DESIGN CORP. Common Stock, $0.001 par value			6,178,252
2018-11-09		3	IMDZ	IMMUNE DESIGN CORP. Common Stock, $0.001 par value			8,650,706
2018-11-09		3	IMDZ	IMMUNE DESIGN CORP. Common Stock, $0.001 par value			8,042,694
2018-11-09		3	IMDZ	IMMUNE DESIGN CORP. Common Stock, $0.001 par value			6,178,252
2018-11-09		3	IMDZ	IMMUNE DESIGN CORP. Common Stock, $0.001 par value			8,650,706
2018-11-09		3	IMDZ	IMMUNE DESIGN CORP. Common Stock, $0.001 par value			8,042,694
2018-11-09		3	IMDZ	IMMUNE DESIGN CORP. Common Stock, $0.001 par value			6,178,252
2018-11-09		3	IMDZ	IMMUNE DESIGN CORP. Common Stock, $0.001 par value			8,650,706
2018-11-09		3	IMDZ	IMMUNE DESIGN CORP. Common Stock, $0.001 par value			8,042,694
2018-11-09		3	IMDZ	IMMUNE DESIGN CORP. Common Stock, $0.001 par value			6,178,252
2018-11-09		3	IMDZ	IMMUNE DESIGN CORP. Common Stock, $0.001 par value			8,650,706
2018-11-09		3	IMDZ	IMMUNE DESIGN CORP. Common Stock, $0.001 par value			8,042,694
2018-11-09		3	IMDZ	IMMUNE DESIGN CORP. Common Stock, $0.001 par value			6,178,252
2018-11-09		3	IMDZ	IMMUNE DESIGN CORP. Common Stock, $0.001 par value			8,650,706
2018-11-09		3	IMDZ	IMMUNE DESIGN CORP. Common Stock, $0.001 par value			8,042,694
2018-11-09		3	IMDZ	IMMUNE DESIGN CORP. Common Stock, $0.001 par value			6,178,252
2018-11-09		3	IMDZ	IMMUNE DESIGN CORP. Common Stock, $0.001 par value			8,650,706
2018-11-09		3	IMDZ	IMMUNE DESIGN CORP. Common Stock, $0.001 par value			8,042,694
2018-11-09		3	IMDZ	IMMUNE DESIGN CORP. Common Stock, $0.001 par value			6,178,252
2018-11-09		3	IMDZ	IMMUNE DESIGN CORP. Common Stock, $0.001 par value			8,650,706
2018-11-09		3	IMDZ	IMMUNE DESIGN CORP. Common Stock, $0.001 par value			8,042,694
2018-11-09		3	IMDZ	IMMUNE DESIGN CORP. Common Stock, $0.001 par value			6,178,252
2018-11-09		3	IMDZ	IMMUNE DESIGN CORP. Common Stock, $0.001 par value			8,650,706
2018-11-09		3	IMDZ	IMMUNE DESIGN CORP. Common Stock, $0.001 par value			8,042,694
2018-11-09		3	IMDZ	IMMUNE DESIGN CORP. Common Stock, $0.001 par value			6,178,252
2018-06-21	2018-06-21	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	36,825	1,167,191	3.26	1.65	60,761	1,925,865
2018-06-21	2018-06-21	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	158,151	5,121,099	3.19	1.65	260,949	8,449,813
2018-06-21	2018-06-21	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	230,555	7,432,656	3.20	1.65	380,416	12,263,882
2018-06-21	2018-06-19	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	179,893	1,130,366	18.93	1.65	296,823	1,865,104
2018-06-21	2018-06-19	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	1,419,907	4,962,948	40.08	1.65	2,342,847	8,188,864
2018-06-21	2018-06-19	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	1,916,760	7,202,101	36.27	1.65	3,162,654	11,883,467
2018-06-20	2018-06-18	4	SNDX	Syndax Pharmaceuticals Inc Warrants	J - Other	188,746	188,746
2018-06-20	2018-06-18	4	SNDX	Syndax Pharmaceuticals Inc Warrants	J - Other	705,863	705,863
2018-06-20	2018-06-18	4	SNDX	Syndax Pharmaceuticals Inc Warrants	J - Other	1,105,391	1,105,391
2018-06-20	2018-06-18	4	SNDX	Syndax Pharmaceuticals Inc Common Stock, $0.0001 par value per share	J - Other	-188,746	85,038	-68.94
2018-06-20	2018-06-18	4	SNDX	Syndax Pharmaceuticals Inc Common Stock, $0.0001 par value per share	J - Other	-705,863	318,021	-68.94
2018-06-20	2018-06-18	4	SNDX	Syndax Pharmaceuticals Inc Common Stock, $0.0001 par value per share	J - Other	-1,105,391	498,025	-68.94
2018-06-01	2018-05-30	4	ARQL	ARQULE INC Common Stock, $0.01 par value per share	S - Sale	-175,813	771,305	-18.56	5.00	-879,083	3,856,602
2018-06-01	2018-05-30	4	ARQL	ARQULE INC Common Stock, $0.01 par value per share	S - Sale	-312,266	3,186,044	-8.93	5.00	-1,561,361	15,930,539
2018-06-01	2018-05-30	4	ARQL	ARQULE INC Common Stock, $0.01 par value per share	S - Sale	-547,860	4,682,669	-10.47	5.00	-2,739,355	23,413,813
2018-04-20	2018-04-18	4	ARQL	ARQULE INC Common Stock, $0.01 par value per share	S - Sale	-217,256	947,118	-18.66	3.10	-673,494	2,936,066
2018-04-20	2018-04-18	4	ARQL	ARQULE INC Common Stock, $0.01 par value per share	S - Sale	-808,449	3,498,310	-18.77	3.10	-2,506,192	10,844,761
2018-04-20	2018-04-18	4	ARQL	ARQULE INC Common Stock, $0.01 par value per share	S - Sale	-1,204,668	5,230,529	-18.72	3.10	-3,734,471	16,214,640
2018-04-11	2018-04-10	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	97,453	950,473	11.42	2.00	194,906	1,900,946
2018-04-11	2018-04-10	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	365,682	3,543,041	11.51	2.00	731,364	7,086,082
2018-04-11	2018-04-10	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	546,865	5,285,341	11.54	2.00	1,093,730	10,570,682
2018-04-11	2018-04-09	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	62,437	853,020	7.90	1.90	118,630	1,620,738
2018-04-11	2018-04-09	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	208,872	3,177,359	7.04	1.90	396,857	6,036,982
2018-04-11	2018-04-09	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	228,691	4,738,476	5.07	1.90	434,513	9,003,104
2018-04-06	2018-04-04	4	ARQL	ARQULE INC Common Stock, $0.01 par value per share	S - Sale	-214,336	1,164,374	-15.55	2.90	-621,574	3,376,685
2018-04-06	2018-04-04	4	ARQL	ARQULE INC Common Stock, $0.01 par value per share	S - Sale	-817,611	4,306,759	-15.96	2.90	-2,371,072	12,489,601
2018-04-06	2018-04-04	4	ARQL	ARQULE INC Common Stock, $0.01 par value per share	S - Sale	-1,269,634	6,435,197	-16.48	2.90	-3,681,939	18,662,071
2018-03-29	2018-03-27	4	XENE	Xenon Pharmaceuticals Inc. Series 1 Preferred Shares	J - Other	238,000	238,000
2018-03-29	2018-03-27	4	XENE	Xenon Pharmaceuticals Inc. Series 1 Preferred Shares	J - Other	861,000	861,000
2018-03-29	2018-03-27	4	XENE	Xenon Pharmaceuticals Inc. Series 1 Preferred Shares	J - Other	1,338,000	1,338,000
2018-03-29	2018-03-27	4	XENE	Xenon Pharmaceuticals Inc. Common Shares, no par value per share	J - Other	-238,000	59,464	-80.01
2018-03-29	2018-03-27	4	XENE	Xenon Pharmaceuticals Inc. Common Shares, no par value per share	J - Other	-861,000	216,694	-79.89
2018-03-29	2018-03-27	4	XENE	Xenon Pharmaceuticals Inc. Common Shares, no par value per share	J - Other	-1,338,000	336,468	-79.91
2018-02-12	2018-02-09	4	CTIC	CTI BIOPHARMA CORP Series O Preferred Stock	A - Award	2,280	2,280
2018-02-12	2018-02-09	4	CTIC	CTI BIOPHARMA CORP Series O Preferred Stock	A - Award	1,024	1,024
2018-02-12	2018-02-09	4	CTIC	CTI BIOPHARMA CORP Series O Preferred Stock	A - Award	3,640	3,640
2018-02-12	2018-02-09	4	CTIC	CTI BIOPHARMA CORP Series O Preferred Stock	A - Award	5,631	5,631
2018-02-12	2018-02-09	4	CTIC	CTI BIOPHARMA CORP Series N Preferred Stock	D - Sale to Issuer	-49	0	-100.00
2018-02-12	2018-02-09	4	CTIC	CTI BIOPHARMA CORP Series N Preferred Stock	D - Sale to Issuer	-48	0	-100.00
2018-02-12	2018-02-09	4	CTIC	CTI BIOPHARMA CORP Series N Preferred Stock	D - Sale to Issuer	-197	0	-100.00
2018-02-12	2018-02-09	4	CTIC	CTI BIOPHARMA CORP Series N Preferred Stock	D - Sale to Issuer	-281	0	-100.00
2018-02-12	2018-02-09	4	CTIC	CTI BIOPHARMA CORP Common Stock, par value $0.001	P - Purchase	699,225	1,295,582	117.25	3.00	2,097,675	3,886,746
2018-02-12	2018-02-09	4	CTIC	CTI BIOPHARMA CORP Common Stock, par value $0.001	P - Purchase	483,708	483,708		3.00	1,451,124	1,451,124
2018-02-12	2018-02-09	4	CTIC	CTI BIOPHARMA CORP Common Stock, par value $0.001	P - Purchase	2,109,280	2,109,280		3.00	6,327,840	6,327,840
2018-02-12	2018-02-09	4	CTIC	CTI BIOPHARMA CORP Common Stock, par value $0.001	P - Purchase	3,041,120	3,041,120		3.00	9,123,360	9,123,360
2018-02-12	2018-02-09	4	CTIC	CTI BIOPHARMA CORP Common Stock, par value $0.001	D - Sale to Issuer	-1,487,294	596,357	-71.38
2018-02-12	2018-02-09	4	CTIC	CTI BIOPHARMA CORP Common Stock, par value $0.001	D - Sale to Issuer	-651,074	0	-100.00
2018-02-12	2018-02-09	4	CTIC	CTI BIOPHARMA CORP Common Stock, par value $0.001	D - Sale to Issuer	-2,295,083	0	-100.00
2018-02-12	2018-02-09	4	CTIC	CTI BIOPHARMA CORP Common Stock, par value $0.001	D - Sale to Issuer	-3,566,549	0	-100.00
2017-12-21	2017-12-19	4	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value	S - Sale	-169,292	122,496	-58.02	26.65	-4,511,632	3,264,518
2017-12-21	2017-12-19	4	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value	S - Sale	-445,615	632,642	-41.33	26.65	-11,875,640	16,859,909
2017-12-21	2017-12-19	4	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value	S - Sale	-667,949	951,300	-41.25	26.65	-17,800,841	25,352,145
2017-12-08		3	SNDX	Syndax Pharmaceuticals Inc Common Stock, $0.0001 par value per share			4,504,500
2017-12-08		3	SNDX	Syndax Pharmaceuticals Inc Common Stock, $0.0001 par value per share			3,924,968
2017-12-08		3	SNDX	Syndax Pharmaceuticals Inc Common Stock, $0.0001 par value per share			3,174,868
2017-12-08		3	SNDX	Syndax Pharmaceuticals Inc Common Stock, $0.0001 par value per share			4,504,500
2017-12-08		3	SNDX	Syndax Pharmaceuticals Inc Common Stock, $0.0001 par value per share			3,924,968
2017-12-08		3	SNDX	Syndax Pharmaceuticals Inc Common Stock, $0.0001 par value per share			3,174,868
2017-12-08		3	SNDX	Syndax Pharmaceuticals Inc Common Stock, $0.0001 par value per share			4,504,500
2017-12-08		3	SNDX	Syndax Pharmaceuticals Inc Common Stock, $0.0001 par value per share			3,924,968
2017-12-08		3	SNDX	Syndax Pharmaceuticals Inc Common Stock, $0.0001 par value per share			3,174,868
2017-12-08		3	SNDX	Syndax Pharmaceuticals Inc Common Stock, $0.0001 par value per share			4,504,500
2017-12-08		3	SNDX	Syndax Pharmaceuticals Inc Common Stock, $0.0001 par value per share			3,924,968
2017-12-08		3	SNDX	Syndax Pharmaceuticals Inc Common Stock, $0.0001 par value per share			3,174,868
2017-12-08		3	SNDX	Syndax Pharmaceuticals Inc Common Stock, $0.0001 par value per share			4,504,500
2017-12-08		3	SNDX	Syndax Pharmaceuticals Inc Common Stock, $0.0001 par value per share			3,924,968
2017-12-08		3	SNDX	Syndax Pharmaceuticals Inc Common Stock, $0.0001 par value per share			3,174,868
2017-12-08		3	SNDX	Syndax Pharmaceuticals Inc Common Stock, $0.0001 par value per share			4,504,500
2017-12-08		3	SNDX	Syndax Pharmaceuticals Inc Common Stock, $0.0001 par value per share			3,924,968
2017-12-08		3	SNDX	Syndax Pharmaceuticals Inc Common Stock, $0.0001 par value per share			3,174,868
2017-12-08		3	SNDX	Syndax Pharmaceuticals Inc Common Stock, $0.0001 par value per share			4,504,500
2017-12-08		3	SNDX	Syndax Pharmaceuticals Inc Common Stock, $0.0001 par value per share			3,924,968
2017-12-08		3	SNDX	Syndax Pharmaceuticals Inc Common Stock, $0.0001 par value per share			3,174,868
2017-12-08		3	SNDX	Syndax Pharmaceuticals Inc Common Stock, $0.0001 par value per share			4,504,500
2017-12-08		3	SNDX	Syndax Pharmaceuticals Inc Common Stock, $0.0001 par value per share			3,924,968
2017-12-08		3	SNDX	Syndax Pharmaceuticals Inc Common Stock, $0.0001 par value per share			3,174,868
2017-11-27		3	RGLS	Regulus Therapeutics Inc. Common Stock, $0.001 par value per share			17,248,837
2017-11-27		3	RGLS	Regulus Therapeutics Inc. Common Stock, $0.001 par value per share			15,027,176
2017-11-27		3	RGLS	Regulus Therapeutics Inc. Common Stock, $0.001 par value per share			12,158,047
2017-11-27		3	RGLS	Regulus Therapeutics Inc. Common Stock, $0.001 par value per share			17,248,837
2017-11-27		3	RGLS	Regulus Therapeutics Inc. Common Stock, $0.001 par value per share			15,027,176
2017-11-27		3	RGLS	Regulus Therapeutics Inc. Common Stock, $0.001 par value per share			12,158,047
2017-11-27		3	RGLS	Regulus Therapeutics Inc. Common Stock, $0.001 par value per share			17,248,837
2017-11-27		3	RGLS	Regulus Therapeutics Inc. Common Stock, $0.001 par value per share			15,027,176
2017-11-27		3	RGLS	Regulus Therapeutics Inc. Common Stock, $0.001 par value per share			12,158,047
2017-11-27		3	RGLS	Regulus Therapeutics Inc. Common Stock, $0.001 par value per share			17,248,837
2017-11-27		3	RGLS	Regulus Therapeutics Inc. Common Stock, $0.001 par value per share			15,027,176
2017-11-27		3	RGLS	Regulus Therapeutics Inc. Common Stock, $0.001 par value per share			12,158,047
2017-11-27		3	RGLS	Regulus Therapeutics Inc. Common Stock, $0.001 par value per share			17,248,837
2017-11-27		3	RGLS	Regulus Therapeutics Inc. Common Stock, $0.001 par value per share			15,027,176
2017-11-27		3	RGLS	Regulus Therapeutics Inc. Common Stock, $0.001 par value per share			12,158,047
2017-11-27		3	RGLS	Regulus Therapeutics Inc. Common Stock, $0.001 par value per share			17,248,837
2017-11-27		3	RGLS	Regulus Therapeutics Inc. Common Stock, $0.001 par value per share			15,027,176
2017-11-27		3	RGLS	Regulus Therapeutics Inc. Common Stock, $0.001 par value per share			12,158,047
2017-11-27		3	RGLS	Regulus Therapeutics Inc. Common Stock, $0.001 par value per share			17,248,837
2017-11-27		3	RGLS	Regulus Therapeutics Inc. Common Stock, $0.001 par value per share			15,027,176
2017-11-27		3	RGLS	Regulus Therapeutics Inc. Common Stock, $0.001 par value per share			12,158,047
2017-11-27		3	RGLS	Regulus Therapeutics Inc. Common Stock, $0.001 par value per share			17,248,837
2017-11-27		3	RGLS	Regulus Therapeutics Inc. Common Stock, $0.001 par value per share			15,027,176
2017-11-27		3	RGLS	Regulus Therapeutics Inc. Common Stock, $0.001 par value per share			12,158,047
2017-10-23	2017-10-19	4	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	34,632	291,788	13.47	15.84	548,484	4,621,192
2017-10-23	2017-10-19	4	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	135,206	1,078,257	14.34	15.84	2,141,325	17,076,895
2017-10-23	2017-10-19	4	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	162,078	1,619,249	11.12	15.84	2,566,910	25,644,856
2017-10-20		3	ARQL	ARQULE INC Common Stock, $0.01 par value per share			21,912,742
2017-10-20		3	ARQL	ARQULE INC Common Stock, $0.01 par value per share			19,332,281
2017-10-20		3	ARQL	ARQULE INC Common Stock, $0.01 par value per share			15,586,621
2017-10-20		3	ARQL	ARQULE INC Common Stock, $0.01 par value per share			21,912,742
2017-10-20		3	ARQL	ARQULE INC Common Stock, $0.01 par value per share			19,332,281
2017-10-20		3	ARQL	ARQULE INC Common Stock, $0.01 par value per share			15,586,621
2017-10-20		3	ARQL	ARQULE INC Common Stock, $0.01 par value per share			21,912,742
2017-10-20		3	ARQL	ARQULE INC Common Stock, $0.01 par value per share			19,332,281
2017-10-20		3	ARQL	ARQULE INC Common Stock, $0.01 par value per share			15,586,621
2017-10-20		3	ARQL	ARQULE INC Common Stock, $0.01 par value per share			21,912,742
2017-10-20		3	ARQL	ARQULE INC Common Stock, $0.01 par value per share			19,332,281
2017-10-20		3	ARQL	ARQULE INC Common Stock, $0.01 par value per share			15,586,621
2017-10-20		3	ARQL	ARQULE INC Common Stock, $0.01 par value per share			21,912,742
2017-10-20		3	ARQL	ARQULE INC Common Stock, $0.01 par value per share			19,332,281
2017-10-20		3	ARQL	ARQULE INC Common Stock, $0.01 par value per share			15,586,621
2017-10-20		3	ARQL	ARQULE INC Common Stock, $0.01 par value per share			21,912,742
2017-10-20		3	ARQL	ARQULE INC Common Stock, $0.01 par value per share			19,332,281
2017-10-20		3	ARQL	ARQULE INC Common Stock, $0.01 par value per share			15,586,621
2017-10-20		3	ARQL	ARQULE INC Common Stock, $0.01 par value per share			21,912,742
2017-10-20		3	ARQL	ARQULE INC Common Stock, $0.01 par value per share			19,332,281
2017-10-20		3	ARQL	ARQULE INC Common Stock, $0.01 par value per share			15,586,621
2017-10-20		3	ARQL	ARQULE INC Common Stock, $0.01 par value per share			21,912,742
2017-10-20		3	ARQL	ARQULE INC Common Stock, $0.01 par value per share			19,332,281
2017-10-20		3	ARQL	ARQULE INC Common Stock, $0.01 par value per share			15,586,621
2017-10-05	2017-10-04	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	63,042	790,583	8.67	1.28	80,946	1,015,109
2017-10-05	2017-10-04	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	235,326	2,968,487	8.61	1.28	302,159	3,811,537
2017-10-05	2017-10-04	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	355,081	4,509,785	8.55	1.28	455,924	5,790,564
2017-10-05	2017-10-03	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	28,918	727,541	4.14	1.24	35,714	898,513
2017-10-05	2017-10-03	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	394,078	2,733,161	16.85	1.24	486,686	3,375,454
2017-10-05	2017-10-03	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	523,601	4,154,704	14.42	1.24	646,647	5,131,059
2017-09-29		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share			4,114,549
2017-09-29		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share			3,600,429
2017-09-29		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share			2,914,534
2017-09-29		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share			4,114,549
2017-09-29		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share			3,600,429
2017-09-29		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share			2,914,534
2017-09-29		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share			4,114,549
2017-09-29		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share			3,600,429
2017-09-29		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share			2,914,534
2017-09-29		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share			4,114,549
2017-09-29		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share			3,600,429
2017-09-29		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share			2,914,534
2017-09-29		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share			4,114,549
2017-09-29		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share			3,600,429
2017-09-29		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share			2,914,534
2017-09-29		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share			4,114,549
2017-09-29		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share			3,600,429
2017-09-29		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share			2,914,534
2017-09-29		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share			4,114,549
2017-09-29		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share			3,600,429
2017-09-29		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share			2,914,534
2017-09-29		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share			4,114,549
2017-09-29		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share			3,600,429
2017-09-29		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share			2,914,534
2017-08-16	2017-08-15	4	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share	P - Purchase	7,429	1,077,694	0.69	2.41	17,920	2,599,613
2017-08-16	2017-08-15	4	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share	P - Purchase	11,429	1,674,468	0.69	2.41	27,569	4,039,152
2017-08-16	2017-08-14	4	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share	P - Purchase	13,337	1,070,265	1.26	2.70	36,058	2,893,568
2017-08-16	2017-08-14	4	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share	P - Purchase	28,007	1,663,039	1.71	2.70	75,720	4,496,192
2017-07-18	2017-07-14	4	CAPS	Capstone Therapeutics Corp. Common Stock, $0.0005 par value	S - Sale	-105,713	890,487	-10.61	0.06	-6,343	53,429
2017-07-18	2017-07-14	4	CAPS	Capstone Therapeutics Corp. Common Stock, $0.0005 par value	S - Sale	-242,236	1,377,652	-14.95	0.06	-14,534	82,659
2017-07-18	2017-07-14	4	CAPS	Capstone Therapeutics Corp. Common Stock, $0.0005 par value	S - Sale	-3,993,637	0	-100.00	0.06	-239,618
2017-06-30	2017-06-27	4/A	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share	P - Purchase	8,496	297,464	2.94	3.04	25,795	903,130
2017-06-30	2017-06-27	4/A	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share	P - Purchase	30,170	1,056,928	2.94	3.04	91,599	3,208,939
2017-06-30	2017-06-27	4/A	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share	P - Purchase	46,795	1,635,032	2.95	3.04	142,074	4,964,121
2017-06-29	2017-06-27	4	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share	P - Purchase	8,496	297,464	2.94	4.00	33,984	1,189,856
2017-06-29	2017-06-27	4	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share	P - Purchase	30,170	1,056,928	2.94	4.00	120,680	4,227,712
2017-06-29	2017-06-27	4	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share	P - Purchase	46,795	1,635,032	2.95	4.00	187,180	6,540,128
2017-06-23	2017-06-22	4	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share	P - Purchase	854	288,968	0.30	4.00	3,416	1,155,872
2017-06-23	2017-06-22	4	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share	P - Purchase	2,884	1,026,758	0.28	4.00	11,536	4,107,032
2017-06-23	2017-06-22	4	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share	P - Purchase	4,525	1,588,237	0.29	4.00	18,100	6,352,948
2017-06-23	2017-06-21	4	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share	P - Purchase	1,362	288,114	0.47	4.00	5,448	1,152,456
2017-06-23	2017-06-21	4	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share	P - Purchase	4,406	1,023,874	0.43	4.00	17,624	4,095,496
2017-06-23	2017-06-21	4	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share	P - Purchase	6,380	1,583,712	0.40	4.00	25,520	6,334,848
2017-06-22	2017-06-20	4	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value	P - Purchase	1,715	201,811	0.86	2.25	3,859	454,075
2017-06-22	2017-06-20	4	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value	P - Purchase	6,359	717,089	0.89	2.25	14,308	1,613,450
2017-06-22	2017-06-20	4	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value	P - Purchase	9,732	1,109,258	0.89	2.25	21,897	2,495,830
2017-06-19	2017-06-19	4	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share	P - Purchase	357	286,752	0.12	3.85	1,374	1,103,995
2017-06-19	2017-06-19	4	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share	P - Purchase	1,271	1,019,468	0.12	3.85	4,893	3,924,952
2017-06-19	2017-06-19	4	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share	P - Purchase	1,967	1,577,332	0.12	3.85	7,573	6,072,728
2017-06-19	2017-06-16	4	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share	P - Purchase	1,064	286,395	0.37	3.85	4,096	1,102,621
2017-06-19	2017-06-16	4	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share	P - Purchase	3,873	1,018,197	0.38	3.85	14,911	3,920,058
2017-06-19	2017-06-16	4	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share	P - Purchase	6,097	1,575,365	0.39	3.85	23,473	6,065,155
2017-06-19	2017-06-15	4	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share	P - Purchase	1,160	285,331	0.41	3.84	4,451	1,094,815
2017-06-19	2017-06-15	4	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share	P - Purchase	3,845	1,014,324	0.38	3.84	14,753	3,891,961
2017-06-19	2017-06-15	4	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share	P - Purchase	6,774	1,569,268	0.43	3.84	25,992	6,021,281
2017-06-14	2017-06-09	4	CTIC	CTI BIOPHARMA CORP Series N3 Preferred Stock, no par value per share	C - Conversion	-536	49	-91.62
2017-06-14	2017-06-09	4	CTIC	CTI BIOPHARMA CORP Series N3 Preferred Stock, no par value per share	C - Conversion	-513	48	-91.44
2017-06-14	2017-06-09	4	CTIC	CTI BIOPHARMA CORP Series N3 Preferred Stock, no par value per share	C - Conversion	-2,115	197	-91.48
2017-06-14	2017-06-09	4	CTIC	CTI BIOPHARMA CORP Series N3 Preferred Stock, no par value per share	C - Conversion	-3,011	281	-91.46
2017-06-14	2017-06-09	4	CTIC	CTI BIOPHARMA CORP Series N3 Preferred Stock, no par value per share	P - Purchase	585	585
2017-06-14	2017-06-09	4	CTIC	CTI BIOPHARMA CORP Series N3 Preferred Stock, no par value per share	P - Purchase	561	561
2017-06-14	2017-06-09	4	CTIC	CTI BIOPHARMA CORP Series N3 Preferred Stock, no par value per share	P - Purchase	2,312	2,312
2017-06-14	2017-06-09	4	CTIC	CTI BIOPHARMA CORP Series N3 Preferred Stock, no par value per share	P - Purchase	3,292	3,292
2017-06-14	2017-06-09	4	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share	C - Conversion	357,333	2,083,651	20.70
2017-06-14	2017-06-09	4	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share	C - Conversion	342,000	651,074	110.65
2017-06-14	2017-06-09	4	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share	C - Conversion	1,410,000	2,295,083	159.31
2017-06-14	2017-06-09	4	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share	C - Conversion	2,007,333	3,566,549	128.74
2017-06-08	2017-06-07	4	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share	P - Purchase	20,594	284,171	7.81	3.85	79,312	1,094,399
2017-06-08	2017-06-07	4	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share	P - Purchase	73,749	1,010,479	7.87	3.85	284,022	3,891,557
2017-06-08	2017-06-07	4	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share	P - Purchase	113,446	1,562,494	7.83	3.85	436,903	6,017,477
2017-06-08	2017-06-06	4	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share	P - Purchase	913	263,577	0.35	3.75	3,424	988,414
2017-06-08	2017-06-06	4	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share	P - Purchase	53,260	936,730	6.03	3.75	199,725	3,512,738
2017-06-08	2017-06-06	4	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share	P - Purchase	96,736	1,449,048	7.15	3.75	362,760	5,433,930
2017-06-07	2017-06-07	4	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value	P - Purchase	3,673	200,096	1.87	2.28	8,379	456,479
2017-06-07	2017-06-07	4	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value	P - Purchase	13,046	710,730	1.87	2.28	29,762	1,621,388
2017-06-07	2017-06-07	4	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value	P - Purchase	20,181	1,099,526	1.87	2.28	46,039	2,508,349
2017-06-07	2017-06-05	4	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value	P - Purchase	3,920	196,423	2.04	2.29	8,979	449,927
2017-06-07	2017-06-05	4	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value	P - Purchase	12,624	697,684	1.84	2.29	28,917	1,598,115
2017-06-07	2017-06-05	4	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value	P - Purchase	19,206	1,079,345	1.81	2.29	43,993	2,472,348
2017-06-01	2017-05-31	4	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value	P - Purchase	2,727	192,503	1.44	2.25	6,128	432,554
2017-06-01	2017-05-31	4	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value	P - Purchase	10,023	685,060	1.48	2.25	22,522	1,539,330
2017-06-01	2017-05-31	4	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value	P - Purchase	15,350	1,060,139	1.47	2.25	34,491	2,382,132
2017-06-01	2017-05-30	4	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value	P - Purchase	1,805	189,776	0.96	2.30	4,144	435,669
2017-06-01	2017-05-30	4	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value	P - Purchase	6,903	675,037	1.03	2.30	15,847	1,549,682
2017-06-01	2017-05-30	4	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value	P - Purchase	10,192	1,044,789	0.99	2.30	23,398	2,398,522
2017-05-19	2017-05-19	4	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value	P - Purchase	1,124	187,971	0.60	2.30	2,585	432,333
2017-05-19	2017-05-19	4	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value	P - Purchase	4,223	668,134	0.64	2.30	9,713	1,536,708
2017-05-19	2017-05-19	4	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value	P - Purchase	6,253	1,034,597	0.61	2.30	14,382	2,379,573
2017-05-19	2017-05-18	4	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value	P - Purchase	2,909	186,847	1.58	2.30	6,690	429,711
2017-05-19	2017-05-18	4	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value	P - Purchase	10,541	663,911	1.61	2.30	24,242	1,526,863
2017-05-19	2017-05-18	4	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value	P - Purchase	16,436	1,028,344	1.62	2.30	37,800	2,364,986
2017-05-19	2017-05-17	4	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value	P - Purchase	5,510	183,938	3.09	2.30	12,666	422,818
2017-05-19	2017-05-17	4	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value	P - Purchase	6,897	653,370	1.07	2.30	15,854	1,501,902
2017-05-19	2017-05-17	4	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value	P - Purchase	24,965	1,011,908	2.53	2.30	57,387	2,326,073
2017-05-11	2017-05-11	4	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value	P - Purchase	675	178,428	0.38	2.34	1,581	418,039
2017-05-11	2017-05-11	4	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value	P - Purchase	2,565	646,473	0.40	2.34	6,010	1,514,622
2017-05-11	2017-05-11	4	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value	P - Purchase	3,794	986,943	0.39	2.34	8,889	2,312,309
2017-05-11	2017-05-10	4	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value	P - Purchase	6,217	177,753	3.62	2.35	14,583	416,955
2017-05-11	2017-05-10	4	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value	P - Purchase	22,092	643,908	3.55	2.35	51,821	1,510,415
2017-05-11	2017-05-10	4	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value	P - Purchase	33,691	983,149	3.55	2.35	79,029	2,306,173
2017-05-11	2017-05-09	4	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value	P - Purchase	3,929	171,536	2.34	2.29	8,989	392,457
2017-05-11	2017-05-09	4	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value	P - Purchase	14,274	621,816	2.35	2.29	32,657	1,422,653
2017-05-11	2017-05-09	4	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value	P - Purchase	21,797	949,458	2.35	2.29	49,869	2,172,265
2017-05-11		3	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value per share			2,630,471
2017-05-11		3	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value per share			2,310,352
2017-05-11		3	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value per share			1,870,417
2017-05-11		3	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value per share			2,630,471
2017-05-11		3	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value per share			2,310,352
2017-05-11		3	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value per share			1,870,417
2017-05-11		3	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value per share			2,630,471
2017-05-11		3	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value per share			2,310,352
2017-05-11		3	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value per share			1,870,417
2017-05-11		3	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value per share			2,630,471
2017-05-11		3	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value per share			2,310,352
2017-05-11		3	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value per share			1,870,417
2017-05-11		3	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value per share			2,630,471
2017-05-11		3	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value per share			2,310,352
2017-05-11		3	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value per share			1,870,417
2017-05-11		3	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value per share			2,630,471
2017-05-11		3	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value per share			2,310,352
2017-05-11		3	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value per share			1,870,417
2017-05-11		3	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value per share			2,630,471
2017-05-11		3	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value per share			2,310,352
2017-05-11		3	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value per share			1,870,417
2017-05-11		3	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value per share			2,630,471
2017-05-11		3	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value per share			2,310,352
2017-05-11		3	NVLS	Nivalis Therapeutics, Inc. Common Stock, $0.001 par value per share			1,870,417
2017-05-11		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value per share			4,665,288
2017-05-11		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value per share			4,098,367
2017-05-11		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value per share			3,319,001
2017-05-11		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value per share			4,665,288
2017-05-11		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value per share			4,098,367
2017-05-11		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value per share			3,319,001
2017-05-11		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value per share			4,665,288
2017-05-11		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value per share			4,098,367
2017-05-11		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value per share			3,319,001
2017-05-11		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value per share			4,665,288
2017-05-11		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value per share			4,098,367
2017-05-11		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value per share			3,319,001
2017-05-11		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value per share			4,665,288
2017-05-11		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value per share			4,098,367
2017-05-11		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value per share			3,319,001
2017-05-11		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value per share			4,665,288
2017-05-11		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value per share			4,098,367
2017-05-11		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value per share			3,319,001
2017-05-11		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value per share			4,665,288
2017-05-11		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value per share			4,098,367
2017-05-11		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value per share			3,319,001
2017-05-11		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value per share			4,665,288
2017-05-11		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value per share			4,098,367
2017-05-11		3	GLYC	GLYCOMIMETICS INC Common Stock, $0.001 par value per share			3,319,001
2017-02-21		3	XOMA	XOMA Corp Common Stock, $0.0075 par value per share			2,197,761
2017-02-21		3	XOMA	XOMA Corp Common Stock, $0.0075 par value per share			1,955,112
2017-02-21		3	XOMA	XOMA Corp Common Stock, $0.0075 par value per share			1,626,449
2017-02-21		3	XOMA	XOMA Corp Common Stock, $0.0075 par value per share			1,734,678
2017-02-21		3	XOMA	XOMA Corp Common Stock, $0.0075 par value per share			2,197,761
2017-02-21		3	XOMA	XOMA Corp Common Stock, $0.0075 par value per share			1,955,112
2017-02-21		3	XOMA	XOMA Corp Common Stock, $0.0075 par value per share			1,626,449
2017-02-21		3	XOMA	XOMA Corp Common Stock, $0.0075 par value per share			1,734,678
2017-02-21		3	XOMA	XOMA Corp Common Stock, $0.0075 par value per share			2,197,761
2017-02-21		3	XOMA	XOMA Corp Common Stock, $0.0075 par value per share			1,955,112
2017-02-21		3	XOMA	XOMA Corp Common Stock, $0.0075 par value per share			1,626,449
2017-02-21		3	XOMA	XOMA Corp Common Stock, $0.0075 par value per share			1,734,678
2017-02-21		3	XOMA	XOMA Corp Common Stock, $0.0075 par value per share			2,197,761
2017-02-21		3	XOMA	XOMA Corp Common Stock, $0.0075 par value per share			1,955,112
2017-02-21		3	XOMA	XOMA Corp Common Stock, $0.0075 par value per share			1,626,449
2017-02-21		3	XOMA	XOMA Corp Common Stock, $0.0075 par value per share			1,734,678
2017-02-21		3	XOMA	XOMA Corp Common Stock, $0.0075 par value per share			2,197,761
2017-02-21		3	XOMA	XOMA Corp Common Stock, $0.0075 par value per share			1,955,112
2017-02-21		3	XOMA	XOMA Corp Common Stock, $0.0075 par value per share			1,626,449
2017-02-21		3	XOMA	XOMA Corp Common Stock, $0.0075 par value per share			1,734,678
2017-02-21		3	XOMA	XOMA Corp Common Stock, $0.0075 par value per share			2,197,761
2017-02-21		3	XOMA	XOMA Corp Common Stock, $0.0075 par value per share			1,955,112
2017-02-21		3	XOMA	XOMA Corp Common Stock, $0.0075 par value per share			1,626,449
2017-02-21		3	XOMA	XOMA Corp Common Stock, $0.0075 par value per share			1,734,678
2017-02-21		3	XOMA	XOMA Corp Common Stock, $0.0075 par value per share			2,197,761
2017-02-21		3	XOMA	XOMA Corp Common Stock, $0.0075 par value per share			1,955,112
2017-02-21		3	XOMA	XOMA Corp Common Stock, $0.0075 par value per share			1,626,449
2017-02-21		3	XOMA	XOMA Corp Common Stock, $0.0075 par value per share			1,734,678
2017-02-21		3	XOMA	XOMA Corp Common Stock, $0.0075 par value per share			2,197,761
2017-02-21		3	XOMA	XOMA Corp Common Stock, $0.0075 par value per share			1,955,112
2017-02-21		3	XOMA	XOMA Corp Common Stock, $0.0075 par value per share			1,626,449
2017-02-21		3	XOMA	XOMA Corp Common Stock, $0.0075 par value per share			1,734,678
2017-01-05	2017-01-03	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	3,234	2,339,083	0.14	1.34	4,333	3,133,669
2017-01-05	2017-01-03	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	1,145	3,631,103	0.03	1.34	1,534	4,864,589
2016-12-30	2016-12-30	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	1,205	2,335,849	0.05	1.34	1,614	3,129,103
2016-12-30	2016-12-30	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	2,348	3,629,958	0.06	1.34	3,145	4,862,692
2016-12-30	2016-12-28	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	77,076	698,623	12.40	1.34	102,943	933,081
2016-12-30	2016-12-28	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	260,046	2,334,644	12.53	1.34	347,317	3,118,151
2016-12-30	2016-12-28	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	401,726	3,627,610	12.45	1.34	536,545	4,845,036
2016-12-20	2016-12-20	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	2,244	621,547	0.36	1.35	3,040	842,134
2016-12-20	2016-12-20	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	8,111	2,074,598	0.39	1.35	10,990	2,810,873
2016-12-20	2016-12-20	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	11,646	3,225,884	0.36	1.35	15,779	4,370,750
2016-12-20	2016-12-19	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	21,021	619,303	3.51	1.36	28,555	841,261
2016-12-20	2016-12-19	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	69,041	2,066,487	3.46	1.36	93,785	2,807,116
2016-12-20	2016-12-19	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	108,202	3,214,238	3.48	1.36	146,982	4,366,221
2016-12-20	2016-12-16	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	47,812	598,282	8.69	1.28	61,199	765,801
2016-12-20	2016-12-16	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	150,451	1,997,446	8.15	1.28	192,577	2,556,731
2016-12-20	2016-12-16	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	236,393	3,106,036	8.24	1.28	302,583	3,975,726
2016-12-02	2016-12-02	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	2,916	550,470	0.53	1.19	3,470	655,114
2016-12-02	2016-12-02	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	18,586	1,846,995	1.02	1.19	22,119	2,198,109
2016-12-02	2016-12-02	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	30,998	2,869,643	1.09	1.19	36,891	3,415,162
2016-12-02	2016-12-01	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	15,161	547,554	2.85	1.18	17,958	648,578
2016-12-02	2016-12-01	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	52,457	1,828,409	2.95	1.18	62,135	2,165,750
2016-12-02	2016-12-01	4	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value	P - Purchase	81,276	2,838,645	2.95	1.18	96,271	3,362,375
2016-12-02		3	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value			7,823,083
2016-12-02		3	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value			6,841,666
2016-12-02		3	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value			5,598,107
2016-12-02		3	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value			7,823,083
2016-12-02		3	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value			6,841,666
2016-12-02		3	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value			5,598,107
2016-12-02		3	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value			7,823,083
2016-12-02		3	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value			6,841,666
2016-12-02		3	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value			5,598,107
2016-12-02		3	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value			7,823,083
2016-12-02		3	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value			6,841,666
2016-12-02		3	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value			5,598,107
2016-12-02		3	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value			7,823,083
2016-12-02		3	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value			6,841,666
2016-12-02		3	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value			5,598,107
2016-12-02		3	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value			7,823,083
2016-12-02		3	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value			6,841,666
2016-12-02		3	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value			5,598,107
2016-12-02		3	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value			7,823,083
2016-12-02		3	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value			6,841,666
2016-12-02		3	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value			5,598,107
2016-12-02		3	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value			7,823,083
2016-12-02		3	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value			6,841,666
2016-12-02		3	INFI	INFINITY PHARMACEUTICALS, INC. Common Stock, $0.001 par value			5,598,107
2016-09-12		3	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share			3,850,758
2016-09-12		3	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share			3,381,916
2016-09-12		3	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share			2,761,110
2016-09-12		3	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share			3,850,758
2016-09-12		3	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share			3,381,916
2016-09-12		3	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share			2,761,110
2016-09-12		3	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share			3,850,758
2016-09-12		3	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share			3,381,916
2016-09-12		3	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share			2,761,110
2016-09-12		3	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share			3,850,758
2016-09-12		3	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share			3,381,916
2016-09-12		3	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share			2,761,110
2016-09-12		3	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share			3,850,758
2016-09-12		3	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share			3,381,916
2016-09-12		3	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share			2,761,110
2016-09-12		3	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share			3,850,758
2016-09-12		3	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share			3,381,916
2016-09-12		3	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share			2,761,110
2016-09-12		3	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share			3,850,758
2016-09-12		3	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share			3,381,916
2016-09-12		3	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share			2,761,110
2016-09-12		3	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share			3,850,758
2016-09-12		3	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share			3,381,916
2016-09-12		3	XENE	Xenon Pharmaceuticals Inc. Common Stock, no par value per share			2,761,110
2016-06-27	2016-06-23	4	ONTY	Cascadian Therapeutics, Inc. Series D Convertible Preferred Stock	A - Award	6,197	6,197		800.00	4,957,600	4,957,600
2016-06-27	2016-06-23	4	ONTY	Cascadian Therapeutics, Inc. Series D Convertible Preferred Stock	A - Award	1,029	1,029		800.00	823,200	823,200
2016-06-27	2016-06-23	4	ONTY	Cascadian Therapeutics, Inc. Series D Convertible Preferred Stock	A - Award	4,519	4,519		800.00	3,615,200	3,615,200
2016-06-27	2016-06-23	4	ONTY	Cascadian Therapeutics, Inc. Series D Convertible Preferred Stock	A - Award	5,505	5,505		800.00	4,404,000	4,404,000
2016-01-11	2016-01-08	4	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share	P - Purchase	58,613	17,263,200	0.34	1.22	71,338	21,011,041
2016-01-11	2016-01-08	4	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share	P - Purchase	32,571	3,090,744	1.07	1.22	39,642	3,761,745
2016-01-11	2016-01-08	4	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share	P - Purchase	90,049	8,850,836	1.03	1.22	109,599	10,772,352
2016-01-11	2016-01-08	4	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share	P - Purchase	186,314	15,592,160	1.21	1.22	226,763	18,977,218
2016-01-11	2016-01-07	4	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share	P - Purchase	8,091	17,204,587	0.05	1.22	9,848	20,939,703
2016-01-11	2016-01-07	4	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share	P - Purchase	29,655	3,058,173	0.98	1.22	36,093	3,722,102
2016-01-11	2016-01-07	4	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share	P - Purchase	87,747	8,760,787	1.01	1.22	106,797	10,662,754
2016-01-11	2016-01-07	4	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share	P - Purchase	508,287	15,405,846	3.41	1.22	618,636	18,750,455
2015-12-22		3	ONTY	Oncothyreon Inc. Common Stock, no par value per share			23,547,788
2015-12-22		3	ONTY	Oncothyreon Inc. Common Stock, no par value per share			21,842,395
2015-12-22		3	ONTY	Oncothyreon Inc. Common Stock, no par value per share			19,541,857
2015-12-22		3	ONTY	Oncothyreon Inc. Common Stock, no par value per share			29,064,800
2015-12-22		3	ONTY	Oncothyreon Inc. Common Stock, no par value per share			23,547,788
2015-12-22		3	ONTY	Oncothyreon Inc. Common Stock, no par value per share			21,842,395
2015-12-22		3	ONTY	Oncothyreon Inc. Common Stock, no par value per share			19,541,857
2015-12-22		3	ONTY	Oncothyreon Inc. Common Stock, no par value per share			29,064,800
2015-12-22		3	ONTY	Oncothyreon Inc. Common Stock, no par value per share			23,547,788
2015-12-22		3	ONTY	Oncothyreon Inc. Common Stock, no par value per share			21,842,395
2015-12-22		3	ONTY	Oncothyreon Inc. Common Stock, no par value per share			19,541,857
2015-12-22		3	ONTY	Oncothyreon Inc. Common Stock, no par value per share			29,064,800
2015-12-22		3	ONTY	Oncothyreon Inc. Common Stock, no par value per share			23,547,788
2015-12-22		3	ONTY	Oncothyreon Inc. Common Stock, no par value per share			21,842,395
2015-12-22		3	ONTY	Oncothyreon Inc. Common Stock, no par value per share			19,541,857
2015-12-22		3	ONTY	Oncothyreon Inc. Common Stock, no par value per share			29,064,800
2015-12-22		3	ONTY	Oncothyreon Inc. Common Stock, no par value per share			23,547,788
2015-12-22		3	ONTY	Oncothyreon Inc. Common Stock, no par value per share			21,842,395
2015-12-22		3	ONTY	Oncothyreon Inc. Common Stock, no par value per share			19,541,857
2015-12-22		3	ONTY	Oncothyreon Inc. Common Stock, no par value per share			29,064,800
2015-12-22		3	ONTY	Oncothyreon Inc. Common Stock, no par value per share			23,547,788
2015-12-22		3	ONTY	Oncothyreon Inc. Common Stock, no par value per share			21,842,395
2015-12-22		3	ONTY	Oncothyreon Inc. Common Stock, no par value per share			19,541,857
2015-12-22		3	ONTY	Oncothyreon Inc. Common Stock, no par value per share			29,064,800
2015-12-22		3	ONTY	Oncothyreon Inc. Common Stock, no par value per share			23,547,788
2015-12-22		3	ONTY	Oncothyreon Inc. Common Stock, no par value per share			21,842,395
2015-12-22		3	ONTY	Oncothyreon Inc. Common Stock, no par value per share			19,541,857
2015-12-22		3	ONTY	Oncothyreon Inc. Common Stock, no par value per share			29,064,800
2015-12-22		3	ONTY	Oncothyreon Inc. Common Stock, no par value per share			23,547,788
2015-12-22		3	ONTY	Oncothyreon Inc. Common Stock, no par value per share			21,842,395
2015-12-22		3	ONTY	Oncothyreon Inc. Common Stock, no par value per share			19,541,857
2015-12-22		3	ONTY	Oncothyreon Inc. Common Stock, no par value per share			29,064,800
2015-12-14		3	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share			58,693,172
2015-12-14		3	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share			52,468,653
2015-12-14		3	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share			46,824,131
2015-12-14		3	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share			60,992,109
2015-12-14		3	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share			58,693,172
2015-12-14		3	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share			52,468,653
2015-12-14		3	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share			46,824,131
2015-12-14		3	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share			60,992,109
2015-12-14		3	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share			58,693,172
2015-12-14		3	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share			52,468,653
2015-12-14		3	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share			46,824,131
2015-12-14		3	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share			60,992,109
2015-12-14		3	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share			58,693,172
2015-12-14		3	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share			52,468,653
2015-12-14		3	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share			46,824,131
2015-12-14		3	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share			60,992,109
2015-12-14		3	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share			58,693,172
2015-12-14		3	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share			52,468,653
2015-12-14		3	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share			46,824,131
2015-12-14		3	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share			60,992,109
2015-12-14		3	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share			58,693,172
2015-12-14		3	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share			52,468,653
2015-12-14		3	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share			46,824,131
2015-12-14		3	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share			60,992,109
2015-12-14		3	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share			58,693,172
2015-12-14		3	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share			52,468,653
2015-12-14		3	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share			46,824,131
2015-12-14		3	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share			60,992,109
2015-12-14		3	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share			58,693,172
2015-12-14		3	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share			52,468,653
2015-12-14		3	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share			46,824,131
2015-12-14		3	CTIC	CTI BIOPHARMA CORP Common Stock, no par value per share			60,992,109
2015-11-05	2015-11-05	4	CCXI	ChemoCentryx, Inc. Common Stock	J - Other	-2,384,577	0	-100.00
2015-11-05	2015-11-04	4	CCXI	ChemoCentryx, Inc. Common Stock	S - Sale	-287,000	2,384,577	-10.74	7.00	-2,009,057	16,692,516
2015-11-05	2015-11-03	4	CCXI	ChemoCentryx, Inc. Common Stock	S - Sale	-73,000	2,671,577	-2.66	6.98	-509,343	18,640,394
2015-11-02	2015-11-02	4	CCXI	ChemoCentryx, Inc. Common Stock	S - Sale	-50,000	2,744,577	-1.79	6.97	-348,515	19,130,525
2015-06-11	2015-06-10	4	CCXI	ChemoCentryx, Inc. Common Stock	S - Sale	-31,000	2,794,577	-1.10	9.01	-279,229	25,171,873
2015-06-11	2015-06-09	4	CCXI	ChemoCentryx, Inc. Common Stock	S - Sale	-924,700	2,825,577	-24.66	9.00	-8,322,392	25,430,476
2015-02-09	2015-02-05	4	ONTY	Oncothyreon Inc. Preferred Stock, $0.0001 per share	J - Other	1,400	1,400
2015-02-09	2015-02-05	4	ONTY	Oncothyreon Inc. Preferred Stock, $0.0001 per share	J - Other	2,600	2,600
2015-02-09	2015-02-05	4	ONTY	Oncothyreon Inc. Common Stock, $0.0001 par value	J - Other	-1,400,000	1,898,293	-42.45
2015-02-09	2015-02-05	4	ONTY	Oncothyreon Inc. Common Stock, $0.0001 par value	J - Other	-2,600,000	3,762,683	-40.86
2014-12-17	2014-12-17	4	ONTY	Oncothyreon Inc. Common Stock, $0.0001 par value	P - Purchase	55,197	3,298,293	1.70	1.73	95,662	5,716,272
2014-12-17	2014-12-17	4	ONTY	Oncothyreon Inc. Common Stock, $0.0001 par value	P - Purchase	98,298	6,362,683	1.57	1.73	170,360	11,027,166
2014-12-17	2014-12-15	4	ONTY	Oncothyreon Inc. Common Stock, $0.0001 par value	P - Purchase	79,434	3,243,096	2.51	1.88	149,249	6,093,453
2014-12-17	2014-12-15	4	ONTY	Oncothyreon Inc. Common Stock, $0.0001 par value	P - Purchase	145,515	6,264,385	2.38	1.88	273,408	11,770,153
2014-12-17		3	ONTY	Oncothyreon Inc. Common Stock, $0.0001 par value			15,401,402
2014-12-17		3	ONTY	Oncothyreon Inc. Common Stock, $0.0001 par value			12,446,194
2014-12-17		3	ONTY	Oncothyreon Inc. Common Stock, $0.0001 par value			15,401,402
2014-12-17		3	ONTY	Oncothyreon Inc. Common Stock, $0.0001 par value			12,446,194
2014-12-17		3	ONTY	Oncothyreon Inc. Common Stock, $0.0001 par value			15,401,402
2014-12-17		3	ONTY	Oncothyreon Inc. Common Stock, $0.0001 par value			12,446,194
2014-12-17		3	ONTY	Oncothyreon Inc. Common Stock, $0.0001 par value			15,401,402
2014-12-17		3	ONTY	Oncothyreon Inc. Common Stock, $0.0001 par value			12,446,194
2014-12-17		3	ONTY	Oncothyreon Inc. Common Stock, $0.0001 par value			15,401,402
2014-12-17		3	ONTY	Oncothyreon Inc. Common Stock, $0.0001 par value			12,446,194
2014-12-17		3	ONTY	Oncothyreon Inc. Common Stock, $0.0001 par value			15,401,402
2014-12-17		3	ONTY	Oncothyreon Inc. Common Stock, $0.0001 par value			12,446,194
2014-07-16	2014-07-16	4	ONTY	Oncothyreon Inc. Warrants	J - Other	-242,814	1,223,484	-16.56	1.59	-386,074	1,945,340
2014-07-16	2014-07-16	4	ONTY	Oncothyreon Inc. Warrants	J - Other	-407,136	2,288,698	-15.10	1.59	-647,346	3,639,030
2014-07-16	2014-07-16	4	ONTY	Oncothyreon Inc. Common Stock, $0.0001 par value	J - Other	-258,230	2,412,290	-9.67	3.24	-836,665	7,815,820
2014-07-16	2014-07-16	4	ONTY	Oncothyreon Inc. Common Stock, $0.0001 par value	J - Other	-296,008	4,512,523	-6.16	3.24	-959,066	14,620,575
2014-07-10	2014-07-01	4	ARRY	ARRAY BIOPHARMA INC Common Stock, $0.001 par value	J - Other	-494,092	7,058,997	-6.54	4.56	-2,253,060	32,189,026
2014-07-03	2014-07-01	4	CAPS	Capstone Therapeutics Corp. Common Stock, $0.0005 par value	J - Other	-616,563	3,993,637	-13.37	0.30	-184,969	1,198,091
2014-07-03		3	ARRY	ARRAY BIOPHARMA INC Common Stock, $0.001 par value			16,369,219
2014-07-03		3	ARRY	ARRAY BIOPHARMA INC Common Stock, $0.001 par value			14,974,663
2014-07-03		3	ARRY	ARRAY BIOPHARMA INC Common Stock, $0.001 par value			20,518,746
2014-07-03		3	ARRY	ARRAY BIOPHARMA INC Common Stock, $0.001 par value			16,369,219
2014-07-03		3	ARRY	ARRAY BIOPHARMA INC Common Stock, $0.001 par value			14,974,663
2014-07-03		3	ARRY	ARRAY BIOPHARMA INC Common Stock, $0.001 par value			20,518,746
2014-07-03		3	ARRY	ARRAY BIOPHARMA INC Common Stock, $0.001 par value			16,369,219
2014-07-03		3	ARRY	ARRAY BIOPHARMA INC Common Stock, $0.001 par value			14,974,663
2014-07-03		3	ARRY	ARRAY BIOPHARMA INC Common Stock, $0.001 par value			20,518,746
2014-07-03		3	ARRY	ARRAY BIOPHARMA INC Common Stock, $0.001 par value			16,369,219
2014-07-03		3	ARRY	ARRAY BIOPHARMA INC Common Stock, $0.001 par value			14,974,663
2014-07-03		3	ARRY	ARRAY BIOPHARMA INC Common Stock, $0.001 par value			20,518,746
2014-07-03		3	ARRY	ARRAY BIOPHARMA INC Common Stock, $0.001 par value			16,369,219
2014-07-03		3	ARRY	ARRAY BIOPHARMA INC Common Stock, $0.001 par value			14,974,663
2014-07-03		3	ARRY	ARRAY BIOPHARMA INC Common Stock, $0.001 par value			20,518,746
2014-07-03		3	ARRY	ARRAY BIOPHARMA INC Common Stock, $0.001 par value			16,369,219
2014-07-03		3	ARRY	ARRAY BIOPHARMA INC Common Stock, $0.001 par value			14,974,663
2014-07-03		3	ARRY	ARRAY BIOPHARMA INC Common Stock, $0.001 par value			20,518,746
2014-07-03		3	ARRY	ARRAY BIOPHARMA INC Common Stock, $0.001 par value			16,369,219
2014-07-03		3	ARRY	ARRAY BIOPHARMA INC Common Stock, $0.001 par value			14,974,663
2014-07-03		3	ARRY	ARRAY BIOPHARMA INC Common Stock, $0.001 par value			20,518,746
2014-03-26	2014-03-25	4	LGND	LIGAND PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale	-10,203	130,175	-7.27	69.95	-713,734	9,106,171
2014-03-26	2014-03-25	4	LGND	LIGAND PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale	-18,019	230,125	-7.26	69.95	-1,260,489	16,098,003
2014-03-26	2014-03-24	4	LGND	LIGAND PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale	-18,306	140,378	-11.54	70.17	-1,284,483	9,849,945
2014-03-26	2014-03-24	4	LGND	LIGAND PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale	-31,698	248,144	-11.33	70.17	-2,224,163	17,411,594
2014-03-25	2014-03-21	4	RGDO	Regado Biosciences Inc Preferred Stock, $0.001 per share	J - Other	2,632	2,632
2014-03-25	2014-03-21	4	RGDO	Regado Biosciences Inc Preferred Stock, $0.001 per share	J - Other	4,577	4,577
2014-03-25	2014-03-21	4	RGDO	Regado Biosciences Inc Common Stock, $0.001 par value	J - Other	-526,436	1,121,221	-31.95
2014-03-25	2014-03-21	4	RGDO	Regado Biosciences Inc Common Stock, $0.001 par value	J - Other	-915,345	1,979,670	-31.62
2014-03-03	2014-02-27	4	PTN	PALATIN TECHNOLOGIES INC Common Stock, par value $.01 per share	S - Sale	-200,827	2,494,521	-7.45	1.09	-218,901	2,719,028
2014-03-03	2014-02-27	4	PTN	PALATIN TECHNOLOGIES INC Common Stock, par value $.01 per share	S - Sale	-33,610	438,127	-7.12	1.09	-36,635	477,558
2014-03-03	2014-02-27	4	PTN	PALATIN TECHNOLOGIES INC Common Stock, par value $.01 per share	S - Sale	-59,388	772,480	-7.14	1.09	-64,733	842,003
2014-02-26	2014-02-26	4	PTN	PALATIN TECHNOLOGIES INC Common Stock, par value $.01 per share	S - Sale	-33,236	2,695,348	-1.22	1.11	-36,869	2,989,950
2014-02-26	2014-02-26	4	PTN	PALATIN TECHNOLOGIES INC Common Stock, par value $.01 per share	S - Sale	-4,416	471,737	-0.93	1.11	-4,899	523,298
2014-02-26	2014-02-26	4	PTN	PALATIN TECHNOLOGIES INC Common Stock, par value $.01 per share	S - Sale	-7,745	831,868	-0.92	1.11	-8,592	922,791
2014-02-26	2014-02-25	4	PTN	PALATIN TECHNOLOGIES INC Common Stock, par value $.01 per share	S - Sale	-151,535	2,728,584	-5.26	1.12	-169,659	3,054,923
2014-02-26	2014-02-25	4	PTN	PALATIN TECHNOLOGIES INC Common Stock, par value $.01 per share	S - Sale	-25,060	476,153	-5.00	1.12	-28,057	533,101
2014-02-26	2014-02-25	4	PTN	PALATIN TECHNOLOGIES INC Common Stock, par value $.01 per share	S - Sale	-44,147	839,613	-5.00	1.12	-49,427	940,031
2014-02-26	2014-02-24	4	PTN	PALATIN TECHNOLOGIES INC Common Stock, par value $.01 per share	S - Sale	-191,804	2,880,119	-6.24	1.16	-222,838	3,346,122
2014-02-26	2014-02-24	4	PTN	PALATIN TECHNOLOGIES INC Common Stock, par value $.01 per share	S - Sale	-29,710	501,213	-5.60	1.16	-34,517	582,309
2014-02-26	2014-02-24	4	PTN	PALATIN TECHNOLOGIES INC Common Stock, par value $.01 per share	S - Sale	-52,528	883,760	-5.61	1.16	-61,027	1,026,752
2014-02-20	2014-02-20	4	LGND	LIGAND PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale	-5,359	79,390	-6.32	73.05	-391,464	5,799,273
2014-02-20	2014-02-20	4	LGND	LIGAND PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale	-112,369	1,685,344	-6.25	73.05	-8,208,319	123,110,840
2014-02-20	2014-02-20	4	LGND	LIGAND PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale	-10,557	158,684	-6.24	73.05	-771,167	11,591,533
2014-02-20	2014-02-20	4	LGND	LIGAND PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale	-18,615	279,842	-6.24	73.05	-1,359,787	20,441,870
2014-02-20	2014-02-19	4	LGND	LIGAND PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale	-2,771	84,749	-3.17	73.03	-202,375	6,189,499
2014-02-20	2014-02-19	4	LGND	LIGAND PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale	-57,370	1,797,713	-3.09	73.03	-4,189,920	131,292,913
2014-02-20	2014-02-19	4	LGND	LIGAND PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale	-5,395	169,241	-3.09	73.03	-394,015	12,360,229
2014-02-20	2014-02-19	4	LGND	LIGAND PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale	-9,464	298,457	-3.07	73.03	-691,187	21,797,300
2014-02-20	2014-02-18	4	LGND	LIGAND PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale	-14,003	87,520	-13.79	74.66	-1,045,409	6,533,902
2014-02-20	2014-02-18	4	LGND	LIGAND PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale	-153,751	1,855,083	-7.65	74.66	-11,478,450	138,493,262
2014-02-20	2014-02-18	4	LGND	LIGAND PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale	-16,331	174,636	-8.55	74.66	-1,219,209	13,037,643
2014-02-20	2014-02-18	4	LGND	LIGAND PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale	-16,915	307,921	-5.21	74.66	-1,262,808	22,988,181
2014-02-19	2014-02-19	4	PTN	PALATIN TECHNOLOGIES INC Common Stock, par value $.01 per share	S - Sale	-19,077	3,071,923	-0.62	1.11	-21,216	3,416,286
2014-02-19	2014-02-19	4	PTN	PALATIN TECHNOLOGIES INC Common Stock, par value $.01 per share	S - Sale	-10,470	530,923	-1.93	1.11	-11,644	590,439
2014-02-19	2014-02-19	4	PTN	PALATIN TECHNOLOGIES INC Common Stock, par value $.01 per share	S - Sale	-14,059	936,288	-1.48	1.11	-15,635	1,041,246
2014-02-19	2014-02-18	4	PTN	PALATIN TECHNOLOGIES INC Common Stock, par value $.01 per share	S - Sale	-110,885	541,393	-17.00	1.18	-130,623	637,761
2014-02-19	2014-02-18	4	PTN	PALATIN TECHNOLOGIES INC Common Stock, par value $.01 per share	S - Sale	-122,443	950,347	-11.41	1.18	-144,238	1,119,509
2014-02-19	2014-02-14	4	PTN	PALATIN TECHNOLOGIES INC Common Stock, par value $.01 per share	S - Sale	-15,622	652,278	-2.34	1.16	-18,139	757,360
2014-02-19	2014-02-14	4	PTN	PALATIN TECHNOLOGIES INC Common Stock, par value $.01 per share	S - Sale	-13,410	1,072,790	-1.23	1.16	-15,570	1,245,616
2014-02-10		3	RGDO	Regado Biosciences Inc Common stock, $0.001 par value			5,080,487
2014-02-10		3	RGDO	Regado Biosciences Inc Common stock, $0.001 par value			4,222,129
2014-02-10		3	RGDO	Regado Biosciences Inc Common stock, $0.001 par value			5,080,487
2014-02-10		3	RGDO	Regado Biosciences Inc Common stock, $0.001 par value			4,222,129
2014-02-10		3	RGDO	Regado Biosciences Inc Common stock, $0.001 par value			5,080,487
2014-02-10		3	RGDO	Regado Biosciences Inc Common stock, $0.001 par value			4,222,129
2014-02-10		3	RGDO	Regado Biosciences Inc Common stock, $0.001 par value			5,080,487
2014-02-10		3	RGDO	Regado Biosciences Inc Common stock, $0.001 par value			4,222,129
2014-02-10		3	RGDO	Regado Biosciences Inc Common stock, $0.001 par value			5,080,487
2014-02-10		3	RGDO	Regado Biosciences Inc Common stock, $0.001 par value			4,222,129
2014-02-10		3	RGDO	Regado Biosciences Inc Common stock, $0.001 par value			5,080,487
2014-02-10		3	RGDO	Regado Biosciences Inc Common stock, $0.001 par value			4,222,129
2013-12-05	2013-12-05	4	CCXI	ChemoCentryx, Inc. Common Stock	P - Purchase	41,451	1,251,914	3.42	5.03	208,358	6,292,871
2013-12-05	2013-12-05	4	CCXI	ChemoCentryx, Inc. Common Stock	P - Purchase	82,849	2,162,381	3.98	5.03	416,449	10,869,424
2013-12-05	2013-12-03	4	CCXI	ChemoCentryx, Inc. Common Stock	P - Purchase	16,175	1,210,463	1.35	4.98	80,590	6,031,011
2013-12-05	2013-12-03	4	CCXI	ChemoCentryx, Inc. Common Stock	P - Purchase	49,325	2,079,532	2.43	4.98	245,757	10,361,060
2013-11-29	2013-11-27	4	LGND	LIGAND PHARMACEUTICALS INC Common Stock	S - Sale	-154,578	2,008,834	-7.15	57.07	-8,822,493	114,653,598
2013-11-29	2013-11-27	4	LGND	LIGAND PHARMACEUTICALS INC Common Stock	S - Sale	-27,058	101,523	-21.04	57.07	-1,544,327	5,794,395
2013-11-29	2013-11-27	4	LGND	LIGAND PHARMACEUTICALS INC Common Stock	S - Sale	-50,934	190,967	-21.06	57.07	-2,907,043	10,899,384
2013-11-29	2013-11-27	4	LGND	LIGAND PHARMACEUTICALS INC Common Stock	S - Sale	-86,435	324,836	-21.02	57.07	-4,933,252	18,539,917
2013-11-29	2013-11-26	4	LGND	LIGAND PHARMACEUTICALS INC Common Stock	S - Sale	-34,917	128,581	-21.36	57.57	-2,010,172	7,402,408
2013-11-29	2013-11-26	4	LGND	LIGAND PHARMACEUTICALS INC Common Stock	S - Sale	-54,444	241,901	-18.37	57.57	-3,134,341	13,926,241
2013-11-29	2013-11-26	4	LGND	LIGAND PHARMACEUTICALS INC Common Stock	S - Sale	-119,139	411,271	-22.46	57.57	-6,858,832	23,676,871
2013-11-20	2013-11-19	4	RIGL	RIGEL PHARMACEUTICALS INC Common Stock	S - Sale	-153,056	646,559	-19.14	2.64	-404,343	1,708,080
2013-11-20	2013-11-19	4	RIGL	RIGEL PHARMACEUTICALS INC Common Stock	S - Sale	-331,566	1,123,848	-22.78	2.64	-875,931	2,968,982
2013-11-06	2013-11-06	4	CCXI	ChemoCentryx, Inc. Common Stock	P - Purchase	8,371	1,194,288	0.71	4.69	39,235	5,597,628
2013-11-06	2013-11-06	4	CCXI	ChemoCentryx, Inc. Common Stock	P - Purchase	11,985	2,030,207	0.59	4.69	56,174	9,515,580
2013-11-06	2013-11-05	4	CCXI	ChemoCentryx, Inc. Common Stock	P - Purchase	74,684	1,185,917	6.72	4.97	370,978	5,890,806
2013-11-06	2013-11-05	4	CCXI	ChemoCentryx, Inc. Common Stock	P - Purchase	35,526	2,018,222	1.79	4.97	176,468	10,025,114
2013-11-06	2013-11-04	4	CCXI	ChemoCentryx, Inc. Common Stock	P - Purchase	5,500	1,111,233	0.50	4.90	26,944	5,443,819
2013-11-05	2013-11-01	4	ONTY	Oncothyreon Inc. Common Stock	P - Purchase	79,360	2,670,520	3.06	1.78	141,261	4,753,526
2013-11-05	2013-11-01	4	ONTY	Oncothyreon Inc. Common Stock	P - Purchase	49,640	4,808,531	1.04	1.78	88,359	8,559,185
2013-11-01	2013-11-01	4	CCXI	ChemoCentryx, Inc. Common Stock	P - Purchase	25,154	1,105,733	2.33	4.92	123,775	5,440,980
2013-11-01	2013-11-01	4	CCXI	ChemoCentryx, Inc. Common Stock	P - Purchase	45,406	1,982,696	2.34	4.92	223,429	9,756,252
2013-11-01	2013-10-31	4	CCXI	ChemoCentryx, Inc. Common Stock	P - Purchase	44,584	1,080,579	4.30	4.97	221,373	5,365,399
2013-11-01	2013-10-31	4	CCXI	ChemoCentryx, Inc. Common Stock	P - Purchase	79,998	1,937,290	4.31	4.97	397,214	9,619,226
2013-11-01	2013-10-30	4	CCXI	ChemoCentryx, Inc. Common Stock	P - Purchase	50,339	1,035,995	5.11	5.04	253,693	5,221,104
2013-11-01	2013-10-30	4	CCXI	ChemoCentryx, Inc. Common Stock	P - Purchase	90,744	1,857,292	5.14	5.04	457,323	9,360,194
2013-10-10	2013-10-09	4	CCXI	ChemoCentryx, Inc. Common Stock	P - Purchase	29,564	985,656	3.09	5.26	155,445	5,182,481
2013-10-10	2013-10-09	4	CCXI	ChemoCentryx, Inc. Common Stock	P - Purchase	53,271	1,766,548	3.11	5.26	280,094	9,288,333
2013-10-10	2013-10-08	4	CCXI	ChemoCentryx, Inc. Common Stock	P - Purchase	401,675	956,092	72.45	5.35	2,148,961	5,115,092
2013-10-10	2013-10-08	4	CCXI	ChemoCentryx, Inc. Common Stock	P - Purchase	30,406	554,417	5.80	5.31	161,310	2,941,293
2013-10-10	2013-10-08	4	CCXI	ChemoCentryx, Inc. Common Stock	P - Purchase	726,626	1,713,277	73.65	5.35	3,887,449	9,166,032
2013-10-10	2013-10-08	4	CCXI	ChemoCentryx, Inc. Common Stock	P - Purchase	47,812	986,651	5.09	5.31	253,652	5,234,381
2013-10-07	2013-10-03	4	CCXI	ChemoCentryx, Inc. Common Stock	P - Purchase	38,599	524,011	7.95	5.49	212,071	2,879,021
2013-10-07	2013-10-03	4	CCXI	ChemoCentryx, Inc. Common Stock	P - Purchase	70,826	938,839	8.16	5.49	389,132	5,158,169
2013-09-25	2013-09-23	4	LGND	LIGAND PHARMACEUTICALS INC Common Stock	S - Sale	-147,806	296,345	-33.28	44.50	-6,577,367	13,187,352
2013-09-25	2013-09-23	4	LGND	LIGAND PHARMACEUTICALS INC Common Stock	S - Sale	-211,217	530,410	-28.48	44.50	-9,399,156	23,603,245
2013-09-13	2013-09-13	4	CCXI	ChemoCentryx, Inc. Common Stock	P - Purchase	3,370	485,412	0.70	6.09	20,520	2,955,722
2013-09-13	2013-09-13	4	CCXI	ChemoCentryx, Inc. Common Stock	P - Purchase	6,307	868,013	0.73	6.09	38,404	5,285,418
2013-09-13	2013-09-11	4	CCXI	ChemoCentryx, Inc. Common Stock	P - Purchase	105,892	482,042	28.15	5.94	629,136	2,863,956
2013-09-13	2013-09-11	4	CCXI	ChemoCentryx, Inc. Common Stock	P - Purchase	210,066	861,706	32.24	5.94	1,248,065	5,119,654
2013-08-12	2013-08-08	4	ONTY	Oncothyreon Inc. Common Stock	P - Purchase	177,940	2,591,160	7.37	1.65	293,512	4,274,118
2013-08-12	2013-08-08	4	ONTY	Oncothyreon Inc. Common Stock	P - Purchase	80,421	4,758,891	1.72	1.65	132,654	7,849,791
2013-08-02	2013-08-01	4	ONTY	Oncothyreon Inc. Common Stock	P - Purchase	35,703	2,413,220	1.50	1.78	63,651	4,302,289
2013-08-02	2013-08-01	4	ONTY	Oncothyreon Inc. Common Stock	P - Purchase	122,641	4,678,470	2.69	1.78	218,644	8,340,776
2013-08-02	2013-07-31	4	ONTY	Oncothyreon Inc. Common Stock	P - Purchase	179,743	4,555,829	4.11	1.71	307,307	7,789,101
2013-06-11	2013-06-07	4	RIGL	RIGEL PHARMACEUTICALS INC Common Stock	P - Purchase	8,102	799,615	1.02	3.47	28,095	2,772,825
2013-06-11	2013-06-07	4	RIGL	RIGEL PHARMACEUTICALS INC Common Stock	P - Purchase	24,598	1,455,414	1.72	3.47	85,298	5,046,939
2013-06-07	2013-06-07	4	ONTY	Oncothyreon Inc. Common Stock	P - Purchase	41,526	2,377,517	1.78	1.83	76,009	4,351,807
2013-06-07	2013-06-07	4	ONTY	Oncothyreon Inc. Common Stock	P - Purchase	74,726	4,376,086	1.74	1.83	136,778	8,009,988
2013-06-07	2013-06-06	4	ONTY	Oncothyreon Inc. Common Stock	P - Purchase	27,384	2,335,991	1.19	1.78	48,768	4,160,166
2013-06-07	2013-06-06	4	ONTY	Oncothyreon Inc. Common Stock	P - Purchase	55,531	4,301,360	1.31	1.78	98,895	7,660,292
2013-06-07	2013-06-05	4	ONTY	Oncothyreon Inc. Common Stock	P - Purchase	5,000	2,308,607	0.22	1.75	8,750	4,040,062
2013-06-07	2013-06-05	4	ONTY	Oncothyreon Inc. Common Stock	P - Purchase	10,300	4,245,829	0.24	1.75	18,025	7,430,201
2013-06-07		3	ONTY	Oncothyreon Inc. Common Stock, $0.0001 par value			4,235,529
2013-06-07		3	ONTY	Oncothyreon Inc. Common Stock, $0.0001 par value			2,303,607
2013-06-07		3	ONTY	Oncothyreon Inc. Common Stock, $0.0001 par value			1,298,842
2013-05-15		3	RIGL	RIGEL PHARMACEUTICALS INC Common Stock, $0.001 par value			1,430,816
2013-05-15		3	RIGL	RIGEL PHARMACEUTICALS INC Common Stock, $0.001 par value			791,513
2013-05-15		3	RIGL	RIGEL PHARMACEUTICALS INC Common Stock, $0.001 par value			6,962,123
2013-05-15		3	RIGL	RIGEL PHARMACEUTICALS INC Common Stock, $0.001 par value			513,545
2013-01-25	2013-01-23	4	LGND	LIGAND PHARMACEUTICALS INC Common Stock	P - Purchase	39,600	2,163,412	1.86	19.78	783,181	42,786,448
2012-12-18	2012-12-14	4	LGND	LIGAND PHARMACEUTICALS INC Common Stock	P - Purchase	5,386	2,123,812	0.25	18.63	100,365	39,575,962
2012-12-10	2012-12-06	4	LGND	LIGAND PHARMACEUTICALS INC Common Stock	P - Purchase	50,100	2,118,426	2.42	17.94	898,959	38,011,553
2012-11-20	2012-11-16	4/A	TRGT	TARGACEPT INC Common Stock	P - Purchase	217,000	1,713,907	14.50	4.00	867,935	6,855,114
2012-11-20	2012-11-16	4/A	TRGT	TARGACEPT INC Common Stock	P - Purchase	378,000	2,977,919	14.54	4.00	1,511,887	11,910,783
2012-11-19	2012-11-16	4	TRGT	TARGACEPT INC Common Stock	P - Purchase	26,800	1,523,707	1.79	5.11	136,902	7,783,552
2012-11-19	2012-11-16	4	TRGT	TARGACEPT INC Common Stock	P - Purchase	46,700	2,646,619	1.80	5.11	238,558	13,519,724
2012-11-19	2012-11-14	4	TRGT	TARGACEPT INC Common Stock	P - Purchase	444,649	1,496,907	42.26	4.00	1,778,596	5,987,628
2012-11-19	2012-11-14	4	TRGT	TARGACEPT INC Common Stock	P - Purchase	772,063	2,599,919	42.24	4.00	3,088,252	10,399,676
2012-11-19		3	ARRY	ARRAY BIOPHARMA INC Common Stock, $0.001 par value			790,501
2012-11-19		3	ARRY	ARRAY BIOPHARMA INC Common Stock, $0.001 par value			456,746
2012-11-19		3	ARRY	ARRAY BIOPHARMA INC Common Stock, $0.001 par value			9,894,589
2012-11-19	2012-11-06	4/A	CCXI	ChemoCentryx, Inc. Common Stock	P - Purchase	40,000	3,750,277	1.08	12.00	479,828	44,987,198
2012-11-19	2012-10-31	4/A	LGND	LIGAND PHARMACEUTICALS INC Common Stock	P - Purchase	4,076	741,627	0.55	14.99	61,096	11,116,395
2012-11-19	2012-10-26	4/A	LGND	LIGAND PHARMACEUTICALS INC Common Stock	P - Purchase	12,515	737,551	1.73	15.26	190,926	11,251,931
2012-11-09	2012-11-08	4	TRGT	TARGACEPT INC Common Stock	P - Purchase	17,400	1,052,258	1.68	4.01	69,718	4,216,187
2012-11-09	2012-11-08	4	TRGT	TARGACEPT INC Common Stock	P - Purchase	31,929	1,827,856	1.78	4.01	127,933	7,323,853
2012-11-09	2012-11-07	4	TRGT	TARGACEPT INC Common Stock	P - Purchase	8,800	1,034,858	0.86	4.08	35,915	4,223,462
2012-11-09	2012-11-07	4	TRGT	TARGACEPT INC Common Stock	P - Purchase	14,300	1,795,927	0.80	4.08	58,361	7,329,537
2012-11-08	2012-11-06	4	CCXI	ChemoCentryx, Inc. Common Stock	P - Purchase	40,000	3,750,277	1.08	12.00	479,828	44,987,198
2012-11-02	2012-10-31	4	LGND	LIGAND PHARMACEUTICALS INC Common Stock	P - Purchase	4,076	741,627	0.55	14.99	61,096	11,116,395
2012-11-02	2012-10-26	4	LGND	LIGAND PHARMACEUTICALS INC Common Stock	P - Purchase	12,515	737,551	1.73	15.26	190,926	11,251,931
2012-11-02	2012-11-02	4	TRGT	TARGACEPT INC Common Stock	P - Purchase	21,500	1,026,058	2.14	4.05	87,150	4,159,126
2012-11-02	2012-11-02	4	TRGT	TARGACEPT INC Common Stock	P - Purchase	36,100	1,781,627	2.07	4.05	146,331	7,221,825
2012-11-02	2012-11-01	4	TRGT	TARGACEPT INC CommonStock	P - Purchase	23,400	1,004,558	2.38	4.05	94,688	4,064,944
2012-11-02	2012-11-01	4	TRGT	TARGACEPT INC Common Stock	P - Purchase	6,700	1,745,527	0.39	4.05	27,112	7,063,275
2012-11-02	2012-10-31	4	TRGT	TARGACEPT INC Common Stock	P - Purchase	5,300	981,158	0.54	4.06	21,495	3,979,283
2012-11-02	2012-10-31	4	TRGT	TARGACEPT INC Common Stock	P - Purchase	46,700	1,738,827	2.76	4.06	189,401	7,052,161
2012-09-10		3	TRGT	TARGACEPT INC Common Stock, $0.001 par value			1,692,127
2012-09-10		3	TRGT	TARGACEPT INC Common Stock, $0.001 par value			975,858
2012-09-10		3	TRGT	TARGACEPT INC Common Stock, $0.001 par value			349,482
2012-08-31		3	CCXI	ChemoCentryx, Inc. Common Stock, $0.001 par value			651,640
2012-08-31		3	CCXI	ChemoCentryx, Inc. Common Stock, $0.001 par value			376,150
2012-08-31		3	CCXI	ChemoCentryx, Inc. Common Stock, $0.001 par value			3,710,277

गैर-डेरिवेटिव या डेरिवेटिव प्रतिभूति की खुला बाज़ार या निजी खरीद

गैर-डेरिवेटिव या डेरिवेटिव प्रतिभूति का खुला बाज़ार या निजी बिक्री

कंपनी से प्रतिभूतियों का अनुदान, पुरस्कार या अन्य अधिग्रहण (जैसे एक ऑप्शन)

डेरिवेटिव का रूपांतरण

कंपनी को प्रतिभूतियों की बिक्री या हस्तांतरण

कंपनी से प्राप्त प्रतिभूतियों के हिस्से का उपयोग करके एक्सरसाइज मूल्य या कर दायित्व का भुगतान

इनसाइडर द्वारा या उसे प्रतिभूतियों का उपहार

इक्विटी स्वैप और समान हेजिंग लेनदेन

कंपनी से प्राप्त डेरिवेटिव प्रतिभूति के एक्सरसाइज या रूपांतरण (जैसे कि एक ऑप्शन)

किसी लेन-देन को स्वेच्छा से फॉर्म 4 पर रिपोर्ट किया गया

अन्य (लेन-देन का वर्णन करने वाले फ़ुटनोट के साथ)